fall mtg 2015 onsite - american academy of facial plastic ... mtg 2015 onsite... · 5 accreditation...

2

Implantech

3

table of contents

Welcome from the Chairs and the President 4

CME Information 5

Invited Speakers 5

Registration and Meeting Information 6

Schedule-at-a-Glance 7

Wednesday Schedule

Essentials in Facial Plastic Surgery Course 8

Microvascular Workshop 8

Thursday Schedule

Morning General Session 9

Afternoon Instruction Courses 9

Afternoon Breakout Sessions 11

Special Live CME Session 12

Friday Schedule


Afternoon Instruction Courses 12\

Young Physicians Non-CME Event 14


Saturday Schedule


Afternoon Instruction Courses 16


Instruction Courses and Paper Presentation Descriptions 19

Poster Abstracts 40

OFPSA Program 50

Speakers and Disclosures 51

Exhibitors 60

Corporate Sponsors 68

Member Recognition 69

Awards and Grant Recipients 69

AAFPRS Leadership 70

1887 Members 71

Howard Legacy Society 72

Capital Campaign Supporters 73

4

WELCOME from the chairsOn behalf of Stephen S. Park, MD,president of the American Academyof Facial Plastic and ReconstructiveSurgery (AAFPRS), we would liketo welcome you to Dallas for theAAFPRS Annual Fall Meeting.We have been honored to developthe scientific program in the newvenue of Dallas, where medicalexpertise and Southern hospitalitymeet. Thanks to an abundance of highlytalented colleagues who will sharetheir expertise and experience, thescientific program is quite rich withpertinent and important clinical topics. A true panoply of facial plasticand reconstructive surgery topics,the scientific program has a balancesurgical and non-surgical topics,esthetics and reconstructive surgery,resurfacing and fillers, practicedevelopment and practice manage-

ment, traditional and emerging technologies, and much,much more. Special sessions include "My Most HumblingMoments," ethical challenges in facial plastic and recon-structive surgery, video vignettes of surgical procedures,cutting edge surgery, "The Great Debate (point-counterpoint)", and "Bringing Battlefield Surgical lessons to thecommunity practitioner," to list only a few. Of note, the scientific sessions are both multi-disciplin-ary and interdisciplinary, including featured guests fromplastic surgery, ophthalmic plastic surgery, and dermatol-ogy/dermatologic surgery. As is special with AAFPRSscientific programs, the faculty is truly international, wherenew techniques and approaches are shared and discussed,with opportunities for both formal and informal interac-tions between faculty and attendee. Please note that we are holding a special CME session“Look Beyond the Obvious--The Future ofAesthetic Medicine,” on Thursday, immediately after theWelcome Reception. Also, the Young Physicians will havea non-CME event on Friday evening with food and bever-age. All are invited to attend these two special events. We hope you share our excitement and are thrilled tobe here. Your clinical knowledge will be enriched through-out the entire meeting schedule. You will enjoy seeing oldfriends and meeting new ones. Our loyal exhibitors areback and we welcome the new ones. Spend time with themand learn about their products and services. The socialinteractions that occur in conjunction with the AAFPRSscientific programs are precious and unforgettable.

Daniel G.Becker, MD

G. Richard Holt,MD

WELCOME from the presidentWelcome to Dallas and, after a fullyear of planning, it is finally here!Putting on a course of this size andcomplexity is the finished product ofhundreds of hours from a handful ofpeople, with a special shout out toDrs. Becker and Holt, Caryl, Rita,Maria, Ann, Ollie, and Steve. Wealso welcome our newest staffmember, Ms. Jackie Gunderson,

who is leading her inaugural event. People are coming from around the globe to attend thismeeting, the flagship product of our Academy. We areespecially proud to welcome our friends from SouthKorea as our honored guest nation. Facial cosmeticsurgery is extremely popular in Korea and they lead theway in many areas such as augmentation rhinoplasty,blepharoplasty, and facial bone contouring. This programhas several opportunities to highlight the nuances of facialplastic surgery as they do it in Korea. It should be eye-opening for most of us. The afternoon instruction courses may seem over-whelming, but I assure you there is now something foreveryone, every hour. Many courses will be followed by ashort abstract presentation that will show the most cuttingedge translational and bench research for the course topic.I hope you enjoy the combination. The keynote speakers are usually the highlight of theentire program for me. Think of how many you canrecollect, even from many years ago. Climbing Mt.Everest, rowing across the Atlantic solo, exploring theBlue Hole off Hawaii, have all been memorable talks. Thisyear is no exception. All four experiences will prove to bedifferent, provoking, even inspiring. They will be deliveredby four world renowned leaders, Wayne Sotile, PhD;Suzan Murray, DVM; Dotti Reeder; and our own WilliamW. Shockley, MD. Don't miss it! Thank you so much for taking the time away fromfamily and work to join us here in Dallas. It is an excitingprogram and a beautiful city.

This year’sguest country isSouth Korea.The AAFPRS wishesto welcome ourspecial guests fromSouth Korea!

5

Accreditation andCredit DesignationThe Educational and Research Foundation for the Ameri-can Academy of Facial Plastic and ReconstructiveSurgery is accredited by the Accreditation Council forContinuing Medical Education (ACCME) to sponsorcontinuing medical education for physicians. TheAAFPRS Foundation designates this live activity for amaximum of 28 AMA PRA Category 1 CreditsTM (plus 4.5for the Microvascular Workshop). Physicians shouldclaim only the credit commensurate with the extent of theirparticipation in the activity.

LEARNING OBJECTIVESAt the conclusion of the general sessions, participants shouldbe able to:1. compare and contrast surgical techniques and ap-proaches across the international spectrum of facial plasticand reconstructive surgery.2. understand and apply ethical decision-making toolswhen addressing ethical dilemmas in patient care andpractice management.3. learn about new techniques and technologies fromrecognized experts that could advance the surgical andnon-surgical care of your patients.4. refine your techniques in facial plastic and reconstruc-tive surgery through the observation of interesting andeducational patient care video presentations.5. develop an improved management plan for your new orexisting practice that enhances both patient care andpractice productivity.6. engage in interactive learning discussions with speakersand other colleagues on clinical issues of concern and/orinterest to our practice.

target audienceThe meeting is offered for continuing medical education ofmedical students, residents, fellows, and practicingphysicians (MDs and DOs) in the field of facial plastic andreconstructive surgery. The program is for physicians withall levels of experience and covers aesthetic, reconstruc-tive, and congenital issues relevant to this specialty.

invited guest speakers

Jack Anderson LectureshipWayne Sotile, PhD, Founder, SotileCenter for Resilience, will addressthe AAFPRS members with hisinsightful talk on “ChoosingResilience: The Key to Thrivingthrough Change” on Thursday,October 1, 2015 at 10:45am.

John Conley LectureshipSuzan Murray, DVM, Chief, WildlifeVeterinary Medical Officer,Smithsonian’s Wildlife HealthProgram, will engage us all with hertalk on “Trans-Species, Trans-boundaries?” on Friday, October 2,2015 at 9:15am.

Women in Facial Plastic SurgeryGuest SpeakerWomen in Facial Plastic Surgery isproud to present their luncheonspeaker, Dotti Reeder. Ms. Reederserves as a managing director on theclient advisory team at TollesonPrivate Wealth Management. Shewill speak on, “Family, Community,and Work: A Juggling Act, But Whohas the Financial Ball?” on Friday,October 2, 2015, at 12:30pm.

Gene Tardy ScholarAAFPRS long-time member anddedicated facial plastic surgeon,William W. Shockley, MD, will bethis year’s Gene Tardy Scholar lecturer. Do not missthe lecture entitled, “The Doctor-Patient Relationship:Can It Survive the Assault?" on Saturday, October 3,2015 at 10:00am.

evaluation and cme creditsThe AAFPRS Foundation’sLEARN (Lifelong Educationaland Research Network) allowsyou to capture meetingevaluation responses and awardCME credits on line at www.aafprs-learn.org.

Please note that in order to access your personal LEARNaccount, you will need to know your AAFPRS log on IDand password. If you do not know your currentAAFPRS ID and password, please see Karen Sloat at theregistration area and she will provide you with thenecessary information to complete your evaluation andclaim your CME credits. Knowing this information aheadof time will avoid delay in obtaining your credits on-site.

6

AAFPRS Membership Booth andVideo Learning CenterMake sure you come by the AAFPRS booth 415 toperuse our publications and learn more about ourprograms. Here, you will also find the Video LearningCenter featuring the John Dickinson Library with over 300videos. You have the opportunity to watch videos beforeyour purchase. On-site discount on all publications andvideos is 10 percent. Non-members are encouraged tocome by during breaks and learn more about the AAFPRS(a gift will be waiting for you).

Credentials TableIf you are an AAFPRS member and are eligible to voteand have not voted online or by mail earlier this summer,you can stop by the Credentials Table (outside the DallasBallroom B/C) to pick up your ballots on Saturday,October 3, 2015 at 8:30am. The Business Meeting andElections will begin promptly at 8:45am.

ExhibitionThe exhibition will be at the Sheraton Hotel, Grand Hall,and will have our loyal exhibitors and a handful of newcompanies featuring their latest products and services. Thehall will be open Thursday, Friday, and Saturday, from9:30am to 4:00pm. All breaks and lunches, as well as theWelcome Reception, will be held in the Exhibit Hall tomaximize your time with our exhibitors. Only registeredphysicians and registered spouses and guests will beadmitted into the exhibition.

RegistrationThe Registration Desk, located in the foyer of the GrandHall will be open daily. The hours are as follows: Wednesday, September 30, 2015 3:00pm-6:00pm Thursday, October 1, 2015 6:30am-6:00pm Friday, October 2, 2015 7:00am-6:00pm Saturday, October 3, 2015 7:00am-5:00pm

Hotel InformationSheraton Dallas Hotel400 North Olive Street, Dallas, TX 75201Phone: (214) 922-800; Fax: (214) 969-76550

The AAFPRS Foundation wishesto thank CareCredit for theirnon-educational grant in support ofour meeting lanyards.

speaker ready roomAll faculty/speakers making a presentation, should visit theSpeaker Ready Room (Pearl 3) to make sure theirpresentations are uploaded and scheduled. The hours areas follows: Wednesday, September 30, 2015 2:00pm-6:00pm Thursday, October 1, 2015 6:30am-6:00pm Friday, October 2, 2015 7:30am-5:30pm Saturday, October 3, 2015 7:00am-4:00pm

welcome receptionAll registered attendees are invited to the WelcomeReception on Thursday, October 1, 2015 from 5:45pm to7:00pm in the Exhibit Hall (Grand Hall). Guests andspouses who are not registered for the meeting maypurchase a ticket to attend the Welcome Reception.

7

schedule-at-a-glanceMost sessions will be held at the Sheraton Dallas Hotel unless otherwise noted as off-site.

The rooms are noted in parentheses.

WEDNESDAY, SEPTEMBER 30, 20157:30am-3:00pm

Committee Meetings (Majestic 1-6)8:00am-2:00pm

Essentials in Facial Plastic Surgery (Austin 1)1:00pm-6:00pm

Microvascular Workshop (Austin 2)3:00pm-10:00pm

Board Meetings (Majestic 1)

THURSDAY, OCTOBER 1, 20157:30am-12:30pm

General Session/Panels (Dallas Ballroom B/C)Jack R. Anderson Video PresentationABFPRS AwardsJack R. Anderson Lectureship

8:00am-4:30pmOFPSA Program (San Antonio A)

12:30pm-1:30pmLunch in the Exhibit Hall (Grand Hall)Fellowship Directors Lunch (The Kitchen Garden)

1:30pm-5:40pmInstruction Courses 1-24 (Dallas Rooms)Breakout Sessions (Dallas and Austin Rooms)

5:45pm-7:00pmWelcome Reception in the Exhibit Hall (Grand Hall)

7:00pm-9:00pmLIVE CME Session: Look Beyond the Obvious--TheFuture of Aesthetic Medicine (Dallas A3)

7:00pm-11:00pmPast Presidents Dinner (off-site)

FRIDAY, OCTOBER 2, 20157:30am-12:30pm

General Session/Panels (Dallas Ballroom B/C)Outgoing President’s AddressJohn Conley Lectureship


12:30pm-1:30pmLunch in the Exhibit Hall (Grand Hall)Women in Facial Plastic Surgery Luncheon (Majestic 4/5)

1:30pm-5:40pmInstruction Courses 25-52 (Dallas and Austin Rooms)Breakout Sessions (Dallas, Austin, San Antonio)

5:45pm-9:00pmYoung Physicians Event (Dallas A3)

7:00pm-11:00pmFounders Club Dinner (off-site)

SATURDAY, OCTOBER 3, 20157:30am-12:30pm

General Session/Panels (Dallas Ballroom B/C)AAFPRS Research Grants and AwardsBusiness Meeting and ElectionsIncoming President’s AddressGene Tardy Scholar


12:30pm-1:30pmLunch in the Exhibit Hall (Grand Hall)1887 Members Luncheon (Room)

1:30pm-5:40pmInstruction Courses 53-76 (Dallas Rooms)Breakout Sessions (Dallas and Austin Rooms)

5:40pmMeeting Adjourned

8

Wednesday, September 30, 2015

ESSENTIALS IN FACIAL PLASTIC SURGERY(Austin 1) Workshop for Residents (no fee for residents)Director: Stephen S. Park, MD

8:00am-8:10am Breakfast/Introduction and WelcomeStephen S. Park, MD

8:10am-8:55am Cutaneous Lesions and FlapsStephen S. Park, MD

8:55am-9:40am Head and Neck Reconstruction/FacialParalysisTerry A. Day, MD

9:40am-10:25am Syndromes and Congenital ProblemsJonathan M. Sykes, MD

10:25am-10:35am Break

10:35am-11:20am Browlift, Blepharoplasty, and Office-based ProceduresTom D. Wang, MD

11:20am-12:05pm Facelift/Liposuction/CutaneousResurfacingEdward H. Farrior, MD

12:05pm-12:30pmLunch

12:30pm-1:15pm RhinoplastyDean M. Toriumi, MD

1:15pm-2:00pm Maxillofacial and Soft Tissue TraumaJohn L. Frodel, Jr., MD

MICROVASCULAR WORKSHOP(Austin 2)Director: Mark Wax, MD

1:00pm-1:10pm IntroductionMark K. Wax, MD

1:10pm-1:20pm Tips from Around the WorldBrett Miles, MD

1:20pm-2:00pm Panel: 3-D Modeling & Patient SpecificPlatesModerator: Mathew Old, MD

O Technical Considerations, Mike Reilly, MDO Mandibular Reconstruction, Mark K. Wax, MDO Maxillary Reconstruction, Daniel Petrisor, MDO Cost and Efficiency, Urjeet Patel, MD

2:00pm-2:40pm Panel "Disasters and Big Problems"Moderator: Mark K. Wax, MDPanelists: Matt Hanasono, MD; NealFutran, MD; Josh Hornigm ND; andRobert Lindau, MD

2:40pm-3:20pm Panel: Facial Reanimation: The GracilisModerator: Sherard Tatum, MD

O QOL and Outcomes of Reconstruction, Tessa A.Hadlock, MDO Technical Advances, Babak Azizzadeh, MDO What Nerve and When, Patrick J. Byrne, MDO Secondary Reconstruction, Amy Pittman, MD

3:20pm-3:50pm Break

3:50pm-4:20pm Panel: Training & Transitions into PracticeModerator: Stephen Kang, MD

O Integrating Residents, Andrew Coughlin, MDO Integrating Fellows, Chad Zender, MDO Transition to Practice, Freedom Johnson, MD

4:20pm-4:40pm The Great Debate: Scapula vs FibulaModerator: Rod Rezaee

O The Fibula Rocks, Tamer Ghanem, MDO The Scapula Rocks, Eric Genden, MD

4:40pm-5:10pm Panel: OutcomesO Survivorship: Flaps in the Cured Population, SteveCannady, MDO Functional Outcomes After Total Glossectomy/laryngectomy, Waleed Ezzat, MDO Methods to Measure Outcomes, Alexander Langerman,MD

5:10pm-5:40pm Panel: Orbital ReconstructionModerator: Judith Skoner, MD

O Soft tissue Reconstruction, Doug Chepeha, MDO Boney Reconstruction, Mike Fritz, MDO How to Facilitate the Use of Prosthetics, RyanHeffelfinger, MD

The AAFPRS Foundation wishes to thank DePuySynthes for their educational grant in support of theEssentials Course.

9

Thursday, October 1, 2015

morning general session(Dallas Ballroom B/C)7:30am-7:40am Tribute to the JAMA Facial Plastic

Surgery Founding Editor Wayne F.Larrabee, Jr, MDStephen S. Park, MD & John S. Rhee, MD

7:40am-9:40am Cutting Edge of RhinoplastyModerator: Dean M. Toriumi, MDPanelists: Hong-Ryul Jin, MD; Yong JuJang, MD; Pietro Palma, MD; andRichard E. Davis, MD

The absolute latest and greatest pearls and techniques

9:40am-10:00am Jack R. Anderson VideoRobert L. Simons, MD and Chuck Cox

This video will highlight the preeminent role of this pioneerin the Academy’s history with materials recently received atthe Robert L. Simons Archives and Heritage Center.

10:00am-10:30am Break in the Exhibit Hall (Grand Hall)

10:30am-10:45am ABFPRS Awards Presentation

10:45am-11:30am Jack R. Anderson Lectureship“Choosing Resilience: The Key to Thrivingthrough Change”Wayne Sotile, PhD, Founder, SotileCenter for Resilience

Physician burnout rates across specialties have never beenhigher. And the personal and organizational consequences ofcompromised physician wellness have been well-documented.Why do some physicians falter in the face of change whileothers thrive? Wayne Sotile has devoted his career to answerthis question. Participants gain insights from self-assess-ments and description of evidence-based tactics thatdifferentiate physicians who thrive through change fromthose who flounder in disillusionment and burnout.

11:30am-12:30pm The Ethical Facial Plastic SurgeonModerator: G. Richard Holt, MDPanelists: J. Regan Thomas, MD; PeterA. Adamson, MD; Donn R. Chatham, MD

Facial plastic surgeons are confronted with challenges along thespectrum of ethics, from minimal to serious impact with aconcomitant range of potential consequences for both thepatient and the surgeon. The ethics of the medical professionrequire keen attention by the facial plastic surgeon to conductherself/himself in a manner reflective of the highest level ofprofessionalism in all aspects of patient care and practicemanagement. Internalized duties and professional responsibili-ties of a physician and external requirements of medical ethicsinform and shape the decision-making in responding to ethicalchallenges in the practice of facial plastic surgery.

12:30pm-1:30pm Lunch in the Exhibit Hall (Grand Hall)

THURSDAY afternoon instruction courses(Dallas Ballrooms)

1:30pm-2:20pm (course descriptions on pages 19-20)IC1 Getting the Best Out of Medical Groups: Deepening(A1) Surgeon and Team Engagement and Resilience

Wayne M. Sotile, PhDIC2 Crooked Nose Correction: Basic To Extreme(A2) Transforming Techniques

Hong Ryul Jin, MD and Tae-Bin Won, MDIC3 Blepharoplasty with Eyelid Ptosis Correction(A3) William E. Silver, MDIC4 The History and Technical Evolution of Facelift(D1) Surgery

Ira D. Papel, MD and Nabil Fuleihan, MDIC5 What Really Works for NonSurgical Skin Tightening/(D2) Lifting and The Skinny on Fat Melting and Freezing

Sabina Fabi, MDIC6 Primary Rhinoplasty: Analytical Comparison of(D3) Results and Revision Rates

Stephen W. Perkins, MD and Scott Shadfar, MDPaper Presentation: Dissection of the ParamedianForehead Flap Pedicle Flap Using Perforator ConceptsP. Daniel Ward, MD

2:30pm-3:20pm (course descriptions on pages 20-22)IC7 Contemporary Management of Upper Facial Trauma(A1) J. David Kriet, MD; Clinton Humphrey, MD and

E. Bradley Strong, MDIC8 Managing Lateral Crural Convexity and the(A2) Compound Tip Deformity: New Approaches to a

Decades Old ProblemBrian Wong, MD and Richard E. Davis, MDPaper Presentation: Technical Evaluation of UnevenSuture LobuloplastiesHeloisa Koerner, MD

IC9 Facial Scar Revision Techniques(A3) J. Regan Thomas, MD

Paper Presentation: Does Primary W-Plasty ImproveThe Scar Appearance of the Paramedian ForeheadFlap Donor Site?Emmanuel Jauregui, MD

IC10 Functional Rhinoplasty and Valve Surgery: A Bi-(D1) Continental Perspective

Minas Constantinides, MD and Dirk Jan Menger, MDPaper Presentation: The Internal Nasal Valve DilatorGraft, a Simple Effective Adjunct to SeptoplastyMatthew Keller, MD

Continued ...

The AAFPRS wishes to thank NKP Medical Marketingfor their educational grant in support of the Jack AndersonLectureship.

10

THURSDAY afternoon instruction courses(Dallas Ballrooms)

IC11 1) Surgical Consideration in Middle Eastern Revision(D2) Rhinoplasty

Sameer Bafaqeeh, MD2) Endonasal Modified Oblique Dome DivisionBashar Bizrah, MD

IC12 1) Short Nose Elongation(D3) Tse Ming Chang, MD

2) Tailor Made Rhinoplasty: From Filler to OperationYu-Hsun Chiu, MD3) How to Bring the Retracted Ala Downward:(Correction of Alar Retraction)Ji Yun Choi, MD

3:20pm-3:50pm Break in the Exhibit Hall (Grand Hall)

3:50pm-4:40pm (course descriptions on pages 22-25)IC13 Frontiers in Orbital Reconstruction(A1) Kris Moe, MDIC14 JAMA Facial Plastic Surgery: Top Articles, Social(A2) Media and New Faces!

John S. Rhee, MD; Dean M. Toriumi, MD; BrianWong, MD; Peter A. Hilger, MD; andSam P. Most, MD

IC15 Design Strategies for Reconstruction of Nasal Defects(A3) Krishna Patel, MD and William W. Shockley, MD

Paper Presentation: Guidelines for Early Division ofthe Forehead Flap Pedicle: Use of Laser-AssistedIndocyanine Green Angiography to Predict Adequacyof NeovascularizationJoshua Surowitz, MD

IC16 Blepharoplasty Video with Discussion, Part 1(D1) Guy Massry, MDIC17 Practical Approaches to Incorporating Research and(D2) Evidence Based Medicine Into a Busy Facial Plastic

Surgery Practice, Part 1Lisa Ishii, MD; Travis Tollefson, MD; Sam P. Most,MD; John S. Rhee, MD; Benjamin C. Marcus, MD;Mike Brenner, MD

IC18 1) What Truly Works in Lower Facelift Rejuvenation(D3) Stephen W. Perkins, MD

2) The Excellent NecklineRobert Brobst, MDPaper Presentation: Efficacy of ATX-101(Deoxycholic Acid) for Reducing Submental FullnessAssociated with Submental Fat in DemographicSubgroups of Subjects from the US/Canadian Phase 3Trials (REFINE-1 and REFINE-2)Corey S. Maas, MD

4:50pm-5:40pm (course descriptions on pages 25-26)IC19 Surgical Techniques for Treating the Aesthetic Male(A1) Patient

Michael Reilly, MD; Babak Azizzadeh, MD andPatrick J. Byrne, MD

IC20 Stem Cell Therapy for Motor Nerve Regeneration -(A2) Overview with Presentation of Preliminary Results

J. Pepper, MDIC21 Facial Reanimation(A3) Tessa A. Hadlock, MD

Paper Presentation: Patient Reported OutcomeMeasures and Quality-of-Life in Dynamic SmileReanimation using Gracilis Free Muscle TransferRyan Smith, MD

IC22 Blepharoplasty Video, Part 2(D1) Guy Massry, MDIC23 Practical Approaches to Incorporating Research and(D2) Evidence Based Medicine into a Busy Facial Plastic

Surgery Practice, Part 2Lisa Ishii, MD; Travis Tollefson, MD; Sam P Most,MD; John S. Rhee, MD; Benjamin C. Marcus, MD;and Mike Brenner, MD

IC24 Rhinoplasty - My Personal Approach(D3) Alexander Berghaus, MD

fellowship directors lunchAll AAFPRS Fellowship Directors are invited to attend aluncheon at The Kitchen Garden on Thursday, October 1,2015 from 12:30pm to 1:30pm.

welcome receptionPlease join your colleagues and visit our loyal exhibitorsduring our happy hour in the Exhibit Hall (Grand Hall) from5:45pm to 7:00pm on Thursday, October 1, 2015. Unregis-tered guests may purchase a $75 ticket to attend.

LIVE CME SessionImmediately after the Welcome Reception is the Live CMEWorkshop from 7:00pm to 9:00pm (Dallas A3). All areinvited to attend. See details on page 12.

The AAFPRS wishes to thank Thermi for theirnon-educational grant in support of the Thursdayafternoon break.

past presidents dinnerAll AAFPRS past presidents are invited to attend the annualblack tie dinner on Thursday, October 1, 2015.This is byinvitation only. Buses will leave promptly at 6:45pm.

11

THURSDAY afternoon Breakout Sessions

Making or Breaking Your Practice:Communications in the Digital Age1:30pm-5:30pm(Austin 3)Moderator: Corey S. Maas, MDFaculty: David Phillips , NKP Medical; Ryan Lehri andJustin Tuschman, Red Spot Interactive; Karson Smith,TouchMD; Jon Hoffenberg, SEOversight; Joyce Sunila,Practice Helpers; Angela O'Mara and Giles Raine , TheProfessional Image; and Michael Byrd, ByrdAtto

This session will have eight topics/speakers and will focuson current trends. Topics include: Patient CommunicationPractice Growth, Reputation Management, How toDifferentiate from the Competition, The Life or Death ofSEO, Patient Loyalty Marketing - More Important thanEver in the Digital Age, Pay-Per-Click Ad Words DoneRight, Review of Digital Marketing -How to Market to theNew Digital Generation and legal landmines and strategies. A diverse panel will focus on their specific areas ofexpertise with pointed questions about the collision ofprivacy and marketing, defense of reputation and thedifficulty in dealing with "review companies" (in thebusiness of generating reviews for which they claimcopyright but can do "nothing about with factual disputes"or voracity of claims); and how much does your websiteand social media mean in practice building? Are onlineconsultations violations of State practice of medicine laws?And how fare can one go in using patients to help marketpractices? This provocative workshop will provide a roadmap for both beginners and those who feel comfortable inthe digital world. The digital age is a tidal wave is here. The modernpractitioner must learn to ride the wave or harness itspower or risk being drowned.

Paper Presentation: Yelp! How We Get 1 and 5 StarReviews (see description on page 19)Nima Shemirani, MD and Jeffrey Castrillion, BS

Restoring Youth Without a Scalpel1:00-5:30pm(Austin 2)Moderator: Steven H. Dayan, MDO 1:00pm-1:15pm Safe and Effective Treatment Combina-tions for Natural Looking Results, Sabrina Fabi, MDO 1:15pm-1:30pm The Non-Surgical Practice is a LitmusTest for Your Practice, Benjamin Bassichis, MDO 1:30pm-1:45pm Selphyl, A Forgotten Filler...Does it havea Role in a Facial Plastics Practice? Matthew White, MDO 1:45pm-2:00pm Next Generation Lips, Raj Chopra, MDO 2:00pm-2:15pm Lisa's Top 10, Lisa Grunebaum, MD

O 2:15pm-2:30pm My Poly-L Lactic Acid Algorithm,Jason Bloom, MDO 2:30pm-2:45pm Are Surgical Midface Lifts a Thing ofthe Past? Rami Batniji, MDO 2:45pm-3:00pm Ultrasound for Tissue Tightening: HowDoes it Fit into a Facial Plastic Surgery Practice, RyanGreene, MDO 3:00pm-3:15pm Bellafill: Are You Aware of the 5-YearData? John Joseph, MDO 3:15pm-3:30pm Optimizing Filler Enhancement:Combining Multiple Products on a Single Patient, JillHessler, MDO 3:30pm-3:45pm Five Cases that Changed My Non-Surgical Practice, Jess Prischmann, MDO 3:45pm-4:00pm Thermi RF-Tight: Does InjectableRadio-Requency Work? Jacob Steiger, MDO 4:00pm-4:15pm PRP in a Facial Plastic Surgery Practice- Fact versus Fiction, Kian Karimi, MDO 4:15pm-4:30pm Fractionated Lasers and TopicalTherapy: Could it be a Potentially RevolutionizingTreatment Modality? Jill Waibel, MDO 4:30pm-4:45pm Dermal and Subdermal RemodelingUtlizing Miro-invasive Energy-Based Devices, Richard D.Gentile, MDO 4:45pm-5:00pm TBD, Jody Comstock, MDO 5:00pm-5:08pm Substantial Improvements in Subject-Assessed Satisfaction with Appearance and PhyschologicalImpact from Combined Facial Aesthetic Treatment withOnabotulinumtoxinA, Dermal Fillers and Bimatoprost:Primary Results from the "Harmony Study", JohnathanSykes, MDO 5:08pm-5:30pm Q &A

Sculpting for the Facial Plastic Surgeon1:00pm-6:00pm(Austin 1) (optional; additional fee applies)Gary Sussman and Steven Neal, MDFirst time offered! This course is designed to train thepart of the brain that is necessary in directing cosmetic andcorrective facial surgery--the training which is usuallylacking in conferences. Since most error in facial plasticsurgery is in judgement rather than technique, this courseconcentrates on helping the brain recognize and correctfacial abnormalities using the medium of clay with one-on-one interaction with two facial sculptors. New Yorkprofessor Gary Sussman and Academy member StevenNeal, MD, have a combined sculpting experience of 70years and will help you further perfect your own sculpturein the OR. Workshop is limited to 50 and sculpting toolsand clay are provided.

12

The AAFPRS Foundation wishes to thank Thermi fortheir non-educational grant in support of the Fridaymorning break.

Friday, October 2, 2015

morning general session(Dallas Ballroom B/C)7:30am-9:00am PANEL: My Facelift Technique:

Exactly How I Do ItModerator: Jonathan M. Sykes, MDPanelists: Ira D. Papel, MD; JamesGrotting, MD; Keith A. LaFerriere, MD;Stephen W. Perkins, MD; and Norman J.Pastorek, MD

9:00am-9:15am Outgoing President’s AddressStephen S. Park, MD

9:15am-10:00am John Conley Lectureship“Trans-Species, Trans-boundaries?”Suzan Murray, DVM, Chief, WildlifeVeterinary Medical Officer,Smithsonian’s Wildlife Health Program


10:30am-11:30am The Great Debate: Point-CounterpointModerator: Theda C. Kontis, MD

O 10:35am Chemical Peel (Fred G. Fedok, MD)vs 10:40am Laser Resurfacing (Louis M. DeJoseph, MD)O 10:45am Midface Lift (Andrew A. Jacono, MD)vs 10:50am Fat Augmentation (Thomas Tzikas, MD)O 10:55am Purse-String Life (John L. Frodel, MD)vs 11:00am Facelift (Stephen W. Perkins, MD)O 11:05am Fillers (Travis Tollefson, MD)vs 11:10am Implants (Peter A. Adamson, MD)O 11:15am-11:30am Q & A

11:30am-12:30pm The Latest and Greatest in ...Moderator: Brian Wong, MD

O 11:30am-11:40am Facial Reanimation, Tessa Hadlock, MDO 11:40am-11:50am Face Transplant , Donald Annino, MDO 11:50am-12:00pm Oculoplastic Surgery,Guy Massry, MDO 12:00pm-12:10pm Cartilage Bending, Sam P. Most, MDO 12:10pm-12:20pm Stem Cells, J.P. Pepper, MDO 12:20pm-12:30pm Lasers, Jill Waibel, MD

12:30pm-1:30pm Lunch in the Exhibit Hall (Grand Hall)Women in Facial Plastic Surgery Lunch(Majestic 4/5)

THURSDAY EVENING special LIVE cme sessionLook Beyond the Obvious--The Future ofAesthetic MedicineLecture and Live Workshop7:00pm-9:00pm(Dallas A3)Steven H. Dayan, MDAs an aesthetic professional, are you clear on who youare and what you do? We are in the midst of a revolu-tion and like most monumental changes, it is not untilafter the fact we recognize what has happened. Non -surgical procedures including lasers, injectables, topicalsand nutraceuticals have exploded in popularity over thepast decade and all of aesthetic medicine has beenaffected. Thus, allowing us to take a deeper, moreintrospective look at what we are actually doing to andfor our patients, as well as redefining who our patientsare. As aesthetic medicine becomes more multi-dimen-sional and we go from treating form and function, toadditionally treating mind and mood, what you do, aswell as who you treat in the coming years may drasti-cally change… Come to the non-surgical adjuncatablecourse at the AAFPRS fall meeting and witness thecoming revolution. Are you ready for it?

The AAFPRS Foundation wishes to thank the followingcompanies for their educational grant in support of thisCME Session.

GaldermaKytheraAllergan

MerzSuneva Medical

13

FRIDAY afternoon instruction courses(Dallas and Austin (AU) Ballrooms)

1:30pm-2:20pm (course descriptions on pages 26-28)IC25 Face Transplant Update(A1) Donald Annino, MDIC26 Concepts, Analysis and Techniques in African(A2) American and Hispanic Rhinoplasty

Ife Sofola, MD; Kofi Boahene, MD; and JavierDiblidox, MDPaper Presentation: Rhinoplasty with AdjuvantEndoscopic Sinus Surgery and MaxillaryReconstruction -The Otolaryngologist's PerspectiveSrinivasa Rao-Mergumala, MD

IC27 Personal Tips for Successful Correction of Severely(A3) Deviated Nose, Short Nose, and Saddle Nose

Yong Ju Jang, MDIC28 Translation of Combat Casualty Care Lessons to the(D1) Community Surgeon-Five Lessons Learned (Part 1)

Moderator: Colonel Joseph Brennan, MDPanelists: Lieutenant Colonel Travis Newberry, MD;Lieutenant Colonel Jose Barrera, and Colonel G.Richard Holt, MD

IC29 Scar Wars: Winning with Lasers(D2) Jill Waibel, MDIC30 Technology Devices for Minimally Invasive Office(D3) Based Facial and Skin Rejuvenation and New

Approaches for Neck RejuvenationRichard D. Gentile, MD, MBA

IC31 Endonasal Management of the Nasal Tip(AU2)Holger Gassner, MD and Norman J. Pastorek, MD

Paper Presentation: Revision and Complication Ratesof 175,842 Patients Undergoing SeptorhinoplastyEmily Spataro, MD

2:30pm-3:20pm (course descriptions on pages 28-30)IC32 Skin Cancer for the Facial Plastic Surgeon(A1) Joshua Rosenberg, MD and Heather Rogers

Ashbach, MDIC33 Grafting Responsibly: Stabilizing the Nose for Better(A2) Long Term Outcomes

Dean M. Toriumi, MDPaper Presentation: Anterior Septal Transplant: ADurable and Cartilage-Efficient Technique for theModified Extracorporeal SeptoplastyMiriam Loyo, MD

IC34 Preoperative, Perioperative, and Postoperative(A3) Management of Eyelid Malpositions in the Cosmetic

PatientSara Wester, MD; Wendy W. Lee MD; LisaGrunebaum, MD and Chrisfouad Alabiad, MD

IC35 Translation of Combat Casualty Care Lessons to the(D1) Community Surgeon-Five Lessons Learned (Part 2)

Moderator: Colonel Joseph Brennan, MDPanelists: Lieutenant Colonel Travis Newberry, MD;Lieutenant Colonel Jose Barrera, and Colonel G.Richard Holt, MD

IC36 LADS: Laser Assisted Drug Delivery(D2) Jill Waibel, MDIC37 1) SOOF Lift Blepharoplasty: Why You Should Be(D3) Using this Approach

M. Sean Freeman, MD2) Endoscopic Browlift: A Segmental ApproachM. Sean Freeman, MD

IC38 Laser Resurfacing and Chemical Peels - A Detailed(AU2)Look at the Pros and Cons, Costs and Benefits, Part 1

Fred G. Fedok, MD; Paul J. Carniol, MD; AllisonHolzapfel, MD; and Mark Hamilton, MDPaper Presentation: Alterations in the Elasticity andPliability of Skin after the Injection of BotulinumToxin AJames Bonaparte, MD


3:50pm-4:40pm (course descriptions on pages 30-31)IC39 A Practical Guide of Sutures in Rhinoplasty(A1) Roxana Cobo, MDIC40 Artful Reconstruction of the Lip and Cheek Defects(A2) Gregory S. Renner, MD

Paper Presentation: Early Surgical Management ofSelect Focal Infantile Hemangiomas: the TissueExpander EffectTara Brennan, MD

Continued ...

women in facial plastic surgery luncheon(Majestic 4/5)The Women in Facial Plastic Surgery are hosting a luncheonon Friday, October 2, 2015 from 12:30pm to 1:30pm. DottiReeder will speak on “Family, Community, and Work: AJuggling Act, But Who has the Financial Ball?” Everyone isinvited to attend. There is no fee to attend but registration isrequired as tickets will be collected at the door.

The AAFPRSFoundation wishes tothank Merz for theirnon-educational grantin support of theluncheon.

14

founders club dinnerThe Annual Founders Club Dinner will be held on Friday,October 2, 2015 from 7:00pm to 11:00pm. This is byinvitation only and will be held off-site.

young physicians eventThe Young Physicians will have a non-CME event onFriday, October 2, 2015 (Dallas A3) from 5:45pm to 9:00pmwith food and beverage. All are invited to attend.

Learn the Artistry of Lyft to Lips asDemonstrated in TwinsModerator: Steven H. Dayan, MDGalderma is pleased to invite you to our “Learn theArtistry of Lyft to Lips” symposium. This excitingprogram will include a presentation and live injectionswith dermal filler innovations brought to you byGalderma. The live injection of twins will showcase thetechniques of Raj Chopra, MD of Plastic SurgeryBeverly Hills, and Jody Comstock, MD, a dermatologistfrom Scottsdale AZ.

The AAFPRS Foundation wishes to thank Galderma fortheir non-educational grant in support of the YoungPhysicians Event.

FRIDAY afternoon instruction courses(Dallas and Austin (AU) Ballrooms)

IC41 How to Perform Multiple Facial Plastic Procedures(A3) Using Local and Level One Sedation Anesthesia (It's

not What You Can Do, But How Much)John Standefer, MD and Jason Swerdloff, MDPaper Presentation: The Use of Propofol/KetamineAnesthesia with Bispectral Monitoring (PKA-BIS)versus Inhalational Anesthetics in Rhytidoplasty - AProspective, Double-blinded, RandomizedComparison StudyKristin Jones, MD

IC42 Designing the e-PTFE (Gore-tex) for Optimum(D1) Result; Use of Conchal Cartilage for Support of

Weak Septal Extension Graft; and Surgery forCorrection of Retracted ColumellaEduardo Yap, MD

IC43 Fat Grafting and Facial Fillers(D2) Sam M. Lam, MD; Mark J. Glasgold, MD; and Tom

Tzikas, MD IC44 Academic Aesthetic Surgery Success Stories, Part 1(D3) Peter A. Hilger, MD; Anthony Brissett, MD; Patrick

J. Byrne, MD; Kofi Boahene, MD; Tom D. Wang,MD; Michael Kim, MD; and Taha Shipchandler, MD

IC45 Laser Resurfacing and Chemical Peels - A Detailed(AU2)Look at the Pros and Cons, Costs and Benefits, Part 2

Fred G. Fedok, MD; Paul J. Carniol, MD; AllisonHolzapfel, MD; and Mark Hamilton, MD

4:50pm-5:40pm (course descriptions on pages 31-33)IC46 An Interactive Course - Handling Extensive Facial(A1) Soft Tissue and Skeletal Injuries

Krishna Patel, MD; Philip R. Langsdon, MD; FredG. Fedok, MD; John L. Frodel, Jr., MD; Robert M.Kellman, MD; and Jessyka Lighthall, MD

IC47 Seven Critical Steps: The Crooked Nose Algorithm(A2) Benjamin C. Marcus, MD and Travis Tollefson, MD

Paper Presentation: Reducing Visibility in theButterfly Graft for Treatment of Nasal Obstruction;Our 10 year experience at OHSUMiriam Loyo, MD

IC48 Advanced Techniques in Modern Volumizing(A3) Blepharoplasty

Andrew A. Jacono, MD and Guy Massry, MDIC49 Rhinoplasty: Improving Results, Nasal Analysis,(D1) Nuances of the Nasal Dorsum and De-Mystifying

Nasal OsteotomiesSpencer Cochran, MD

IC50 Preparing for the Certification Examination in(AU2)Facial Plastic Surgery

Roxana Cobo, MD; Sam M. Lam, MD; andDirk Jan Menger, MD

IC51 Academic Aesthetic Surgery Success Stories, Part 2(D3) Peter A. Hilger, MD; Anthony E. Brissett, MD;

Patrick J. Byrne, MD; Kofi Boahene, MD; Tom D.Wang, MD; Michael Kim, MD; and TahaShipchandler, MD

IC52 The Difficult Cosmetic Lower Lid- Bulging, Sagging,(D2) and Retraction

Sofia Lyford-Pike, MD; Peter A. Hilger MD; and AliMokhtarzadeh, MD

15

Attracting Patients1:30pm-5:30pm(Austin 1)Moderator: Edwin F. Williams, III, MDO Sweating and Shedding (plus Restoring) Hair--Adiscussion of some of the keys to building a busy nationaland international practice, Jeffrey S. Epstein, MDO Privadermia--The Best of Both Worlds, Ben Marcus, MDO Attracting Patients, Andrew C. Campbell, MDO Generate Higher Revenue from Your Patients with Simple2-Minute Targeted Marketing Tool, Jon Mendelsohn, MDO Shoe Leather to Success, Edward Buckingham, MDO Ugh, I’ve been Yelped, Steven Dayan, MD

Aesthetic Plastic Surgery on the East Asian Face1:30pm-3:30pm(San Antonio B)O 1:30pm-2:00pm Upper Blepharoplasty: Non-IncisionSuture Technique, Ji Yoon Choi, MDO 2:00pm-2:30pm Facial Rejuvenation in an Asian,Tack-Keun Kwon, MDO 2:30pm-3:00pm Facial Bone Contouring Surgery,Sang Hoon Park, MDO 3:00-3:30pm Augmentation Rhinoplasty, In-Sang Kim, MD

Facial Reconstruction: Pearls of Facial FlapReconstruction3:30pm-5:30pm(San Antonio B)Moderator: Craig S. Murakami, MDO 3:30pm-3:50pm Pearls of Ear Reconstruction, Shan R.Baker, MDO 3:50pm-4:10pm Pearls of Scalp Reconstruction, AmitBhrany, MDO 4:10pm-4:30pm Pearls of Lip Reconstruction, J. DavidKriet, MDO 4:30pm-4:50pm Pearls of Cheek Reconstruction, Sam P.Most, MDO 4:50pm-5:10pm Pearls of Nasal Tip and AlarReconstruction, Stephen S. Park, MDO 5:10pm-5:30pm Panel Discussion: Challenging Cases

FRIDAY afternoon Breakout Sessions

Facelift - Getting From Good to Great1:30pm-5:30pm(Austin 3)Moderator: Andrew A. Jacono, MDO 1:30pm-1:45pm Graduated Dissection in the High LateralSMAS Approach to Face Lifting, Ed Buckingham, MDO 1:45pm-2:00pm Laser Assisted Face Lifting, Richard D.Gentile, MDO 2:00pm-2:15pm How and When to Employ The ExtendedSMAS Flap in Rhytidectomy, Stephen W. Perkins, MDO 2:15pm-2:30pm Employing Limited SMAS DissectionTechniques Without Compromising Results, BabakAzzizadeh, MDO 2:30pm-2:45pm Extending the Deep Plane Facelift forMaximal Face and Neck Rejuvenation, Andrew A. Jacono,MDO 2:45pm-3:00pm Vertical Vector Facelifting to MaximizeRejuvenation and Minimize Rhytidectomy Incisions, TomD. Wang, MDO 3:00m-3:15pm How to Combine Fat Grafting withFacelifting Simultaneously, Mark Glasgold, MDO 3:15pm-3:30pm Medial Extension of the SMAS Flap toMaximize Midface Rejuvenation, William J. Binder, MDO 3:30pm-3:45pm How to Perform Deep Plane FaceliftDissection and Why I Continue to Do It After 20 YearsNeil A. Gordon, MDO 3:45pm-4:00pm Dealing with the Difficult Neck andManaging the Sub-platysmal Space, Andrew C. Campbell,MDO 4:00pm-4:15pm Feldman Full Corset MidlinePlatysmaplasty, When and How, Mike Nayak, MDO 4:15pm-4:30pm Performing Facelifts Under LocalAnesthesiaO 4:30pm-4:45pm My Graduated Approach to Face andNeck, Jose Patrocino, MDO 4:45pm-5:30pm Facelift Panel and Case Discussion

16

SATURDAY afternoon instruction courses(Dallas Ballrooms)

1:30pm-2:20pm (course descriptions on pages 33-35)IC53 Injectables State of the Art(A1) Corey S. Maas, MD

Paper Presentation: Five Year Bellafill Clinical Trialon Long-Term Safety of PMMA-collagen for theCorrection of Nasolabial FoldsJohn Joseph, MD

IC54 1) Secondary Rhinoplasty without the Use of Costal(A2) Cartilage: A Successful Long Term Experience

Stephen W. Perkins, MD2) Revision Rhinoplasty: Strategic Evaluation andTechnical Solutions Ira D. Papel, MDPaper Presentation: Revisional Rhinoplasty:Aesthetic and Functional Doctor - Patient AssessmentHeloisa Koerner, MD; Cézar Berger, MD; andDaniella Candia Barra, MD

IC55 1) Improved Patient Care through Lawsuit(A3) Protection and Prevention

Tracy Ahmad2) Malpractice in Facial Plastic SurgeryFerdinand Becker, MD

IC56 1) Cleft Lip in Yemen: A 13-Year Study(D1) Mohamed Al Saeedi, MD

2) Care of the Cleft Palate Patient: A Problem BasedApproach to Closing the Gap and ManagingVelopharyngeal Insufficiency plus Unilateral Cleft LipRepair: Keys to Optimizing Lip and Primary NasalResultsJoseph Rousso, MD

IC57 A Personal Evolution of Facial Rejuvenation:(D2) Toward Simplification Using the "Delta" Plication

TechniqueJames C. Grotting, MD

IC58 1) Droopy Nasal Tip: Different Treatment(D3) Techniques

Alireza Mesbahi, MD2) Advancement Genioplasty by OsteoplasticTechniquesMohsen Naraghi, MD3) Middle Eastern RhinoplastyMohsen Naraghi, MD

1887 luncheonAll 1887 members are invited to attend a luncheon onSaturday, October 3, 2015 (Majestic 4/5) from 12:30pm to1:30pm. The lunch is our way of thanking you for yourgenerosity in 2014 and 2015. If you are not an 1887 mem-ber (please refer to list on page 71), it is not too late. Comesee Ann Jenne at the registration area. (By invitation only.)

The AAFPRS Foundation wishes to thank PCA Skinfor their non-educational grant in support of theResearch Grants and Awards.

Saturday, October 3, 2015

morning general session(Dallas Ballroom B/C)7:30am-8:30am How I Do It: 3-Minute Surgical Video

BlastsO Reconstructive Rhinoplasty, David W. Kim, MDO Finesse Points for the Nasal Tip, Dean M. Toriumi, MDO Vertical Caudal Strut and the Anterior Septal TabTechniques, Philip J. Miller, MDO Approach to the Asian Nose, Yong Ju Jang, MDO My Approach to Facelift , Benjamin C. Paul, MDO My Approach to the Upper Eyelid, Norman J. Pastorek,MDO My Approach to the Lower Eyelid, Stephen W. Perkins,MDO Key Maneuvers in Otoplasty, Peter A. Adamson, MDO Surgical Female Hairline Advancement, Sheldon S.Kabaker, MDO Skin Resurfacing, David Holcomb, MDO Halo Laser Technique, Andrew C. Campbell, MDO Periorbital/Midface Periorbital HA Filler, Samuel M. Lam,MD

8:30am-8:45am AAFPRS Research Grants and Awards8:45am-10:00am Business Meeting and Elections

Incoming President’s AddressEdwin F. Williams, III, MD

10:00am-10:30am Gene Tardy Scholar“The Doctor-Patient Relationship: Can ItSurvive the Assault?"William W. Shockley, MD


11:00am-12:30pm PANEL: My Most Humbling Momentsin 30+ Years of PracticeModerator: J. Regan Thomas, MDPanelists: Peter A. Hilger, MD; Wayne F.Larrabee, Jr., MD; Robert L. Simons,MD; Stephen W. Perkins, MD; andG. Richard Holt, MD


17

IC69 Orthognathic Surgery Planning and Execution, Step-(D2) by-Step Overview

Alexander Rabinovich, MDIC70 A Potpourri of Nasal Tip Finesse Techniques(D3) Peter A. Adamson, MD

Paper Presentation: The Use of AutologousInterdomal Fibroadipose Tissue as a Graft ForImprovement of Nasal Tip ContourAmit Kochhar, MD

4:50pm-5:40pm (course descriptions on page 38-39)IC71 Optimal Re-contouring of the Face and Neck(A1) (Part 2)

Fred G. Fedok, MD and Philip R. Langsdon, MDIC72 Modern Concepts in Nasal Reconstruction(A2) Holger Gassner, MD; Kofi D. Boahene, MD;

and Patrick J. Byrne, MDIC73 1) Rhinoplasty in the Southern Tip of Europe: The(A3) Portuguese Experience

Diogo Carmo, MD2) Conservative No Hump Removal Rhinoplasty -Cosmetic and Functional OutcomesMario Ferraz, MD3) Rhinoplasty: How Far Can We Reach UsingClosed Access?Antonio Nassif Filho, MD

IC74 How to Get Involved with Foreign Medical Mission(D1) Trips: FACE TO FACE International

J. Charlie Finn, MD; Manoj Abraham, MD; KarenSloat

IC75 TBD(D2)IC76 Craniofacial Surgery(D3) Sherard Tatum, MD

Paper Presentation: Visual and Functional Integrationof Craniofacial ProsthesesGregory Gion, MD

2:30pm-3:20pm (course descriptions on pages 35-36)IC59 Comprehensive Facial Aging Surgery: From(A1) Consultation to After Care

Jonathan M. Sykes, MDIC60 Hair Transplant 101(A2) Sam M. Lam, MDIC61 1) Effective Tissue-Conservative Strategies for(A3) Contouring the Wide Nasal Tip

Richard E. Davis, MD; Ivan Wayne, MD and MilosKovacevic, MD2) Rhinoplasty in the Ultra-Thick and Ultra-ThinSkinned NoseRichard E. Davis, MD; Ivan Wayne, MD and MilosKovacevic, MDPaper Presentation: Development and validation ofExpectations of Aesthetic Rhinoplasty Scale (EARS)Mohsen Naraghi, MD

IC62 Thin Skin Rhinoplasty: Aesthetic Considerations and(D1) Surgical Approach

Peter A. Hilger, MD and Michael Brenner, MDIC63 Adjunctive Procedures to Improve the Facelift Result(D2) including the Secondary Facelift

James C. Grotting, MDIC64 Advanced Techniques and Nuances in Deep Plane(D3) Rhytidectomy

Andrew A. Jacono, MD and Neil A. Gordon, MD


3:50pm-4:40pm (course descriptions on pages 37-38)IC65 Optimal Re-contouring of the Face and Neck (Part 1)(A1) Fred G. Fedok, MD and Philip R. Langsdon, MD

Paper Presentation: Novel Facial DimensionsDescribing Positioning of Key Anatomic ElementsPhilip Young, MD

IC66 Navigating the Problematic Lower Eyelid in Facial(A2) Rejuvenation

Craig Czyz, DO and Jill Foster, MDIC67 1) Correction of External Valve Dysfunction: Rib(A3) versus Cephalic Crural Turn-In to Support the

Lateral CrusHenry Barham, MD and Richard Harvey, MD2) The Expanding Indications for the ButterflyGraft in Middle Nasal Vault ReconstructionJ. Madison Clark, MD

IC68 Creation of the AAFPRS FACE TO FACE(D1) International Mission Trip Database

Manoj Abraham, MD; Joseph Rousso, MD;Ryan Brown, MD; and Karen Sloat

18

SATURDAy afternoon Breakout Sessions

Rhinoplasty: Getting from Good to Great1:30pm-3:30pm(Austin 3)Moderator: Tom D. Wang, MDPanelists: Richard E. Davis, MD; Oren Friedman, MD;Grant Hamilton, MD; Benjamin Marcus, MD; Craig S.Murakami, MD; and Dean M. Toriumi, MDThis panel of educators will share their thoughts on how onelearns to become a better rhinoplasty surgeon. Eachpanelist will share both technical and philosophicalviewpoints on this life-long process of improvement.Topics will include: why rhinoplasty is so difficult to learnand master, how best to start in rhinoplasty as aninexperienced surgeon, ways to accelerate the learningprocess, how to deal with mistakes and being honest withoneself, commitment to excellence, the teaching andlearning of rhinoplasty in training programs.

Biotechnology Advances in Facial Plastic Surgery3:30pm-5:30pm(Austin 2)Moderator: Andrew C. Campbell, MDO 3:30pm-3:40pm 5FU - TBDO 3:40pm-3:50pm Non-Surgical Rhinoplasty, TBDO 3:50pm-4:00pm Update on Hair Procedures, Sam M.Lam, MDO 4:00pm-4:10pm Thermi RF, Jason Bloom, MDO 4:10pm-4:20pm Radiesse Hands, A Personal Experience,Jason Bloom, MDO 4:20pm-4:30pm Fillers in Canada, Jamil Asaria, MDO 4:30pm-4:40pm Revance, John Joseph, MDO 4:40pm-4:50pm Kybella, John Joseph, MDO 4:50pm-5:00pm Septal Perforation Repair using PDSPlates, Umang Mehta, MDO 5:00pm-5:10pm One Year Experience with Halo Laser -Andrew A. Campbell, MDO 5:10pm-5:20pm Infini, Steve Weiner, MDO 5:20pm-5:25pmXAF5 Ointment for Eyelid Fat, AnOverview, Andrew A. Campbell, MDO 5:25pm-5:30pm Q & A

Hair Procedures for the Facial Plastic Surgeon: FUEand More1:30pm-5:30pm(Austin 1)Moderator: Jeffrey S. Epstein, MDFaculty: John Bitner, MD; Lisa Ishii, MD; andGorana Kuka, MD

I’ve Finished Training....Now What? Options AfterFellowship1:30pm-3:30pm(Austin 2)Moderators: Sunny Park, MD and Taha Z. ShipchandlerMDO 1:30pm-1:42pm Working in a Multispecialty GroupSunny Park MD, MPHO 1:42pm-1:54pm Can Academics Be Like PrivatePractice?Taha Z. Shipchandler, MDO 1:54pm-2:06pm Pros and Cons of Owning a PrivatePractice, Haena Kim, MDO 2:06pm-2:18pm Transitioning to Academics followingTraining, Andrea Jarchow, MDO 2:18pm-2:30pm Finding My Niche and Building aPractice at Kaiser, Noah Meltzer, MDO 2:30pm-2:35pm Q & AO 2:35pm-2:47pm Joining My Fellowship Director'sPracticeAngela Sturm-O'Brien, MDO 2:47pm-2:59pm Things I've Learned from Being inAcademics, P. Daniel Ward, MDO 2:59pm-3:11pm Why I Chose a Solo Private PracticeHeather Waters, MDO 3:11pm-3:23pm How to Get Involved in the AAFPRSas a Young Physician, Andrew Winkler, MDO 3:23pm-3:30pm Q & A

The Nuts and Bolts of Opening up a PrivatePractice3:30pm-5:30pm(Austin 3)Moderator: Sunny Park, MDO 3:30pm-3:45pm An Overview of Starting Up, SunnyPark, MDO 3:45pm-4:10pm Panel: Operations: The ManyDecisions I Made for Running My Practice, KristinaTansavatdi, MDO 4:10pm-4:35pm Panel: You are the Boss: Employees101, David Gilpin, MDO 4:35pm-5:00pm Panel: Marketing: Where, When andHow to Start, Jason Bloom, MDO 5:00pm-5:25pm Panel: How I Deal with FinancialAspects of My Practice, Robert Brobst, MDO 5:25pm-5:30pm Q & A

6:00pm Meeting Adjournment

See you next year in Nashville, TN forthe Annual Fall MeetingOctober 4-9, 2016.

19

THURSDAY afternoon1:30pm Breakout SessionPaper Presentation: Yelp! How We Get 1 and 5 Star ReviewsNima Shemirani, MD and Jeffrey Castrillion, BSCore Competencies: Patient Care, InterpersonalCommunications Skills, ProfessionalismLevel of Evidence: Level IV - Case seriesStudy Objective: To evaluate the reasons why plasticsurgeons receive both 1 and 5 star reviews.Design: An online review of over 800 Yelp entries forplastic surgeons in 5 major cities was performed.Method: We included five of the nation?s largest cities witha high Plastic Surgeon (PS) density per square mile. Over800 individual Yelp Reviews were analyzed from 40different private practices. To gain a better understandingof the review rating, we looked at entries that had a 3sentence minimum to describe the patient experience. Thefive mjor cities included Los Angeles, Chicago, SanFrancisco, Miami, and New York. Using the reviews wethen created 5 main categories which the reviews mainlyemphasized. 1) Bedside Manner; 2) Results; 3) Cost; 4)Honesty or Pressure to book and; 5) Physician Knowledge.Office staff ratings were also included.Conclusions: For 5 star reviews, a pleasant bedside mannerwas mentioned most often. Interestingly, great results wasthird most important for a 5 star review. For 1 star reviews,again, poor bedside manner was mentioned most often.Perceived dishonesty and pressure was mentioned in a closesecond. Poor results was mentioned thirdly. Improvingbedside manner is the most effective way to improve Yelpscores.

1:30pm - 2:20pmIC1 Getting the Best Out of Medical Groups: DeepeningSurgeon and Team Engagement and ResilienceWayne M. Sotile, PhDBring out the best in people! This is one of the mostdaunting mandates for practice administrators today; onethat requires driving accountability in diverse groups whilehelping each to get beyond psychological barriers thatinterfere with passionate engagement in meaningful work. Inthis session, Wayne Sotile, Founder of the Center forPhysician Resilience, in Davidson, NC, teaches his practicalmodel for accomplishing this goal. Drawing material fromhis more than 35 years of experience working with medicalprofessionals and their organizations, Dr. Sotile teachespractical applications from the broad fields of motivationalpsychology, performance management, and leadershipresilience. This presentation will provide toolkit of skills forbetter understanding and motivating physicians and staffteam members while enjoying themselves in the process.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) describe four ways to shape positiveworkplace behaviors; 2) discuss key findings frommotivation research and practical implications for enhancingyour leadership style; and 3) list three strategies for drivingaccountability and professionalism in your workplace

IC2 Crooked Nose Correction: Basic To ExtremeTransforming TechniquesHong Ryul Jin, MD and Tae Bin Won, MDLevel of Evidence: Level IV - Case seriesThe course will highlight surgical techniques used to correctthe crooked nose. Conventional as well as novel, basic aswell as extreme transforming techniques, modified andtailored to the severity and type of crooked nose will beelaborated using cases, intraoperative photos and videos.Learning Objective(s): At the end of the course, attendeesshould be able to rethink the previous correction techniquesand be able to modify and refine them to adapt to theseverity and type of crooked noses.

IC3 Blepharoplasty with Eyelid Ptosis CorrectionWilliam E. Silver, MDLevel of Evidence: Level IV - Case seriesThis course will address the following: classification ofptosis; how to diagnose degree and type of ptosis; showexamples of the different types of ptosis; how each type ofptosis is approached for correction; combine blepharoplastywith ptosis repair; address technical problems associatedwith correcting the ptosis; show video of anterior (levatorapproach) repair; and follow up with early and long termpost op photos.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) approach surgically the correction ofeyelid ptosis and combine it with blepharoplasty whenindicated; 2) recognize eyelid ptosis and measuring theamount when evaluating patients coming into the office forblepharoplasty.

IC4 The History and Technical Evolution of FaceliftSurgeryIra D. Papel, MD and Nabil Fuleihan, MDLevel of Evidence: Level IV - Case seriesThis course will look at the historical evolution of facelifttechniques and how this impacts modern facial plasticsurgery practice. We will focus on not only history, but alsoanatomic breakthroughs and how the most moderntechniques were incrementally developed. We will showpatient examples and discuss which techniques are indicatedfor specific clinical situations.Learning Objective(s): At the end of the course, attendeesshould be able to understand the steps by which modernfacelift surgery has evolved and how this impacts clinicaloutcomes.

IC5 What Really Works for NonSurgical Skin Tightening/Lifting and The Skinny on Fat Melting and FreezingSabina Fabi, MDAt the conclusion of this session, participants should be ableto: explain the role of focused ultrasound technology in skintightening; differentiate between radiofrequency modalitiesfor tightening lax skin; choose which skin tighteningdevice(s) may best fit into their clinical practice; selectappropriate laser and energy-based modalities for skin

instruction courses and paper presentations

20

tightening; and recite potential complications associated withskin tightening technologies; explain the role of cryolipolysisin body contouring; differentiate between radiofrequency,ultrasound and freezing modalities for fat reduction; choosewhich fat reduction device(s) may best fit into their clinicalpractice; select appropriate energy-based modality for fatdestruction; and recite potential complications associatedwith fat reduction technologies.

IC6 Primary Rhinoplasty: Analytical Comparison ofResults and Revision RatesStephen W. Perkins, MD and Scott Shadfar, MDLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseRhinoplasty techniques utilizing the external columellarapproach may allow a surgeon to more easily accomplishthe desired aesthetic and structural goals for their patientsusing complex grafting techniques. However, the use ofdorsal crushed cartilage grafts and lobular grafting maypredispose patients to a higher rate of contour irregularitiesnecessitating secondary intervention. There still remains arole for the endonasal approach in rhinoplasty.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) learn that the use of the externalcolumellar approach to rhinoplasty does not reducecomplications or result in fewer revisions; 2) incorporate asurgical algorithm to manage patients presenting for primaryrhinoplasty; and 3) understand the techniques utilized togain reproducible outcomes in rhinoplasty.

Paper Presentation: Dissection of the Paramedian ForeheadFlap Pedicle Flap Using Perforator ConceptsP. Daniel Ward, MD; Daniel Cox, MD; and Vasu Divi, MDCore Competencies: Practice-based Learning andImprovement, Medical Knowledge, Patient CareLevel of Evidence: Level II - Lesser-quality, randomizedcontrolled trial; prospective cohort study; or systematicreview of these studiesDesign: Retrospective case review of the first 7 patients whohad a modified, perforator-based dissection of the foreheadflap pedicle, which allows for a vertical glabellar closure ofthe donor site, rather than the standard, inverted-V scar thatmay disrupt the medial brow position.Method: The forehead flap pedicle was successfullydissected using this alternative technique in seven patients.Study Objective: To determine the feasibility of aperforator-based approach to dissection of the forehead flappedicle.Conclusions: The alternative technique we describe takesadvantage of the reliable anatomy of the supratrochlearartery and eliminates the need for scar extension into thebrow and narrows the pivot point for the flap. This allowsthe surgeon to avoid the inverted V shaped scar and tobetter camouflage the scar in the vertical glabellar crease. Italso decreases the risk of medial brow malposition that canoccur using the traditional approach.Learning Objective(s): At the end of the course, attendees

should be able to understand the vascular anatomy of theforehead flap and learn a modification of the technique thatmay improve patient outcomes.

2:30pm-3:20pmIC7 Contemporary Management of Upper Facial TraumaDavid Kriet, MD; Clinton Humphrey, MD and E. BradleyStrong, MDLevel of Evidence: Level II - Lesser-quality, randomizedcontrolled trial; prospective cohort study; or systematicreviewManagement of upper facial trauma is particularlychallenging as it commonly involves the orbit, naso-orbitalethmoid (NOE) region, and frontal sinus. We will addresscontemporary management of these areas including thetranscaruncular approach to the medial orbital wall, trans-nasal wiring of NOE fractures, and current thoughts onfrontal sinus trauma. We will offer tips and pearls fortreating these difficult cases.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) gain a greater understanding of thecurrent treatment options and surgical approaches for themanagement of medial orbital wall and naso-orbital ethmoidfractures; and 2) have improved insight into thecontemporary algorithm for managing frontal sinusfractures.

IC8 Managing Lateral Crural Convexity and the CompoundTip Deformity: New Approaches to a Decades OldProblemBrian Wong, MD and Richard E. Davis, MDLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseA critical objective of nasal tip rhinoplasty is the correctionof lateral crural convexity (LCC). LCC and malpositionlead to broad and amorphous nasal tip shape.Contemporary and historical techniques to correct thiscompound tip deformity will be reviewed, and we willintroduce lateral crural tensioning, an innovative approach torefine nasal tip architecture and functional stability.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) understand contemporary approachesto managing the convex and malpositioned lateral crura; and2) understand the use of the lateral crural tension approach.

Paper Presentation: Technical Evaluation of Uneven SutureLobuloplastiesHeloisa Koerner, Cassiano Moreti, MD; and Caio Soares,MDCore Competencies: Practice-based Learning andImprovementLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseDesign: Through the uneven technical suture, theretropositioning lobe is simulated by a simple black nylon4,0 suture. This suture iniciates in the higher part of theprotuding lobe and ends posteriorly towards the skin of the


21

mastoid region. The lobe position shall coincide with theplane of the ear.Method: We evaluated 18 patients with floppy ear associatedwith protrusion of the lobe during diagnosis. Theyunderwent otoplasty with the eclectic technique associatedwith uneven suture lobuloplasties. Through a protocoldesigned by millimeter measurements of retro-auriculardistances, we evaluated the aesthetic postoperative results.Conclusions: The technique of uneven suture lobuloplastiaswas easy to perform, safe and hassle free,. It also had goodaesthetic results after 6 months of evaluation.Learning Objective(s): At the end of the course, attendeesshould be able to demonstrate the postoperative results after6 months of correction of the protruding lobe through theuneven suture technique.

IC9 Facial Scar Revision TechniquesJ. Regan Thomas, MDLevel of Evidence: Level V - Expert Opinion, case report orclinical exampleA spectrum of proven facial scar treatments will bediscussed. Attention will be focused on scar evaluation,selection of appropriate scar treatment modalities, andstepwise demonstration of selected techniques. Clinicallyapplicable surgical steps will be illustrated and discussedutilizing patient examples.Learning Objective(s): At the end of the course, attendeesshould be able to learn the proper patient scar evaluationand the selection for best treatment option.

Paper Presentation: Does Primary W-plasty Improve theScar Appearance of the Paramedian Forehead Flap DonorSite?Emmanuel Jauregui, MD; Neelima Tammala, MD; RahulSeth, MD; Sarah Arron, MD; Isaac Neuhaus, MD; SiegridYu, MD; Roy Grekin, MD; and P. Daniel Knott, MDCore Competencies: Practice-based Learning andImprovement, Evidence-based Health CareLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseDesign: Retrospective chart review with blindedphotographic analysis.Method: Clinical history and operative reports werereviewed for 34 patients who underwent paramedianforehead flap performed by either of two academic facialplastic surgeons between November of 2011 and May of2014 at the University of California, San Francisco MedicalCenter. Paramedian forehead flaps were raised primarilywith either a W-plasty design or with a traditional straight-line design. Standard photographs of the donor site, taken atleast 90 days following surgery were reviewed and scored ina blinded fashion by 4 dermatologic surgeons using visualanalogue and Likert scales. The 2 groups were similar interms of mean age and gender (W-plasty: 69, SL: 61.8; W-plasty males: 84%, SL: 60%). Patients undergoing W-plastyclosure had better mean likert (3.71 v 3.43, p=0.13) andVAS (71.7 v 65.6, p=0.058) scores than patients undergoingstraight-line closure.

Conclusions: Patients undergoing paramedian forehead flapdonor site closure using a W-plasty technique demonstrateda trend towards better mean scar appearance at least 90days following surgery, when compared with patients whosedonor sites were closed using a straight line technique.Although statistical significance was not achieved, a largerpatient cohort may be required to demonstrate significance.Study Objective: To evaluate the aesthetic outcomes of W-plasty versus traditional straight-line (SL) closure techniquesof the paramedian forehead flap donor site.Learning Objective(s): At the end of the course, attendeesshould be able to evaluate ideal methods to close foreheadflap donor sites.

IC10 Functional Rhinoplasty and Valve Surgery: A Bi-Continental PerspectiveMinas Constantinides, MD and Dirk Jan Menger, MDLevel of Evidence: Level II - Lesser-quality, randomizedcontrolled trial; prospective cohort study; or systematic reviewFunctional rhinoplasty presents unique challenges. Whichmethods are available to measure nasal patency andPROMs? How useful are spreader grafts? How can battengrafts be positioned properly? What is the utility of lateralcrural strut grafts? Two experienced rhinoplasty surgeonswill share their approaches in this problem-focused course.Cases and presented complications will help clarify thistechnically demanding topic.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) describe differences in uses of variousgrafts in nasal obstruction surgery; and 2) immediately applya new technique in the practice of functional rhinoplasty.

Paper Presentation: The Internal Nasal Valve Dilator Graft,a Simple Effective Adjunct to SeptoplastyMatthew Keller, Curtis W. Gaball, MD and Scott Lovald, PhDCore Competencies: Practice-based Learning andImprovement, Medical Knowledge, Patient CareLevel of Evidence: Level V - Expert Opinion, case report orclinical exmapleDesign: Retrospective case-series. Functional and cosmeticoutcomes from 18 patients are reported, and the surgicalmethod is described.Method: Eighteen patients with septal deviation and INVnarrowing were treated. No noticeable change in nasalcontour occurred except in one early patient in whom thegraft was too short and thick. This patient refused revisionsurgery because his breathing was acceptable. All patientsbut one had excellent functional results. This patient hadpersistent nasal dyspnea and required revision surgery toaddress an unrelated external valve issue. The seriessuccessfully treated attendant snoring, CPAP intolerance,and exercise related nasal dyspnea.Conclusions: The internal nasal valve septal tension graft isa low-risk, simple, and effective adjunct to septoplasty.Learning/Subject Objective(s): Internal nasal valvenarrowing is a common cause of persistent nasal dyspnea


22

after septoplasty and turbinate reduction surgery. Herein,the authors report the use of septal cartilage as a tensionband plate to lateralize the upper lateral cartilages andimprove nasal airway patency similar to over-the-counternasal dilator strips. The graft makes use of cartilage fromthe primary surgical site that would otherwise go unused. Ituses thinner cartilage than the traditional auricular cartilagebutterfly graft and the magnitude of its effect is under thesurgeon's influence. This novel technique does not require asecond surgical site, as does the butterfly graft, and causeslittle to no cosmetic change.

IC11 1) Surgical Consideration in Middle Eastern RevisionRhinoplastySameer Bafaqeeh, MDLevel of Evidence: Level V - Expert Opinion, case report orclinical exampleMany of our referred unhappy or dissatisfied revision caseshave been to the plastic surgeon for their primaryassessment or their first surgery and referred to us for bothfunctional and aesthetic correction of their iatrogenicdeformities. The external approach is applied for mostrevision cases, which offers several advantages: directvisualization of underlying anatomic structures, adequatediagnosis of the existing deformity, and exact placement ofgrafts and implants. The treatment is also multifactorial:osteotomy and rasp techniques are used to realign; (intact,crushed, diced, or morsilized) cartilage grafts are used to fillin, camouflage, smooth out, elevate, and contour differentdefects. In severe cases, irradiated rib cartilage or alloplasticGore-Tex in Fascia lata are used to fill in large defects whenother grafting options are not available. The most commonpost-operative rhinoplasty deformities encountered aredescribed and how they can be corrected is presented, withpearls for preventing such problems.

2) Endonasal Modified Oblique Dome DivisionBashar Bizrah, MDLevel of Evidence: Level I - High-quality, multi-centered orsingle-centered, randomized controlled trialIllustrated course on endonasal modified oblique domedivision based on the Goldman's Tip but without delivery ofthe lateral crus and marginal rim incision. This maintains anintact rim and avoids lateral crus exposure, minimising post-operative problems along the alar rim and sidewalls such asnotching, retraction, collapse, deviation or asymmetry. Thistechnique enables adequate tip projection, definition,rotation and refinement in selected cases.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) avoid exposure of lateral crus andavoid alar rim incision to reduce post-operative problems offibrosis, scarring and wound contracture (this is important inMiddle Eastern and Gulf patients--Fitzpatrick skin types 3,4and 5--where the skin contains more fibroblasts leading tomore scarring; 2) know technique on incisions rather thanexcisions to preserve anatomical structure; 3) enable

procedure to be done under local anesthesia with sedation,reduce operative time and reduce post-operative recoverytime.

IC12 1) Short Nose ElongationTse Ming Chang, MDLevel of Evidence: Level V - Expert Opinion, case report orclinical exampleShort nose is described as being less than 1/3 of the faciallength and is common in Asians. Short nose is usuallycharacterized by low radix, flat nasal dorsum and probablyover-rotated nasal tip. To correct short nose, nasal dorsumshould be augmented, nasal starting point should be elevatedand the nasal tip should be downward rotated.Learning Objective(s): At the end of the course, attendeesshould be able to correct short nose deformity.

2) Tailor Made Rhinoplasty: From Filler to OperationYu-Hsun Chiu, MDLevel of Evidence: Level V - Expert Opinion, case report orclinical exampleAugmentation rhinoplasty is popular in Asia. Alloplastic,autologous, and homologous materials have been used forthis purpose with different success rates since thetechnique’s inception. Each of these methods hasadvantages and disadvantages. We will discuss the aestheticlimitations and complication of different materials, and howto improve their versatility.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) understand and apply the differentmaterials for augmentation rhinoplasty; 2) understand,prevent, recognize, and correct complications of differentmaterials.3) How to Bring the Retracted Ala Downward: (Correctionof Alar Retraction)Ji Yun Choi, MDLevel of Evidence: Level IV - Case SeriesAlar retraction is one of the most challenging problems tocorrect in nasal surgery. Among the alar rim deformities,alar retraction is one of the most frequently observed. It isdifficult to correct, recurs easily, and needs delicatehandling. This course introduces the use of an advancedisland flap in conjunction with composite graft technique,alar rotation flap technique and lateral crural strut grafttechnique and cases to correct severe alar retraction.Learning Objective(s): At the end of the course, attendeesshould be able to correct alar retraction.

3:50pm-4:40pmIC13 Frontiers in Orbital ReconstructionKris Moe, MDLevel of Evidence: Level II - Lesser-quality, randomizedcontrolled trial; prospective cohort study; or systematicreviewReconstruction of complex orbital defects can be extremelychallenging due to complex anatomy, confined workingspaces, and the close proximity of critical and complex


23

neurovascular structures. Furthermore, failure to restorepremorbid anatomy can lead to debilitating outcomes withdevastating effects on quality of life. A number of newtechniques and innovations have had a great impact onimproving orbital reconstructive outcomes. These includeendoscopic orbital surgery; navigation-guided surgery;mirror-image overlay techniques for preoperative virtualreconstruction and planning. This presentation will describethese innovations, review the relevant literature, anddemonstrate applications for adoption into reconstructivesurgery.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) describe the technique and anatomy ofendoscopic orbital surgery; and 2) understand the use ofmirror-image overlay in pre-operative surgical planning andnavigation-guided surgery.

IC14 JAMA Facial Plastic Surgery: Top Articles, SocialMedia and New FacesJohn S. Rhee, MD; Dean M. Toriumi, MD; Brian Wong,MD; Peter A. Hilger, MD; and Sam P. Most, MDLevel of Evidence: Level V - Expert Opinion, case report orclinical exampleParticipants will be introduced to the latest journaldevelopments including new CME and journal club features,smartphone and tablet apps, and updated Web site features.For potential authors, the workshop will discuss specificways to improve chances for manuscript acceptance. Topicswill include tips on manuscript construction and optimizationfor a specific manuscript category. For potential reviewers,the workshop will discuss the importance of a fair andthorough peer review process and tips on conductingeffective critiques.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) know specific ways to improvechances for manuscript acceptance; and 2) learn theimportance of a fair and thorough peer review process andtips on conducting effective critiques.

IC15 Design Strategies for Reconstruction of Nasal DefectsKrishna Patel, MD and William Shockley, MDLevel of Evidence: Level V - Lesser-quality, randomizedcontrolled trial; prospective cohort study; or systematicreviewNasal reconstruction requires thoughtful analysis and carefulplanning, especially in the setting of defects caused byoncologic resections and major traumatic injuries. Thisinteractive course will systematically analyze nasal defectsand formulate reconstructive plans. The case scenarios willdiscuss the reconstructive options that enable restoration ofboth function and aesthetics.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) analyze both partial and full thicknessnasal defects and formulate a reconstructive plan that willaddress all deficient layers of the nose; and 2) determine thetiming of surgeries, especially when multiple stages arerequired, or delays occur related to postoperative radiation.

Paper Presentation: Guidelines for Early Division of theForehead Flap Pedicle: Use of Laser-assisted IndocyanineGreen Angiography to Predict Adequacy of NeovascularizationJoshua Surowitz, MD and Sam P. Most, MDCore Competencies: Medical Knowledge, Patient Care,Evidence-based Health CareLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseStudy Objective: The aim of the present study was toquantify flap neovascularization two weeks following initialflap transfer in order to describe an algorithm for earlier flappedicle division in select patient populations.Design: This prospective and retrospective study wasperformed at Stanford University, after approval by theStanford Institutional Review Board. Laser-assistedindocyanine green angiography was used to image patientsprior to initial flap transfer, immediately following initial flaptransfer, prior to pedicle division with the pedicleatraumatically clamped, and immediately following pedicledivision and flap insetting. Analysis of data and calculationof relative perfusion was performed using SPY-Q software.Method: Participants included in the study were patientswith defects appropriate for paramedian forehead flapreconstruction and meeting inclusion criteria (partial-thickness defects, >50% of recipient bed with vascularizedtissue, lack of nicotine use).Main Outcome Measures: Perfusion was calculated usingthe SPY-Q software as the percentage of the area of interestrelative to a predetermined reference point in normalperipheral tissue.A total of 10 patients were enrolled. The mean relativeperfusion of the forehead donor site prior to flap transferwas 61%, 81.4% upon initial flap transfer, 57.5% at thetime of atraumatic pedicle clamping, and 58.6% afterpedicle division and flap insetting. There were no flapfailures or other complications.Conclusions: The present study demonstrates that in selectpatients (those meeting inclusion criteria) division of thepedicle at two weeks following initial flap transfer is safe.This is significant in that earlier pedicle division and flapreduces the duration of facial deformity for the patient.Learning Objective(s): At the end of the course, attendeesshould be able to understand the application of ICGangiography in determining adequacy of neovascularizationin paramedian forehead flap nasal reconstruction.

IC16 Comprehensive Upper and Lower Blepharoplasty withSurgical Adjuncts, Video Session, Part 1Guy Massry, MDBoth upper and lower blepharoplasty have evolvedsignificantly from primarily excisionally based procedures, inwhich surgery focused on tissue subtraction (skin/muscleand fat), to procedures which emphasize tissue preservationand augmentation. With this paradigm shift have come avariety of surgical adjuncts which allow a more options isattaining a tailored aesthetic ideal for each individual patientbased on findings and needs. In this 1 hour video,


24

contemporary standard blepharoplasty techniques will bereviewed/presented. In addition, numerous surgicaladjuncts which focus on enhancing outcomes will bedetailed. A question and answer session will follow.

IC17 Practical Approaches to Incorporating Research andEvidence Based Medicine Into a Busy Facial Plastic SurgeryPractice, Part 1Lisa Ishii, MD; Travis Tollefson, MD; Sam P. Most, MD;John S. Rhee, MD; Benjamin C. Marcus, MD; MikeBrenner, MDThis Evidence-Based Medicine (EBM)/Research sessionwill examine how to integrate best evidence, scientificresearch, and clinical experience to optimize decisionmaking in patient care. We will use a two-pronged, case-based approach to demonstrate the rationale for using EBMin practice, and how research informs EBM. Panelmembers will discuss the far-reaching implications of EBMfor surgical practitioners and then build on this foundationby highlighting practical examples of facial plastics researchinnovations, including evidence that facial plastic surgeonscan apply broadly in their practice. We will further reviewresearch gaps, and present areas of opportunity tocoordinate research efforts and achieve higher levels ofevidence.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) understand what EBM is2) know howresearch informs EBM; and 3) know how to incorporateEBM into their practice.

IC18 1) What Truly Works in Lower Face LiftRejuvenationStephen W. Perkins, MDLevel of Evidence: Level V - Expert Opinion, case report orclinical exampleThis panel will be highly interactive and each experienced ,well know facelifting faculty will be challenged directly todefend and explain exactly why he/she does what he/shedoes and why. This panel will 'clean out' the 'non-sense' andgive the attendees a true evaluation of varying techniquesproposed to rejuvenate the jawline and neckline.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) learn actual techniques that work andlast in lower face rejuvenation; 2) learn why experiencedfaculty differ in some of their approaches; and 3) learn whynon-surgical approaches or limited approaches to faceliftingoften fail to deliver.

2) The Excellent NecklineRobert Brobst, MDLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseTo objectively examine the improvement and duration ofchange of the mentocervical angle (MCA) following a Kellyclamp, platysmaplasty with a modified, deep plane extendedSMAS rhytidectomy, with identification of patientdemographics and clinical findings applicable to outcomes,

procedure related complications, and the timing and type ofrevisions with this technique.Learning Objective(s): At the end of the course, attendeesshould be able to understand the techniques utilized to gainreproducible long-term outcomes in rhytidectomy.

Paper Presentation: Efficacy of ATX-101 (DeoxycholicAcid) for Reducing Submental Fullness Associated withSubmental Fat in Demographic Subgroups of Subjects fromthe U.S. and Canadian Phase 3 Trials (REFINE-1 andREFINE-2)Corey Maas, MD; Fredric S. Brandt, MD; Paul F. Lizzul,MD; Todd M. Gross MD; and Frederick C. Beddingfield,III, MDCore Competencies: Evidence-based Health CareLevel of Evidence: Level I - High-quality, multi-centered orsingle-centered, randomized controlled trialStudy Objective: Submental fat (SMF) may present as anunappealing fullness that can negatively affect well-being.ATX-101 is a patented formulation of pure syntheticdeoxycholic acid that causes focal adipocytolysis and hasbeen extensively studied for SMF reduction and submentalcontouring. This abstract reports the efficacy of ATX-101 insubgroups of subjects enrolled in the US/Canadian pivotalphase 3 trials.Design: In two randomized double-blind placebo-controlledtrials (REFINE-1 and REFINE-2), subjects with SMFgraded as moderate or severe by the investigator and by thesubject using the Clinician-Reported Submental Fat RatingScale (CR-SMFRS) and the Patient-Reported SubmentalFat Rating Scale (PR-SMFRS), respectively, were treatedwith ATX-101 2 mg/cm2 (area-adjusted) or placebo. Theco-primary efficacy endpoints were 1-grade improvementfrom baseline at 12 weeks after last treatment in compositeCR-SMFRS/PR-SMFRS and 2-grade improvement in thecomposite endpoint. ATX-101 was compared to placebowithin 18 subgroups based on 9 demographic or baselinecharacteristics (sex, age, race, ethnicity, body mass index[BMI], baseline SMF severity [CR-SMFRS and PR-SMFRS], Fitzpatrick skin type, and skin laxity). Also, 1-grade CR-SMFRS response rates (CR-1) were comparedfor the two demographic or baseline characteristicsubgroups for each variable (eg sex: males vs females).Method: Both co-primary efficacy endpoints were met ineach trial. A pooled analysis of all 1022 randomized subjects(from both trials) showed that 78.5% of ATX-101?treatedsubjects achieved a CR-1 response compared with 35.3% ofplacebo-treated subjects (p<0.001). A significant treatmenteffect with ATX-101 was observed within all 18 subgroups.In ATX-101?treated subjects, CR-1 response was high in allsubgroups (?70%) and ?75% in 14 subgroups. When twosubgroups of the same demographic or baselinecharacteristic were compared, the difference in CR-1response between the subgroups within the ATX-101treatment group was not clinically meaningful and rangedfrom 0.1% (age) to 8.7% (ethnicity) with the exception ofrace (which was 10.2% [perhaps owing to the small sample


25

size for non-white subjects]), indicating minimal differencein CR-1 response rates as a function of subjectcharacteristics. In addition, a multivariate logistic regressionmodel predicting responder rates for CR-1 from the 9demographic variables indicated no effect of 7 of thevariables on treatment response, and only slightly higherresponse rates (not clinically meaningful) for subjects withhigher baseline SMF severity (84.3% vs 79.6%, p=0.002)and lower BMI (83.8% vs 79.1%, p=0.043).Conclusions: These results confirm that ATX-101 isefficacious in reducing SMF and improving submentalcontour regardless of subject characteristics at baseline.Learning Objective(s): At the end of the course, attendeesshould be able to describe the consistency in treatmentresponse to ATX-101 with regard to reduction in submentalfat across different subgroups based on demographic orbaseline characteristics.

4:50pm-5:40pmIC19 Surgical Techniques for Treating the Aesthetic MalePatientMichael Reilly, MD; Babak Azizzadeh, MD and Patrick J.Byrne, MDLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseThis course will provide background on the basis of themale aesthetic from the social and behavioral scienceliterature. We will then discuss specific surgical techniquesfor optimizing outcomes with aging face and rhinoplastysurgery for the male patient.Learning Objective(s): At the end of the course, attendeesshould be able to describe decision making and surgicaltechniques to optimize outcomes for the aesthetic male patient.

IC20 Stem Cell Therapy for Motor Nerve Regeneration -Overview with Presentation of Preliminary ResultsJ. Pepper, MDLevel of Evidence: Level V - Expert Opinion, case report orclinical exampleAlthough the application of stem cell biology to motor nerveregeneration holds great promise, there are significanthurdles that must be overcome prior to clinical use.Preliminary in vitro and animal transplant data will bediscussed in combination with a review of stem cell biologythat will be useful to a clinical audience.Learning Objective(s): At the end of the course, attendeesshould be able to have a basic understanding of neuralregeneration and the potential applications of stem celltherapy for motor nerve repair.

IC21 Facial ReanimationTessa A. Hadlock, MDThis course will cover comprehensive assessment andmanagement of the paralyzed face, and will highlight usefulalgorithms for diagnostic and therapeutic strategies.Learning objectives include understanding the breadth ofconditions resulting in facial paralysis, applying a zonalassessment paradigm to evaluation of the paralyzed face,and fully appreciating medical and surgical managementoptions for this complicated entity.

Paper Presentation: Patient Reported Outcome Measuresand Quality-of-Life in Dynamic Smile Reanimation usingGracilis Free Muscle TransferRyan M. Smith, MD and Peter C. Revenaugh, MDCore Competencies: Evidence-based Health CareLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseStudy Objective: The aesthetic goals of gracilis free muscletransfer for treatment of facial paralysis are assumed toimprove social function and self-perception. Patient reportedoutcomes measured with validated quality-of-lifeinstruments should be used to gauge success followingreanimation with this technique. The objective of this studyis to investigate the use of patient reported outcomesmeasured with validated quality-of-life instruments aftergracilis free muscle transfer.Design: A systematic review of the literature was performedto identify the use of patient reported outcome measuresafter dynamic smile reanimation with gracilis free muscletransfer. The collection of this data using validated quality-of-life instruments was assessed.Method: Of 326 articles identified, 68 articles reportedgracilis free muscle transfer. Of those articles, 18 werefound to include patient reported outcome measures. Onlysix studies measured changes in quality-of-life using avalidated instrument. Four of the six used the FacialClinimetric Evaluation Scale, one used the Facial DisabilityIndex, and one used the SF-36 health survey. The remaining12 articles used non-validated ad hoc questionnaires,assessments or direct interview methods.Conclusions: Patient reported outcomes are arguably themost important factor after gracilis reanimation, howeveronly a minority of studies included such outcomes. Thereare only two validated quality-of-life instruments for thefacial paralysis population and each has inherent limitationsmaking them less applicable following surgical reanimation.A validated quality-of-life instrument for assessing patientreported outcomes following gracilis free muscle transfer isneeded.Learning Objective(s): At the end of the course, attendeesshould be able to gain familiarity with methods used forreanimation of the paralyzed face and to learn aboutmeasurement of quality-of-life in these patients.


26

IC22 Comprehensive Upper and Lower Blepharoplasty withSurgical Adjuncts, Video Session, Part 2Guy Massry, MD (see IC 16)

IC23 Practical Approaches to Incorporating Research andEvidence Based Medicine into a Busy Facial Plastic SurgeryPractice, Part 2Lisa Ishii, MD; Travis Tollefson, MD; Sam P Most, MD;John S. Rhee, MD; Benjamin C. Marcus, MD; and MikeBrenner, MD(Same description and learning objectives as IC17)The following presentations are planned:Introduction to EBM (Dr. Brenner, Dr. Most, Dr. Ishii);Practicing EBM in an interdisciplinary cleft team (Dr.Tollefson); The rhinoplasty collective (Dr. Marcus); Thenew era of medicine--how to examine cost effectiveness intreatment of nasal obstruction (Dr. Most); Numbers, Lettersand Grade: Refining the Pyramid of Evidence (Brenner);Best practices of an academic-community relationship forconducting research (Dr. Rhee); and Cochrane reviews,systematic reviews, and using them in a facial plastic andreconstructive surgery practice (Dr. Ishii).

IC24 Rhinoplasty - My Personal ApproachAlexander Berghaus, MDLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseThe course presents the authors approach in rhinoplasty,including preoperative evaluation, the value of computerimaging, patient selection, main aspects of informedconsent, decision between open and closed surgery, nasaltip, middle vault, and bony structures surgery, relevance ofgrafts and cartilage flaps, and postop care and follow up.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) become acquainted with acomprehensive concept for rhinoplasty; and 2) avoid severemistakes in decision making in rhinoplasty surgery.

FRIDAY afternoon

1:30pm-2:20pmIC25 Face Transplant UpdateDonald Annino, MDThe course will explain the role of face transplantation in thereconstructive ladder. The course will review the experienceof the Face Transplantation program at the Brigham andWomen's Hospital. It is the busiest face transplant center inthe US, having done a total of 7 transplants.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) understand the role of facetransplantation in reconstruction; and 2) know the dvantagesand disadvantages of face transplantation.

IC26 Concepts, Analysis and Techniques in AfricanAmerican and Hispanic RhinoplastyIfe Sofola, MD; Kofi Boahene, MD; and Javier Diblidox,MDLevel of Evidence: Level V - Expert Opinion, case report orclinical exampleRhinoplasty in patients of African and Hispanic descent ison the rise. An ethnic sensitive approach in analyzing andperforming rhinoplasty in these groups is needed. Thiscourse provides concepts in ethnic sensitive rhinoplastydeveloped from the analysis of the African nose based onobservations made in over 350 consecutive patients and theHispanic nose in over 500 consecutive patients seekingprimary and revision rhinoplasty. Techniques for achievingnatural and aesthetically harmonious results in patients inthese groups is presented.Learning Objective(s): At the end of the course, attendeesshould be able to systematically analyze the African andHispanic nose in an ethnic sensitive manner for aestheticrhinoplasty and manage the thick skin nose, reduce flaredand wide nostrils with minimal scarring, create tip and dorsaldefinition in an ethnically sensitive manner.

Paper Presentation: Rhinoplasty with Adjuvant EndoscopicSinus Surgery and Maxillary Reconstruction -TheOtolaryngologist's PerspectiveSrinivasa Rao-Mergumala and Mr. Santdeep PaunCore Competencies: Practice-based Learning and ImprovementLevel of Evidence: Level IV - Case seriesStudy Objective: To present a series of patients whounderwent Rhinoplasty with Adjuvant Endoscopic SinusSurgery (RAESS). To document the diagnostic processfollowed and evaluate the efficacy safety and complications.To present two rare cases of Endoscopic MaxillaryReconstruction (EMR), in the first patient with unilateralmaxillary hypoplasia with facial asymmetry and of a secondpatient with large maxillary defect involving incisive maxillaextending in to maxillary sinus following multiple faileddental surgeries and their effective management.Design: Retrospective Clinical study of aseries of 18consecutive patients who underwent RAESS along with131patients, had rhinoplasty were evaluated over a five yearperiod. There were 12 women and 6 men with a mean ageof 36 years. 11 patients had chronic sinusitis, 5 patients hadnasal polyposis and two patients had maxillary defects.Method: The study included a series of patients whounderwent RAESS as a day case for facial cosmoses andfor concurrent sinus disease / nasal polyposis refractory tomedical therapy. They had preoperative CT scan of thesinuses sand standard pre and postoperative clinicalphotographs. The efficacy, safety and complications ofRAESS were analysed. They were followed up at oneweek, three months and six monthly. Follow up rangedfrom one to two years.Conclusions: RAESS offers a safe, cost- effective approachwith excellent results with good patient satisfaction in thestudy group. EMR with bone cement / moulded cartilage


27

can be an initial alternative to bone grafting avoidingadditional procedures at different operative siteavoiding thatoperative site pain and other related complications. Patientspresenting with nasal obstruction and sinus disease toleratedthis minimally invasive sophisticated RAESS procedureswithout added morbidity. Functional endoscopic nasalsurgery allows a clearer view of the operative field focusingon septum and turbinates and allows more accuratecorrection of nasal and sinus obstruction, and better controlof bleeding. Hence, allowing to treat the functional andinflammatory sinus and nasal disorders in a single stage, aswell as having aesthetic improvement.Learning Objective(s): At the end of the course, attendeesshould be able to learn the efficacy, safety and problemsassociated with rhinoplasty with adjuvant endoscopic sinussurgery and feasibility of endoscopic maxillaryreconstruction of congenital or acquired maxillaryabnormalities such as maxillary hypoplasia and iatrogenicmaxillary defects.

IC27 Personal Tips for Successful Correction of SeverelyDeviated Nose, Short Nose, and Saddle NoseYong Ju Jang, MDLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseSuccessful correction of deviated nose, short nose, andsaddle nose requires a comprehensive knowledge onanatomical defects and proper game plan. In this course, mymodification of extracorporeal septoplasty, septalreconstruction using costal cartilage, selection of dorsalaugmentation material and tip surgery technique will beintroduced.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) learn how to perform modifiedextracorporeal septoplasty; and 2) learn how to use costalcartilage effectively to correct severely deformed nose.

IC28 Translation of Combat Casualty Care Lessons to theCommunity Surgeon-Five Lessons Learned (Part 1)Moderator: Colonel Joseph Brennan, MDPanelists: Lieutenant Colonel Travis Newberry, MD;Lieutenant Colonel Jose Barrera, and Colonel G. RichardHolt, MDOver the past 10 years of combat casualty care in theMiddle East by military otolaryngologist-head and necksurgeons, many clinical lessons have been learned that canbe translated to the care of civilian casualties with face,head, and neck wounds. Not only will the civilianotolaryngologist-head and neck surgeon be faced with theusual trauma-motor vehicular and industrial accidents, andassailant injuries-but there is an increasing risk for casualtiesfrom natural and terroristic disasters. Lessons learned incaring for recent combat casualties can, and should be,translated to caring for civilian casualties, often withextensive wounds and injuries. The combat experiencedpanel members will discuss these lessons learned, addressedunder the topics of "life-saving head and neck skill sets,"

"soft tissue repair," "midface repair," and "mandible repair."A question and answer session will complete thispresentation.

IC29 Scar Wars: Winning with LasersJill Waibel, MD

IC30 Technology Devices for Minimally Invasive OfficeBased Facial and Skin Rejuvenation and NewApproaches for Neck RejuvenationRichard D. Gentile, MD, MBALevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseIn aesthetic practices minimally invasive or no down timeprocedures are the fastest growing and most demandedprocedures for anti aging. In conjunction with this theaesthetic technology industry continues to manufacture highquality technology devices for facial plastic surgeons andother core professionals. This course reviews the currenttechnology options available including lasers, radiofrequencydevices, ultrasound and others that facial plastic surgeonsmay wish to utilize in their practices.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) learn the basis for effectiveness ofenergy based devices for facial rejuvenation; and 2)understand potential complications of energy based devices.

IC31 Endonasal Management of the Nasal TipHolger Gassner, MD and Norman J. Pastorek, MDLevel of Evidence: Level IV - Case seriesSurgery of the nasal tip represents an important andchallenging aspect of rhinoplasty. The authors present analgorithmic approach to the correction of the nasal tip.Strategies to obtain elegant results with less invasivetechniques are presented. Illustrative cases are presentedand discussed, including difficult, revisional and congenitalcases.Learning Objective(s): At the end of the course, attendeesshould be able to better understand endonasal approachesand management of the nasal tip.

Paper Presentation: Revision and Complication Rates of175,842 Patients Undergoing SeptorhinoplastyEmily Spataro, MD; Jay F. Piccirillo, MD; DorinaKallogjeri, MD, MPH; Gregory Branham, MD; and ShaunC Desai, MDCore Competencies: Evidence-based Health CareLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseStudy Objective: The goal of this study is to determine theincidence of revision surgery and complications followingseptorhinoplasty, as well as to determine risk factorsassociated with these revisions and complications.Design: Retrospective cohort analysis of 175,842 patientsundergoing septorhinoplasty from the Healthcare Cost andUtilization Project (HCUP) State Inpatient Database (SID),State Ambulatory Surgery Database (SASD), and State


28

Emergency Department Database (SEDD) from California(CA), New York (NY) and Florida (FL).Method: A cohort of 175,842 patients undergoingseptorhinoplasty between 2005 and 2008 were collectedfrom the CA, NY and FL SASD. Revisit information forthese patients was then collected from the SASD, SID andSEDD between 2005 and 2012, with a minimum follow-uptime of 3 years. The rates of revision and complicationsafter an index septorhinoplasty were calculated, andbivariate analyses were performed to investigaterelationships of complications with demographic and clinicalcharacteristics. A multivariate model was then used todetermine risk factors for the occurrence of revision surgeryand complications.Conclusions: The overall rate of revision surgery followingseptorhinoplasty is 3.3%. Factors correlating with increasedrate of revision include age 13-18 years old, female gender,drug use, and surgery for cosmetic or congenital nasaldeformities. The average rate of complications is 1.1%. Themost frequent complications were infection, epistaxis orhematoma, and nasal obstruction, perforation, or synechiae.Learning Objective(s): At the end of the course, attendeesshould be able to understand overall revision rates andcomplications of septorhinoplasty.

2:30pm-3:20pmIC32 Skin Cancer for the Facial Plastic SurgeonJoshua Rosenberg, MD and Heather Rogers Ashbach, MDLevel of Evidence: Level I - High-quality, multi-centered orsingle-centered, randomized controlled trialThis course will review the diagnosis and treatment of pre-malignant lesions and non-melanoma skin cancer through amultidisciplinary approach involving dermatology and facialplastic surgery. We will review the accurate diagnosis ofskin lesions, emphasizing the characteristics of high risk skinlesions. Discussion regarding treatment options will involvethree key parts: the review of non-surgical treatment options(i.e. appropriate use of cryo therapy, emerging indicationsfor the use of vismodegib for basal cell carcinoma and theuse of topical treatments); discussion of evidence indicationsfor Mohs surgery vs. Wide Local Excision; and thediscussion of non-melanoma skin cancers that areinappropriate for Mohs surgery, the indications fordiagnostic imaging and treatment of nodal drainage basins,including current evidence for the use of sentinel nodebiopsy for non-melanoma skin cancer. Reconstruction ofskin defects is not the focus of this course, butreconstructive options will be reviewed when appropriate.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) assess a variety of skin pathology andidentify high risk lesions requiring further work-up andtreatment; and 2) initiate the appropriate work-up andtreatment options for high risk skin lesions and non-melanoma skin cancers.

IC33 Grafting Responsibly: Stabilizing the Nose for BetterLong Term OutcomesDean M. Toriumi, MDLevel of Evidence: Level V - Expert Opinion, case report orclinical exampleOutcomes in rhinoplasty can be a variable depending ontechniques used and precision in execution. In this coursewe will discuss how cartilage grafting can be executed withfewer complications and better long term outcomes.Cartilage grafting of the middle vault and nasal tip will becovered using intraoperative photography and video.Representative patient examples will be presented todemonstrate the use of each of the described grafts.Spreader grafts, septal extension grafts, lateral crrual strutgrafts and tip grafts will be covered in addition to otherstructural grafts. Some aspects of costal cartilage graftingwill be covered as well.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) recognize the different structuralgrafting maneuvers and execute them in their practice; and2) be able to minimize complications related to the use ofstructural grafts.

Paper Presentation: Anterior Septal Transplant: A Durableand Cartilage-efficient Technique for the ModifiedExtracorporeal SeptoplastyMyriam Loyo, MD; Edward El Rassi, MD; C. BlakeSullivan, MD; and Tom Wang, MDCore Competencies: Practice-based Learning andImprovementLevel of Evidence: Level IV - Case seriesStudy Objective: To describe a technique for extracorporealseptoplasty to reconstruct the anterior septum with the useof an extended spreader graft and a columnellar strut. Theadvantages of the reconstruction and the stability of therepair are studied.Design: Retrospective analysis of preoperative and post-operative pictures.Method: Retrospective review of 40 patients with at leastone year of follow up after rhinoplasty with anterior septaltransplant for the treatment of nasal obstruction with caudalseptum deviation. The main outcomes of interest wereimprovements in tip projection and rotation, as well as tipsymmetry on base view.Conclusions: The anterior septal transplant is an effectivetechnique to straighten the deviated caudal septum. Thetechnique avoids complications at the rhinion by preservingthe dorsal strut. The cartilage available is maximized for thereconstruction by using two separate grafts; the extendedspreader and columnellar strut. In spite of small grafts beingused, the reconstruction relies on the three-dimensionalanatomy of the nose and is stable over time.Learning Objective(s): At the end of the course, attendeesshould be able to describe a modified technique forextracorporeal septoplasty with cartilage-efficientreconstruction of the anterior septum by using an extendedspreader graft articulating to a columnellar strut.


29

IC34 Preoperative, Perioperative, and PostoperativeManagement of Eyelid Malpositions in the CosmeticPatientSara Wester, MD; Wendy W. Lee MD; Lisa Grunebaum,MD and Chrisfouad Alabiad, MDLevel of Evidence: Level V - Expert Opinion, case report orclinical exampleUpper and lower eyelid malpositions are common and occurin isolation or in conjunction with other eyelid malpositions.Failure to recognize these pre-operatively can lead to asuboptimal cosmetic result and dangerous ocular sequelae.This course highlights the variety of upper and lower eyelidmalpositions the surgeon will encounter along with examtechniques used to identify them. The participant will alsogain an understanding of the surgical approach to upper andlower eyelid malpositions. Cases will be presenteddemonstrating ocular complications and eyelid malpositionsthat occur after eyelid surgery and strategies to prevent.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) identify upper and lower lid eyelidmalpositions; 2) understand surgical approaches to treateyelid malpositions; and 3) identify and manage post-operative complications including new eyelid malpositions.

IC35 Translation of Combat Casualty Care Lessons to theCommunity Surgeon-Five Lessons Learned (Part 2)Moderator: Colonel Joseph Brennan, MDPanelists: Lieutenant Colonel Travis Newberry, MD;Lieutenant Colonel Jose Barrera, and Colonel G. RichardHolt, MD (see IC28 for description)

IC36 LADS: Laser Assisted Drug DeliveryJill Waibel, MD

IC37 1) SOOF Lift Blepharoplasty: Why You Should BeUsing this ApproachM. Sean Freeman, MDLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseFacial plastic experts who offer lower lid rejuvenation needto know how to do a SOOF lift blepharoplasty. This coursewill teach this approach and convince the uninitiated whythey should learn how to use this approach. Operative videowill be used to aid in this effort.Learning Objective(s): At the end of the course, attendeesshould be able to teach facial plastic surgeons why theyshould be using this approach and how it is done.

2) Endoscopic Browlift: A Segmental ApproachM. Sean Freeman, MDI like to refer to endoscopic brow surgery as a 'Goldilocksconundrum'. We don't want our patients to have results thatlook to high or too low but just right; but how do weaccomplish that? This talk will help the facial plastic surgeonindividualize the release technique to the patient based onseveral preoperative findings on exam. Operative video willbe used to aid in the teaching of this concept.

Learning Objective(s): At the end of the course, attendeesshould be able to teach facial plastic surgeons that they haveto have multiple release techniques to increase thepredictability of this procedure.

IC38 Laser Resurfacing and Chemical Peels - A DetailedLook at the Pros and Cons, Costs and Benefits (Part 1)Fred G. Fedok, MD; Paul J. Carniol, MD; AllisonHolzapfel, MD; and Mark Hamilton, MDLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseA variety of facial skin resurfacing methods exist with eachhaving a spectrum of favorable and unfavorable attributes.Each clinician utilizing such methods makes a decison aboutwhat modalities to offer in their individual practice. In thiscourse the two presenters will outline various parametersthat typically go into such decision making such as: patientselection, expected outcome, costs, patient downtime andrecovery, utilization of practice resources, and marketappeal. The two presenters will bring to the presentation areview of the current literature on the topic and real worldperspective from their practices. There will be a focus onmedium depth and deep chemical peels and fractionatedlaser technologies.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) list the various factors that should beconsidered when employing new procedures in theirpractice; and 2) be better equipped to discuss treatmentoptions with patients.

Paper Presentation: Alterations in the Elasticity and Pliabilityof Skin after the Injection of Onabotulinum Toxin AJames Bonaparte, MD and David Ellis, MDCore Competencies: Medical Knowledge, Evidence-basedHealth CareLevel of Evidence: Level II - Lesser-quality, randomizedcontrolled trial; prospective cohort study; or systematicreview of these studiesStudy Objective: To test the hypothesis that theadministration of a botulinum toxin A will result in anincrease in skin pliability and elasticity as assessed by thecutometer.Design: This was a prospective cohort study in whichpatients were treated with a botulinum toxin and assessed atbaseline, two-weeks and two, three and four months postinjection.Method: 40 women with moderate to severe facial rhytideswere prospectively enrolled.Conclusions: For all sites, pliability, elastic recoil and theUv/Ue parameters were significantly related to time.Specifically, pliability and elastic recoil increased while theUv/Ue ration decreased for all sites up to three months post-injection (p<0.001). The glabella maintained this response atfour months post-injection (p=0.001). These results suggestthat on a botulinum toxin A results in a short term increasein skin elasticity and pliability with evidence that there is anincrease in the organization of collagen in the skin.


30

Learning Objective(s): At the end of the course, attendeesshould be able to understand the effect botulinum toxin hason the skin, understand the principles of the cutometerwhen measuring skin biomechanics.

3:50pm-4:20pmIC39 A Practical Guide of Sutures in RhinoplastyRoxana Cobo, MDAll rhinoplasties use suturing techniques to align, helpdefine, project and rotate. It becomes important tounderstand what result is obtained with each suture that isused and to learn how to make the proper decisionsdepending on the patients nasal deformity. In this coursethe most important suturing techniques will be covered usinga comprehensive, step-by-step demonstration withintraoperative pictures and videos. Representative patientexamples will be used to explain each case. Suturingtechniques like the lateral crural steal, dome definingsutures, transdomal suturing techniquest, intercrural suture,septocolumellar suture will be explained in addition to otherimportant learning suturing techniques.Learning Objectives: At the end of the course, the attendeesshould be able to: 1) know the most important suturingtechniques used in rhinoplasty; 2) have a clearunderstanding on the surgical techniques used; and 3)understand the indications and limitations of each technique.

IC40 Artful Reconstruction of the Lip and Cheek DefectsGregory S. Renner, MDLevel of Evidence: Level IV - Case seriesThis course is intended to be a review and comparison ofvaried techniques useful to reconstruction of large and morecomplicated defects of the upper and lower lips; and toexamin the cheek as an aesthetic unit, exploring in detailsurgical techniques that are important to providing optimalaesthetic restoration to these important subunites of theface. It will focus on choices for reconstruction with strongconsideration to cosmetic and functional outcomes and tospecial difficulties experienced with each. Conceptspertinent to artful skin graft and flap reconstructions will bediscussed in detail.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) discuss cosmetically superior methodsof designing reconstructions for the cheek and lips; 2)review multiple plans that optimize form and function in thecheeks and lips; and 3) adapt much of the presentedinformation to their own practice in midfacialreconstruction.

Paper Presentation: Early Surgical Management of SelectFocal Infantile Hemangiomas: the Tissue Expander EffectTara E. Brennan, MD; Milton Waner, MD and Teresa O.,MDCore Competencies: Practice-based Learning andImprovement, Medical Knowledge, Patient CareLevel of Evidence: Level IV - Case seriesStudy Objective: To identify focal head and neck lesions

which will likely not completely involute with medicalmanagement and which are ideal for a one-stage surgicalexcision. Surgery is more effective for these lesions, andthe tissue expansion effect of the hemangioma facilitatesexcision with primary closure. Recognizing these lesions as adistinct category within infantile hemangiomas will savethese patients from prolonged medical treatment, the longterm effects of which have not been well studied.Design: Expert opinion based on more than 20 yearsexperience of the senior surgeon working at a tertiaryvascular anomalies referral center. Included arephotographic case examples of patients with focal infantilehemangiomas of the lip, nose, eyelid, and forehead, beforeand after surgical excision.Method: We demonstrate superior aesthetic and functionalresults achieved over time with surgical management offocal infantile hemangiomas. Prolonged medical therapy isnot necessary in these cases. We demonstrate how thetissue expansion effect of a focal infantile hemangiomafacilitates excision of the lesion and primary closure withoutdistortion of anatomical subunits.Conclusions: We urge clinicians to consider early surgicalintervention in infants with select focal hemangiomas overprolonged observation and medical management throughoutchildhood. The psychological benefit of early removal ofthese disfiguring lesions has not been quantified, but isimmediately evident to clinicians and the families ofpatients, alike. Further, the costs and unknown long-termsequelae of beta-blocker medication have also not yet beenquantified, but will gain increasing salience in the currentmedical climate.Learning Objective(s): At the end of the course, attendeesshould be able to identify focal head and neck lesions whichwill likely not completely involute with medical managementand which are ideal for a one-stage surgical excision.

IC41 How to Perform Multiple Facial Plastic ProceduresUsing Local and Level One Sedation Anesthesia (It's notWhat You Can Do, But How Much)John Standefer, MD and Jason Swerdloff, MDLevel of Evidence: Level V - Expert Opinion, case report orclinical exampleWe will present our experience of over 10,000 facialprocedures performed under Local Anesthesia using LevelOne sedation. Experience has shown us that multipleprocedures can be done safely using a dilulte local anestheticand Level One sedation. Patient satisfaction scores,painscores and tolerance are monitored and reported. Patientexamples of before and after are presented.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) safely administer local anesthsiaperforming multiple facial procedures in one setting usingLevel One Sedation; and 2) practice patient safety andcomfort.


31

Paper Presentation: The Use of Propofol/KetamineAnesthesia with Bispectral Monitoring (PKA-BIS) versusInhalational Anesthetics in Rhytidoplasty - A Prospective,Double-blinded, Randomized Comparison StudyKristin A. Jones, MD and Keith A. LaFerriere, MDCore Competencies: Practice-based Learning andImprovement, Patient Care, Evidence-based Health CareLevel of Evidence: Level I - High-quality, multi-centered orsingle-centered, randomized controlled trialStudy Objective: To evaluate and compare post-surgicaloutcomes in patients following administration of eitherpropofol-ketamine anesthesia with bispectral monitoring(PKA-BIS) or inhalational anesthesia during lower faceliftsurgery.Design: Prospective randomized, double-blinded comparisonstudy of two anesthetic types in 30 consecutive femalepatients undergoing rhytidoplasty by a single surgeon at asingle outpatient surgery center.Method: Outcome measures included nausea, vomiting,pain, overall feeling of well-being, time to awaken, time todischarge, and cost. Patient measures were recorded usinga combination of a validated post-operative recoveryquestionnaire (QOR-40)13,14 and visual analog scales.Results were recorded immediately following surgery and onpost-operative days 1 and 7.Conclusions: A statistically significant reduction inemergence time and time to meet discharge criteria was seenin patients receiving PKA-BIS anesthesia. Patient-reportedlevels of post-operative nausea, vomiting, and confusion onthe day of surgery were also decreased in the PKA-BISgroup. These subjective differences approached, but didnot reach, statistical significance. Differences in globalrecovery scores, post-operative overall feeling of well-being,and post-operative pain perception between PKA-BIS andinhalational anesthesia groups did not reach statisticalsignificance. Cost of anesthesia administration was similarbetween the PKA-BIS and inhalational anesthesia groups.Learning Objective(s): At the end of the course, attendeesshould be able to better understand options for anesthesiaadministration during facelift.

IC42 Designing the e-PTFE (Gore-tex) for OptimumResult; Use of Conchal Cartilage for Support of WeakSeptal Extension Graft; and Surgery for Correction ofRetracted ColumellaEduardo Yap, MDLevel of Evidence: Level IV - Case seriesSouth East Asian noses are small, upturn with hanging alaand retracted columella. Septum is commonly used asSeptal Extension Graft to counterrotate the tip and relocatedthe columella more caudally but sometimes the SEG may besmall and conchal cartilage is used for further support. e-PTFE is often used for dorsum and its popularity has leadto complications e.g. implant deviation/visibility andinfection. Short video clips will be shown with attention tothe finer details in techniques.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) know the use of conchal cartilage for

support of SEG. 2)know the surgical treatment for a betterala-columella relationship outcome. 3) know thetechniques in designing the shape of the e-PTFE as dorsalimplant for the best aesthetic result with least complications.

IC43 Fat Grafting and Facial FillersSam M. Lam, MD; Mark J. Glasgold, MD; and TomTzikas, MDThe course will cover the following topics: Introduction toVolume Aesthetics, Evolving Considerations (Dr. Glasgold);Fat Grafting Methodology: How I Do It (Dr. Tzikas); andFacial and Eye Framing: Seeing Triangles and Ovals (Dr.Lam).

IC44 Academic Aesthetic Surgery Success Stories (Part 1)Peter A. Hilger, MD; Anthony Brissett, MD; Patrick J.Byrne, MD; Kofi Boahene, MD; Tom D. Wang, MD;Michael Kim, MD; and Taha Shipchandler, MDLevel of Evidence: Level V - Expert Opinion, case report orclinical exampleAn experienced faculty will be available to provide insightsgained over years of successful practice; share strategiesthat worked and those that didn't; discuss barriers andfrustrations encountered and how they were or aremanaged; outline essential elements for success includingstaffing, funding, practice site, marketing and the integrationwith reconstructive surgery within an academicenvironment. The course will be structured to encourageinteraction among faculty and attendees.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) learn a variety of tactics that havebeen essential in building an aesthetic practice; and 2) gaininsights that may be most applicable in their unique practiceenvironment.

IC45 Laser Resurfacing and Chemical Peels - A DetailedLook at the Pros and Cons, Costs and Benefits (Part 2)Fred G. Fedok, MD; Paul J. Carniol, MD; AllisonHolzapfel, MD; and Mark Hamilton, MD (see IC38 fordescription)

4:50pm-5:40pmIC46 An Interactive Course - Handling Extensive FacialSoft Tissue and Skeletal InjuriesKrishna Patel, MD; Philip R. Langsdon, MD; Fred G.Fedok, MD; John L. Frodel, Jr., MD; Robert M.Kellman, MD; and Jessyka Lighthall, MDLevel of Evidence: Level II - Lesser-quality, randomizedcontrolled trial; prospective cohort study; or systematicreviewThis course will discuss cases of extensive facial trauma,from fractures to gunshot wounds. Presenters will describemethods to handle extensive fractures; from re-establishment of facial buttresses to handling palatal andother complicated unstable cases. The format is based onaudience interaction and dialogue between the audience andpresenters.


32

Learning Objective(s): At the end of the course, attendeesshould be able to: 1) understand how to reconstruct themassively fractured patient; and 2) construct an surgicalsequence order during pan facial fractures.

IC47 Seven Critical Steps: The Crooked Nose AlgorithmBenjamin C. Marcus, MD and Travis Tollefson, MDLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseOne of the cornerstones of nasal surgery is repair of acrooked or twisted nasal deformity. This course will presenta concise algorithm for dealing with the crooked nose. Wewill provide key elements of 1) Diagnosis 2) Selectingtreatment options 3)Timing of repair 4) Key pearls of preand post care to increase surgical success.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) understand how to evaluate anddiagnose the crooked and injured nose; and 2) be able touse the algorithm provided to select the correct surgical planto ideally correct the crooked nose.

Paper Presentation: Reducing Visibility in the ButterflyGraft for Treatment of Nasal Obstruction; Our 10 yearExperience at OHSUMyriam Loyo, MD; Deniz Grecci, MD; and and TomWang, MDCore Competencies: Practice-based Learning andImprovementLevel of Evidence: Level II - Lesser-quality, randomizedcontrolled trial; prospective cohort study; or systematicreview of these studiesStudy Objective: To describe the modifications made to thebutterfly graft after the last 10 years of experience to treatnasal obstruction and prevent its visibility.Design: Prospective cohort and blinded surveyMethod: We prospectively collected nasal obstructionsymptoms evaluation scores (NOSE scores) as well asclinic-demographic data on 14 patients who underwentrhinoplasty with 1 year follow up. Separately, we designed asurvey for blinded observers to try to detect butterfly graftson patients 1 year after their rhinoplasty.Results: We demonstrate stable improvement in NOSEscores 1 year after rhinoplasty with butterfly graft (averagepre-op NOSE score 72 and average post-op 24, t-testp<0.0001). Sixteen observers participated in the blindedsurvey for the study. When the graft was present, observersdetected it 66% of the time. When the graft was notpresent, 40% of the time observers suspected it waspresent.Conclusions: The modified butterfly graft is an effective toolin the treatment of nasal obstruction with acceptablevisibility.Learning Objective(s): At the end of the course, attendeesshould be able to use the butterfly graft to treat internalnasal valve collapse and prevent its visibility.

IC48 Advanced Techniques in Modern VolumizingBlepharoplastyAndrew A. Jacono, MD and Guy Massry, MDLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseLower Eyelid Rejuvenation can be accomplished with manytechniques which includes both non-surgical and surgicalapproaches. In surgery, the approaches range fromtransconjunctival to transcutaneous approaches, from fatexcision to fat repositioning/preservation or fat transfer, andwith no, some or aggressive manipulation of the orbicularisoculi muscle. Procedures discussed include hyaluronic acidinjections, autologous fat transfer, extended lowerblepharoplasty with orbital fat transposition, limited incisiontransconjunctical approaches, orbicularis redraping, and skinexcision versus skin redraping. An algorithm and decisionmaking tree for lower eyelid rejuvenation is presented.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) understand technical aspects ofblepharoplasty volumizing procedures including orbital oattranspositions (from both transcutaneous andtransconjunctival approaches), and autologous fat grafting;and 2) learn closed and open approaches to the orbicularismuscle that can impact volume changes in blepharoplastyand improve results.

IC49 Rhinoplasty: Improving Results, Nasal Analysis,Nuances of the Nasal Dorsum and De-Mystifying NasalOsteotomiesSpencer Cochran, MDLevel of Evidence: Level V - Expert Opinion, case report orclinical exampleThis course is designed for rhinoplasty surgeons of all levelsand presents a systematic approach to analyzing the nosethat for a transition of the analysis to a coherent operativeplan; examines nuances of managing the dorsum in primaryand secondary rhinoplasty including hump reduction,augmentation, spreader grafts, and correction of a dorsaldeviation; examines the misconceptions of osteotomies anddiscusses improved techniques for osteotomy performance.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) learn a systematic means of analyzing arhinoplasty patient that allows for a transition of the analysisto a coherent operative plan; 2) recognize common nasaldeformities; 3) improve functional and aesthetic results inprimary and secondary rhinoplasty; and 4) improve resultsin primary and secondary rhinoplasty.

IC50 Preparing for the Certification Examination in FacialPlastic SurgerySam M. Lam, MD; Dirk Jan Menger, MD; and RoxanaCobo, MDThe important final step for physicians specializing in facialplastic surgery will be board certification. To achieveIBCFPRS or ABFPRS certification, facial plastic surgeonsare required, among other things, to pass a two-day writtenand oral examination in facial plastic and reconstructive


33

surgery. The prospective applicant will sit for thisexamination either as a requirement for fellowshipcompletion or as part of the regular application process.This course will provide study and preparation assistance tophysicians sitting for the examination. An overview of examtopics will be presented, along with a discussion of variousstudy skills that may be useful in preparing for the exam.Learning Objective(s). At the end of the course, participantsshould be able to: 1) have a general understanding of whichtopics will be covered on the examination; 2) be familiarwith available study materials; and 3) improve the efficiencyand effectiveness of their study skills.

IC51 Academic Aesthetic Surgery Success Stories (Part 2)Peter A. Hilger, MD; Anthony E. Brissett, MD; Patrick J.Byrne, MD; Kofi Boahene, MD; Tom D. Wang, MD;Michael Kim, MD; and Taha Shipchandler, MD (see IC44for description)

IC52 The Difficult Cosmetic Lower Lid- Bulging, Sagging,and RetractionSofia Lyford-Pike, MD; Peter A. Hilger MD; and AliMokhtarzadeh, MDLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseLower lid blepharoplasty is one of the most successful andgratifying operations in aesthetic facial surgery. Subtlecomplexities of the procedure and lower lid anatomyhowever predispose this surgery to challenges andcomplications. These are encountered even by the mostexperienced surgeon. This course will focus on suchchallenges and techniques to prevent and treat possiblecomplications. Importantly, this course offers theperspective and expertise of both facial and oculoplasticsurgeons.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) learn risk factors for adverse outcomesin lower lid blepharoplasty with an oculopastic surgeonsperspective and appreciate strategies to prevent problems;and 2) learn technical pearls with video demonstration ofefficient techniques.

SATURDAY afternoon1:30pm-2:20pmIC53 Injectables State of the ArtCorey S. Maas, MDThis advanced course will present a contemporary algorithmfocusing on site specific selection of soft tissue fillers,advanced uses and nuances of Botulinum toxin therapy.The newly approved injectable agents will be introducedincluding best practices with Kybella, Voluma and RestylaneSilk and Lyft with methods to optimize results, reduceexpenses and increase patient loyality. Each segment willbriefly cover basic science and relevant studies with thefocus on video demonstrations by various expert injectorsincluding Dr. Maas.

Paper Presentation: Five Year Bellafill Clinical Trial onLong-Term Safety of PMMA-collagen for the Correction ofNasolabial FoldsJohn Joseph, MDCore Competencies: Medical Knowledge, Evidence-basedHealth CareLevel of Evidence: Level I - High-quality, multi-centered orsingle-centered, randomized controlled trialStudy Objective: To substantiate the safety of Bellafill usinga 5 year prospective study to assess the correction of thenasolabial fold and the safety of the PMMA-collagenproduct.Design: This trial was an open-label prospective postapproval study conducted at 23 centers in the United States.1008 subjects were skin tested and enrolled in the trial.Method: All subjects received treatment at Day 1 afterhaving a negative skin test at least 28 days prior. They wereallowed a touch-up as needed at Day 30 and at Day 60.Subjects returned for assessment and photographs 3 monthsafter the last treatment. At regular intervals, subjects wererequired to fill out a detailed subject follow up questionnaireand a satisfaction survey. Subjects with potential adverseevent concerns were asked to return to their sites forevaluation. All subjects received a final in-office evaluationat the end of the study (60 months).Conclusions: 871 subjects completed the study (87%). 88%of the subjects had no treatment related adverse events. Atotal of 17 cases of biopsy-proven granulomas werereported. 7 cases were rated as mild, 8 were moderate, and2 were severe. 9 cases resolved by the end of the study andan additional 6 were improving. Both severe cases resolvedand no cases worsened with severity. The incidence ofgranuloma was 1.7%. Therefore, granulomatous reactionsappeared to be infrequent with PMMA-collagen. There wasa high degree of patient satisfaction over the course of thetrial with 79% of the subjects feeling satisfied to verysatisfied at 12 months and 78% feeling satisfied to verysatisfied at the end of the trial. Bellafill is a safe andeffective treatment for the correction of nasolabial foldswith high satisfaction rates maintained through 5 years.Learning Objective(s): At the end of the course, attendeesshould be able to understand and evaluate the efficacy andsafety of Bellafill over a 5 year period.

IC54 1) Secondary Rhinoplasty without the Use of CostalCartilage: A Successful Long Term ExperienceStephen W. Perkins, MDLevel of Evidence: Level IV - Case seriesThis course is designed to demonstrate that it is rarelynecessary to harvest and use costal cartilage in secondaryrhinoplasty. A carefully thought out approach to revisingmultiple previously operated upon noses with techniquesthat preserve existing cartilage and maximize the use ofconchal cartilage for reconstruction and augmentation.Detailed analysis with a surgical plan presented anddemonstrated with intra operative photos, video clips,artistic illustrations and plenty of pre and post op results of


34

the techniques shown.Learning Objective(s): At the end of the course, attendeesshould be able to learn multiple ways of achieving excellentlong term rhinoplasty results without the 'routine' use ofcostal cartilage.

2) Revision Rhinoplasty: Strategic Evaluation and TechnicalSolutionsIra D. Papel, MDLevel of Evidence: Level IV - Case seriesThis course will focus on placing revision rhinoplastychallenges into an ordered diagnostic sequence, and thenintroduce rational surgical techniques to repair the specificproblems in the most efficient and least invasive manner.Clinical examples will be used to correlate the findings withtechniques and outcomes.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) improve diagnostic evaluation ofrevision rhinoplasty patients; and 2) apply specific andefficient surgical techniques for various revision rhinoplastyfindings.

Paper Presentation: Revisional Rhinoplasty - Aesthetic andFunctional Doctor - Patient AssessmentHeloisa Koerner, MD; Cézar Berger, MD; and DaniellaCandia Barra, MDCore Competencies: Practice-based Learning andImprovementLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseDesign: Retrospective comparative study. Comparitionbetwen patiets' complaints and theirs surgeons' evaluations.Method: A prospective study of 43 patients undergoingrevisional rhinoplasty and its surgeons through aquestionnaire about epidemiological questions and subjectiveaesthetic and functional complaints of patients and theirfunctional deformities observed by surgeons was conducted.After these, data were correlated to observe the frequencyof concomitant reports between doctors and patients.Conclusions: Fallen tip followed by residual bone humpwere the main patient complaints confirmed by theobjective examination by their doctors. The presence of37.2% of patients with nasal obstruction complaints showsthat more attention should be given to the functionaldeformities during the first surgery. The differencesobserved between patients' complaints and surgeons'reviews reinforce the need of detailed evaluation and patientclarification regarding their expectations and actual surgicalpossibilities.Learning Objective(s): At the end of the course, attendeesshould be able to profile the major aesthetic and functionalreported complaints by patients undergoing rhinoplastyrevisonal and correlate them to internal and external nasalobjective evaluation by their surgeons.

IC55 1) Improved Patient Care through Lawsuit Protectionand PreventionTracy AhmadLevel of Evidence: Level V - Expert Opinion, case report orclinical exampleThis course teaches proven and effective strategies toprevent and protect against lawsuits, allowing facial plasticand reconstructive surgeons the peace of mind necessary tofocus on improved patient care. You will learn lawsuitprotection strategies most advisors are unaware of.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) maintain focus on improved patientcare rather than lawsuit defense; 2) structure a practice forlawsuit protection and prevention; and 3) reduce liabilityinsurance costs.

2) Malpractice in Facial Plastic SurgeryFerdinand Becker, MDLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseThis course is based on a retrospective review of closedclaim malpractice cases over a 10 year span in the State ofFlorida. Details on the types of claims, frequency,settlement/judgement amounts are included.Learning Objective(s): At the end of the course, attendeesshould be able to gain significant insight on malpractice infacial plastic surgery and will know how to avoidmalpractice actions in their practices.

IC56 1) Cleft Lip in Yemen: A 13-Year StudyMohamed Al Saeedi, MDLevel of Evidence: Level V - Expert Opinion, case report orclinical exampleCleft lip is the most common congenital anomaly in Yemenand in our study we discovered this congenital anomaly ishigh in the cities in the high mountains, with a difficult styleof living and malnourished and hard working mothers. Wemake a transposition flap from the cleft side muscle andmicosa support the protrusion of the middle part of the lip tolook more aesthetic.Learning Objective(s): At the end of the course, attendeesshould be able to perform a cleft lip repair and achieve goodaesthetic look.

2) Care of the Cleft Palate Patient: A Problem BasedApproach to Closing the Gap and ManagingVelopharyngeal Insufficiency plus Unilateral Cleft LipRepair: Keys to Optimizing Lip and Primary Nasal ResultsJoseph Rousso, MDLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseAssessing the most critical steps in the care of the cleftpalate patient, and identifying which factors are most likelyto cause post-operative complications. Reviewing the typesof repairs that can be used, the meticulous attention that isnecessary for the repositioning of the velar musculature, andclose post-operative follow up in a team-based setting to


35

achieve optimal results. In addition we will review anddiscuss our evidenced-based principles in the surgicaltreatment of velopharyngeal insufficiency.Learning Objective(s): At the end of the course, attendeesshould be able to understand the most appropriate principlesin surgical repair of the cleft palate and surgical treatment ofvelopharyngeal insufficiency.

IC57 A Personal Evolution of Facial Rejuvenation: TowardSimplification Using the “Delta” Plication TechniqueJames C. Grotting, MDThe course outlines the rationale behind his transition fromtraditional extended SMAS flap elevation to his moreconservative plication technique to rejuvenate the mid face,jowls, and neck.

IC58 1) Droopy Nasal Tip: Different Treatment TechniquesAlireza Mesbahi, MDCore Competency: Practice-Based Learning andImprovementLevel of Evidence: Level V - Expert Opinion, case report orclinical exampleDroopy Nasal Tip is a very common problem duringRhinoplasty operation that must be addressed according tothe underlying cause by different surgical techniques .During this course I will review with participants practicallydifferent treatment modalities for correction the droopynasal tip during rhinoplasty with pictures and video clips .Asdroopy nasal tip is very common in the middle eastern nosesI had many patients with this problem & I will share withthem my great experience in this regard .Learning Objective(s): At the end of the course, attendeesshould be able to learn the best treatment modalities forcorrection of droopy nasal tip.

2) Advancement Genioplasty by Osteoplastic TechniquesMohsen Naraghi, MDLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseThe importance of chin in facial harmony may beunderestimated by facial plastic surgeons. In this coursedifferent chin parameters contributing to the facial profileharmony will be described. Osteoplastic techniques for chinadvancement will be demonstrated through instructivevideos. Post-operative results and tips to preventcomplications will be presented.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) know different chin parameterscontributing to the facial profile harmony and select theappropriate cases; and 2) apply different osteoplastictechniques for chin advancement and avoid complicationsand best results.

3) Middle Eastern RhinoplastyMohsen Naraghi, MDLevel of Evidence: Level IV - Case seriesMiddle Eastern rhinoplasty has been considered as one of

the most difficult primary rhinoplasty procedures. Heavyand thick skin cause misjudgment in planning for surgicaltechnique. In this course, special anatomic considerations,different approaches, common pitfalls and preventivemeasures in the surgery of the Middle Eastern noses will bediscussed.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) know anatomic characteristics and riskfactors in the Middle Eastern noses; and 2) select the besttechnique for each type of the Middle Eastern noses.

2:30pm-3:20pmIC59 Comprehensive Facial Aging Surgery: FromConsultation to After CareJonathan M. Sykes, MDThe public desire to improve facial appearance with facialrejuvenation procedures has increased. This heighteneddemand is a result of increased media attention to a youthfulappearance and more aesthetic practitioners and more andvaried aesthetic procedures.In order to successful treat aesthetic patients, the surgeonmust recognize and pay attention to 4 important issues.These include: 1) preoperative patient selection, 2)procedure choice, 3) meticulous surgical execution, and 4)empathetic postoperative care. This course will providedetailed description of a variety of facial aging proceduresincluding all periorbital and lower facial aging surgicalprocedures, and minimally invasive injectable procedures.The lecture will also outline which patient types do wellwith which procedures. Lastly, the course will describe thepsychological factors that impact appropriate patientselection and successful perioperative care.

IC60 Hair Transplant 101Sam M. Lam, MDThis course will cover medical therapies, hairline designprinciples, recipient-site creation, regenerative medicine,marketing, FUE vs.FUT.

IC61 1) Effective Tissue-Conservative Strategies forContouring the Wide Nasal TipRichard E. Davis, MD; Ivan Wayne, MD; and MilosKovacevic, MDLevel of Evidence: Level IV - Case seriesAchieving a durable, attractive, and functional nasal tipcontour remains one of the greatest challenges in cosmeticnasal surgery. Excision-based techniques inevitably lead toreduced skeletal support and are prone to unpredictablelong-term tip deformities, but the results of classic tip suturetechniques may also produce unfavorable outcomes.Lobular pinching, inversion of the lateral crura, and/orretraction of the alar margin are all common sequelae ofthese tip-narrowing strategies. We present alternativemethods for controlled refinement of the wide nasal tip.Various strategies are presented including alternative tip-suturing techniques, tip cartilage redistribution techniques, amodification of the lateral crural transposition technique,


36

and integrated structural grafts for support of the alar rim.These strategies all conserve tip cartilage for betterstructural stability and more predictable long-termoutcomes.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) better understand the drawbacks andadverse consequences of excision-based tip-narrowingtechniques; 2) develop a clear understanding of the skeletalconfiguration needed to produce a sturdy and well-proportioned tip framework; and 3) acquire new techniquesfor achieving a fully-functional and attractive tipconfiguration without excessive cartilage resection.

2) Rhinoplasty in the Ultra-Thick and Ultra-Thin SkinnedNoseRichard E. Davis, MD; Ivan Wayne, MD; and MilosKovacevic, MDLevel of Evidence: Level IV - Case seriesTwo of the most difficult problems to overcome inrhinoplasty are achieving aesthetically pleasing long termresults in thick skin patients and thin skin patients. Twoexperience rhinoplasty surgeons will present theirapproaches to overcoming these challenges.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) recognize the unique characteristics ofthe thin skin patient and possible long term sequalla afterrhinoplasty surgery; and 2) develop a surgical plan for thethick skin patient.

Paper Presentation: Development and Validation ofExpectations of Aesthetic Rhinoplasty Scale (EARS)Mohsen Naraghi, MD and Mohammad Atari, MDCore Competencies: Practice-based Learning andImprovement, Medical Knowledge, Patient CareLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseDesign: The first part of the study is scale development.The second phase is case-control.Method: A total sample of 162 students (105 females, 55males, and 2 missing gender) was recruited for constructionstage. A sample of 20 aesthetic rhinoplasty patients (10BDD patients and 10 non-BDD patients) was recruitedusing purposeful sampling strategy. An item pool of sixitems was administered to participants. Items weredeclarative statements to be answered on a 6-point Likertscale ranging from "completely agree" to "completelydisagree". Scores were correlated with a measure of generalpsychopathology. Moreover, independent t-test was used todifferentiate BDD patients and non-BDD patients.Conclusions: Findings from this study provided evidence forreliability and validity of EARS. The instrument wasinternally consistent and temporally stable. This 6-item scaledemonstrated satisfactory validity. Finally, this 6-item self-report scale has the adequate psychometric properties andmay be used in research and clinical settings.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) develop a brief scale for measurement

of expectations toward aesthetic rhinoplasty (EARS); 2)provide evidence for reliability and validity of EARS; and 3)provide a basis for pre-operative screening of BodyDysmorphic Disorder.

IC62 Thin Skin Rhinoplasty: Aesthetic Considerations andSurgical ApproachPeter A. Hilger, MD and Michael Brenner, MDLevel of Evidence: Level IV - Case seriesThin nasal skin reveals subtle imperfections of theunderlying framework and has profound implications forrhinoplasty. The inattention to this subject is striking, giventhe small tolerances in these patients. We discuss riskfactors for parchment thin skin, bossae, and relatedcomplications, presenting several techniques for achievingoptimal rhinoplasty outcomes.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) identify variants of thin skin anddescribe the range of surgical considerations that pertain torhinoplasty in such patients; and 2) describe interventionsthat are useful in achieving optimal outcomes andpreventing/correcting complications of rhinoplasty in thepatient with thin nasal skin.

IC63 Adjunctive Procedures to Improve the Facelift Resultincluding the Secondary FaceliftJames C. Grotting, MDThis course emphasizes techniques that complement the liftby filling depressions, smoothing contours, rejuvenatingoverlying skin and improve sagging oral commissures.

IC64 Advanced Techniques and Nuances in Deep PlaneRhytidectomyAndrew A. Jacono, MD and Neil Gordon, MDLevel of Evidence: Level II - Lesser-quality, randomizedcontrolled trial; prospective cohort study; or systematicreviewRecently, their has been a greater understanding of theanatomy of the face and neck, including the midface's fatcompartments, ligaments and musculature as well as theplatysma muscle's ligamentous attachments. This course willexplore incorporating these anatomic understandings withdeep plane rhytidectomy. Areas of focus will include deepplane dissection of the midface, treatment of the buccal fatcompartment, complete platysma dissection and release,vertical vectoring in resuspension, and the implications ofthese techniques on incision approaches. The speakers givetheir understanding after experience with over 2,500 deepplane rhytidectomies.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) understand surgical dissection planeswith deep plane rhytidectomy and how they differ fromSMAS flap approaches; and 2) utilize advanced anatomicknowledge of facial retaining ligamaent release to maximizemidface and neck rejuvenation.


37

3:50pm-4:40pmIC65 Optimal Re-contouring of the Face and Neck (Part 1)Fred G. Fedok, MD and Philip R. Langsdon, MDCore Competency: Practice-Based Learning andImprovement, Medical Knowledge, Patient Care, Evidence-based Health CareLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseThis course will present a cogent system for the participantto engage the treatment of the aging face and neck throughrytidectomy. Topics to be covered include: skin elevationdecisions...with vascular limits, standard and extensive deepplain lifting decisions (near vs far, low + high overinfraorbital) and skin, sub q fat, subplatysmal fat andmuscular suspension decisions for neck. Numerous caseswill be presented as well as video supplements. Time willremain for audience participations and questions.Learning Objective(s): At the end of the course, attendeesshould be able to diagnose and treat various aspects of theaging face.

Paper Presentation: Novel Facial Dimensions DescribingPositioning of Key Anatomic ElementsPhilip Young, MDCore Competencies: Practice-based Learning andImprovement, Medical Knowledge, Patient Care, Evidence-based Health Care, Systems-based PracticeLevel of Evidence: Level II - Lesser-quality, randomizedcontrolled trial; prospective cohort study; or systematicreview of these studiesDesign: This is a survey where we will ask participants torate pictures to determine the most attractive picture. Fromthere, we can extrapolate what is ideal to these participantsand likely to the general population.Method: We will have 10-15 sections of line drawings andmorphed pictures to test these elements and our goals is tohave 150 surveys to find the best looking arrangement. 4pictures will be affiliated with each of the 10-15 sections.They will be asked to rate pictures 1-4 where 1 is the mostattractive picture and 4 is the least attractive picture.Conclusions: We will determine some key relationshipsamong important anatomic elements to elucidate more aboutthe secrets of facial beauty. This will add to our growingknowledge surrounding our new theory on facial beautycalled the Circles of Prominence.Learning Objective(s): At the end of the course, attendeesshould be able to determine the correct positioning of theear, nose, mouth, eyebrows, etc and how it relates toshadowing within the face. This will further help elucidatethe mystery of facial beauty that was originally proposed inour study published in the Archives of Facial Plastic Surgerycalled the Circles of Prominence.

IC66 Navigating the Problematic Lower Eyelid in FacialRejuvenationCraig Czyz, DO and Jill Foster, MDLevel of Evidence: Level V - Expert Opinion, case report orclinical exampleThere exist numerous treatment options for facialrejuvenation particularly the midface. The surgeon must beable to design a treatment plan based upon each individualpatient, sometimes requiring multiple treatment modalities.This course provides a treatment paradigm for choosing theappropriate procedure(s) based upon the patient'spresentation. The discussed modalities include, but are notlimited to, blepharoplasty with or without fat remove ortransposition, fat transfer, tissue fillers, siliconeaugmentation, orbicularis oculi plication, SOOF lifting,canthoplasty, canthopexy, and laser resurfacing.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) select appropriate facial rejuvenationprocedure(s) based upon patient lower eyelid deficits; 2)formulate surgical plan(s) consisting of multiple modalitiesweighing the benefits versus insufficiencies of eachprocedure.

IC67 1) Correction of External Valve Dysfunction: Ribversus Cephalic Crural Turn-in to Support the Lateral CrusHenry Barham, MD and Richard Harvey, MDLevel of Evidence: Level II - Lesser-quality, randomizedcontrolled trial; prospective cohort study; or systematicreviewExternal nasal valve dysfunction (EVD) is a common causeof nasal obstruction. We will discuss functionally andcosmetically viable options for correction of EVD includingtwo techniques to support the weak lateral crus in EVD, ribor costal cartilage lateral crural strut graft versus cephaliccrural turn-in.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) develop functionally and cosmeticallyviable options for correction of EVD; and 2) evaluate rib orcostal cartilage lateral crural strut graft versus cephalic cruralturn-in.

2) The Expanding Indications for the Butterfly Graft inMiddle Nasal Vault ReconstructionJ. Madison Clark, MDLevel of Evidence: Level II - Lesser-quality, randomizedcontrolled trial; prospective cohort study; or systematicreviewThe Butterfly graft has become a vital part of ourarmamentarium, and as rhinoplasty surgeons gain moreexperience with it, its indications are expanding. Beyond itsuse in secondary rhinoplasty and reconstruction, its use inprimary cases (both cosmetic and functional cases) will bediscussed in detail.Learning Objective(s): At the end of the course, attendeesshould be able to have a complete understanding of therationale behind the appropriate choice for middle nasalvault reconstruction among the various options, includingthe Butterfly graft.


38

IC68 Creation of the AAFPRS FACE TO FACEInternational Mission Trip DatabaseManoj Abraham, MDThe AAFPRS FACE TO FACE database was created togather and organize patient data from international surgicalmission trips. Similar to Electronic Medical Records(EMR), this database is particularly useful on internationalmission trips as it allows more accurate tracking of patientsand outcomes, and ultimately data analysis.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) understand the process involved increating the AAFPRS FACE TO FACE international missiontrip database; and 2) understand the similarities of thisdatabase to EMR systems, and the specific benefits anddisadvantages as it relates to international mission trips.

IC69 Orthognathic Surgery Planning and Execution, Step-by-Step OverviewAlexander Rabinovich, MDLevel of Evidence: Level II - Lesser-quality, randomizedcontrolled trial; prospective cohort study; or systematicreviewThis is a step-by-step practical overview of orthognathicsurgery panning and case execution for clinicians whocurrently perform or would like to perform this treatment.It includes an overview of diagnosis requiring orthognaticsurgery, digital case planning and CAD/CAM surgical guidefabrication, as well as step-by-step overview of theprocedure.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) learn how to plan an orthognathic case;2) know how to prepare surgical guides for a case; and 3)learn the steps of the surgical procedure.

IC70 A Potpourri of Nasal Tip Finesse TechniquesPeter A. Adamson, MDLevel of Evidence: Level V - Expert Opinion, case report orclinical exampleThis presentation will outline the surgical indications,techniques and outcomes for a variety of finesse rhinoplastymanoeuvres. Topics discussed will include intermediatecrural overlay, lateral crural overlay, transposition ofcephalically malplaced lower lateral cartilage and alar basereduction. Video demonstrations are included.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) know the indications and select theappropriate patients for the described techniques; and 2)perform the described techniques skillfully to achieveimproved rhinoplasty results.

Paper Presentation: The Use of Autologous InterdomalFibroadipose Tissue as a Graft for Improvement of NasalTip ContourAmit Kochhar, MD and Ira D. Papel, MDCore Competencies: Practice-based Learning andImprovement, Medical Knowledge, Patient CareLevel of Evidence: Level IV - Case seriesStudy Objective: At the conclusion of this activityparticipants should be able to discuss the technique ofharvesting interdomal fibroadipose tissue and its use as agraft for nasal tip contour reconstruction.Design: A retrospective clinical chart review.Method: This report describes our experience usinginterdomal fibroadipose tissue for nasal tip contouring thatcan be safely and efficiently harvested with no donor sitemorbidity. The soft tissue is elevated off the nasal tip,exposing the fibroadipose tissue between the domes andanterior septal angle. It is carefully harvested and saved.The interdomal fibroadipose tissue is then applied as a onlaygraft to improve tip projection, contour and soften the edgesof cartilage grafts. This technique was applied to 50 patientsover 2 years. An informed consent was obtained from allpatients. Clinical evaluation and photographic documenta-tion were reviewed after 12 months of follow-up period.Conclusions: Interdomal fibroadipose tissue grafts provide anatural appearing nasal tip. Placing this tissue over cartilagegrafts provides a fine cover that conceals the possibleirregularities or distortions that may appear in thepostoperative period.Learning Objective(s): At the end of the course, attendeesshould be able to discuss the technique of harvestinginterdomal fibroadipose tissue and its use as a graft for nasaltip contour reconstruction.

4:50pm-5:40pmIC71 Optimal Re-contouring of the Face and Neck (Part 2)Fred G. Fedok, MD and Philip R. Langsdon, MD (see IC65for description)

IC72 Modern Concepts in Nasal ReconstructionHolger Gassner, MD; Kofi D. Boahene, MD; and Patrick J.Byrne, MDLevel of Evidence: Level IV - Case seriesThe reconstruction of complex and total nasal defects ischallenging. The panelists will present various concepts ofsurgical reconstruction, including advanced microvasculartechniques, prelamination of a paramedian forehead flap andthe use of endonasal flaps.Learning Objective(s): At the end of the course, attendeesshould be able to better understand modern and advancedconcepts of nasal reconstruction.


39

IC73 1) Rhinoplasty in the Southern Tip of Europe: ThePortuguese ExperienceDiogo Carmo, MDLevel of Evidence: Level IV - Case seriesThe authors have typified the most relevant ethnic featuresand deformities seen in the Portuguese patients noses. Morethan 200 consecutive rhinoplasty patients were analyzed.Rhinoplasty in these patients will involve most of the usualtechniques that are employed in a rhinoplasty. Specificfeatures and demands of these patients are a challenge thatdetermines specific surgical skills and strategies. All thesepoints will be stressed from the diagnosis till specific surgicalstrategies and techniques.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) identify the main anatomic andaesthetic differences encountered in the patient candidatefor rhinoplasty; 2) learn strategies to deal with these noses;and 3) acquire a general overview on the prevention andmanagement of possible complications.

2) Conservative No Hump Removal Rhinoplasty: Cosmeticand Functional OutcomesMario Ferraz, MDLevel of Evidence: Level IV - Case seriesThe most common complaints among rhinoplasty patientsare related to the dorsum stigmas - inverted V, irregularitiesand functional issues as internal valve collapse. We show inthis course the 'SPAR technique' used by the lecturer forover 5 years in which no hump removal is necessary nordorsum reconstruction with spreaders even in very highdorsum/ tension noses. Long term follow up will be shown.SPAR = Septal Pyramidal Adjustment and RepositionLearning Objective(s): At the end of the course, attendeesshould be able to: 1) demonstrate the SPAR tecnique and itscosmetic and functional outcomes in deviated, crooked andtension noses being the most conservative possible; and 2)add the Tecnique in its rhinoplasty arsenal.

3) Rhinoplasty: How Far Can We Reach Using ClosedAccess?Antonio Nassif Filho, MDLevel of Evidence: Level V - Expert Opinion, case report orclinical exampleThe course duration of 40 minutes is to present results,showing various techniques used indoors with the goal toshows that we can have good results with this type ofsurgical approachLearning Objective(s): At the end of the course, attendeesshould be able to show good results using this approacheven in difficult cases.

IC74 How to Get Involved with Foreign Medical MissionTrips: FACE TO FACE InternationalJ. Charlie Finn, MD; Manoj Abraham, MD; Karen SloatIn this session, we will share experience gained in severalmedical mission trips. We will discuss practicalities in howto become involved as a participant and how new missiontrips are started. We will discuss fundraising, travel andsupply resources available, international medical licensing,and. skill sets needed.

IC75 TBD

IC76 Craniofacial SurgerySherard Tatum, MDLevel of Evidence: Level IV - Case seriesThe care of patients with craniofacial disorders ischallenging, exciting and rewarding. It involves detailedknowledge of the rare conditions treated, advanced surgicalskills, and the ability to work well with colleagues in aninterdisciplinary team approach. Some of the conditionsinclude syndromic and nonsyndromic synostosis,hypertelorism and craniofacial microsomia. Many of theskills translate to other conditions from trauma andneoplasms.Learning Objective(s): At the end of the course, attendeesshould be able to: 1) delineate major craniofacialsyndromes; and 2) become familiar with the management ofcraniofacial syndromes.

Paper Presentation: Visual and Functional Integration ofCraniofacial ProsthesesGregory Gion, MDCore Competencies: Patient CareLevel of Evidence: Level IV - Case seriesStudy Objective: To review and present classic and esotericmethods used in facial prosthetic restoration. To reviewacross facial defect types from superficial to severe andpredict outcome success after discussion of age, skin type,defect size and shape, etc.Design: Case series.Method: Photo showcase with discussion of evaluation ofprostheses in terms of visual integration and functionalintegration.Conclusions: Aesthetics and retention of facial prosthesesare 2 areas that the prosthetist/anaplastologist has excellentcontrol over, and they directly impact what the author hasreferred to as 'visual' and 'functional' integration. Skill, timeand will are equally important in the planning, fabricatingand fitting of prostheses to offer patients complete andsuccessful outcomes.Learning Objective(s): At the end of the course, attendeesshould be able to learn critical evaluation of facial prostheticresults and learn the best retention methods for facialprosthetics.


40

(1) PNAM Decreases Operative Time in PatientsUndergoing Primary Unilateral Complete Cleft LipRepair with Tip RhinoplastyTerrell Bibb, MD; Miles Grant, MD; Phillip Watkins, MD;and Joshua C. Demke, MDCore Competencies: Evidence-based Health CareLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseLearning Objectives: At the end of this presentation,participants should be able to discuss the effect ofpresurgical nasoalveolar molding (PNAM) on the degree ofdifficulty, in terms of operative time, of primarycheilorhinoplasty in unilateral cleft lip and alveolus patien tswith or without cleft palate (UCLA +/- CP)Study Objective: We sought to objectively compare onevariable that is generally held as a good measure of degreeof difficulty - namely, duration of surgical time for UCLA +/- CP patients who underwent primary cheilorhinoplasty.Design: Retrospective chart reviewMethod: We hypothesized that PNAM reduces the difficultyof the primary cheilorhinoplasty, resulting in reducedoperative time. A total of 25 UCLA +/- CP patients whounderwent primary cheilorhinoplasty were identified. Wecollected each patient?s PNAM use, age, date of operation,and operative time. Twelve patients had used PNAM whilethe other 13 had not. A Kolmogorov-Smirnoff 2-sample testwas used to compare the empirical distributions ofprocedure times between our 2 groups. The operative timedistribution of the PNAM group was significantly lower thanthe no PNAM group (p = 0.049).Conclusions: This study suggests that PNAM is associatedwith shorter operative times. This surrogate measurementindicates PNAM can decrease the degree of difficulty ofprimary cheilorhinoplasty for surgeons. Additional studiesare needed to quantify the degree of difference in operativetimes and establish if the effect is causal rather thancorrelative

(2) Oral Cavity Reconstruction UsingOsteo-adipofascial Microvascular FlapsBrian J. Boyce, MD; David Cognetti, MD; Joseph Curry,MD; Adam Luginbuhl, MD; Ryan N. Heffelfinger, MD;Howard D. Krein, MD; and Akshay Sanan, MDCore Competencies: Medical Knowledge, Patient CareLevel of Evidence: Level IV - Case seriesLearning Objectives: Understand the technique and anatomyof osseo-adipofascial free flaps, Understand advantages ofosseo-adipofascial flaps in oral cavity reconstructionStudy Objective: Microvascular free tissue transfer hasrevolutionized the reconstruction of complex defects of thehead and neck. A combined osseous and soft tissue defect isa common defect encountered in oral cavity reconstruction.While the cutaneous portion of the flap is typically used forsoft tissue reconstruction, there has been an increasingamount of literature on the use of adipofascial flaps. Wepresent our experience and outcomes using osteo-adipofascial microvascular flaps in the reconstruction of oralcavity defects.

Design: Case series at a tertiary teaching hospital.Method: A retrospective review of all adipofascial compositefree flaps performed at Thomas Jefferson UniversityHospital from June 2006 until January 2015 was performed.A total of 9 patients were included in the analysis. All datawas extracted from a review of the inpatient record,operative reports, and outpatient clinical chart.Conclusions: Both radial forearm and fibular osteo-adipofascial flaps are excellent reconstructive options forcomposite defects of the oral cavity given their advantagesover cutaneous skin paddles. All the flaps survived withoutany post-operative complications. This type of flap shouldbe added to the armamentarium of head and neckreconstructive microvascular surgeons.

(3) Adverse Reactions of Different Implant Materials:A Histologic StudyJi Yun Choi, MDCore Competencies: Practice-based Learning andImprovementLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseLearning Objectives: Gore-tex, siliconeStudy Objective: Gore-Tex and sillicone is known to be arelatively safe material. However, it leads to complications.Although widely used, the reasons complications occur arepoorly understood. Thus, this study attempted to investigatehistological changes between the Gore-Tex and silicone,removed within a certain period of time after rhinoplasty,and its neighboring tissues.Design: This study targeted Gore-Tex and siliconerhinoplasty patients who underwent reoperation betweenMay 2002 and March 2008. Patients whose Gore-Tex andsilicone was removed due to infection or inflammation wereexcluded from the study, but patients who desiredreoperation due to aesthetic dissatisfaction were included.Method: A light microscope was used to examine the Gore-Tex samples after they were fixed in 10% neutral formalin,embedded in paraffin, sectioned at a thickness of 4 to 5 lm,and stained with hematoxylin-eosin. More specifically, theexamination focused on tissue ingrowth into the Gore-Tex,the extent of calcification, foreign body reaction, andchanges in the Gore-Tex structure.Conclusions: After the Gore-Tex samples had been in placefor an extended period of time, the neighboring tissues grewinto the central portions of the samples, which enhancedadhesion between the samples and the tissues. In addition,Gore-Tex samples that had been implanted for longerperiods of time were associated with decreased thicknessand calcification, foreign body reactions, and increasedstructural changes.Silicone implants were noted to induce calcification wheninserted for a long time, causing long-term morphologicchanges. Calcification was first observed grossly with thenaked eye after 5 years 8 months of insertion. With lightmicroscopy, calcification debris could be seen after 4 years.After implant insertion for more than 9 years, focalcalcification could be seen in 50 percent of implants. When

poster presentations

41

implants had been inserted for more than 15 years, adenatured type of large calcification was clearly observed.Plasma cell, macrophage, and neutrophil proliferation wasnoted in the softtissue capsule surrounding the superficialcalcifications in those individuals with an early inflammatoryresponse, and lymphocyte proliferation was noted in thosewith a late inflammatory response.

(4) Current Trends in Facelift SurgeryStephanie Culver, MD; William Matthew White, MD; andBenjamin Paul, MDCore Competencies: Practice-based Learning andImprovement, Patient CareLevel of Evidence: Level V - Expert Opinion, case report orclinical exmapleLearning Objectives: To examine and understand currentpractices in preoperative, perioperative, and postoperativecare and management of patient undergoing rhytidoplasty.Study Objective: To identify and understand currentpractices in preoperative, perioperative, and postoperativecare and management of patient undergoing rhytidoplastyand how these trends have changed over time.Design: Anonymous online survey completed on a voluntarybasis by members of AAFPRS.Method: An IRB- and AAFPRS-approved web-basedsurvey was distributed to the members of the AAFPRS viae-mail. The survey was composed of six sections: 1)background and demographics 2) preoperative facelift care3) intraoperative facelift decision making 4) post-operativefacelift management 5) alternative therapy to facelift surgery6) results of facelift surgery.Conclusions: Results: Demographics: Of the eighty-eightmembers of the AAFPRS who responded, the groupperformed a median of 21-50 facelift surgeries per year andonly 12.5% reported performing greater than 100 faceliftsurgeries per year. The average cost of surgery reportedwas $8,413 based upon open responses. The majority ofsurgeons are fully focused on cosmetic surgery (64%),operate in a surgical suite rather than hospital (83%), andwork in a private practice setting (74%).Preoperative: In the preoperative setting, 52% of surgeonsadminister Arnica in all cases and 27% never prescribeArnica. Antibiotics are used before surgery (60%), intra-operatively (85%), and post-operatively (60%). COX-2inhibitors are used to reduce opioid by only 4% of surgeonsin all cases.Intraoperative: Most surgeons use general anesthesia, and,notably, 65% would never use laryngeal mask airway(LMA). 82% target the SMAS in some form during thefacelift. Most do not treat submandibular glands (89%).Composite, subperiosteal, and endoscopic facelifttechniques are rarely employed ? <20% of respondentsoffer these techniques. 68% no longer perform skin onlysurgery, and half no longer perform S-lift (50%) orcomposite lift (48.33%). 61.5% admit a change in theirfacelift procedure approach during their career.Postoperative/Results: The vast majority (90%) of

participants reported a revision rate of <10%. Hematoma,nerve damage, and hypertrophic scar are the mostcommonly experienced complications. Temporarypostoperative paresis of the marginal mandibular nerve waswitnessed by 33.7% of surgeons. 1.3% of participantsreported a single patient with permanent marginalmandibular nerve paralysis. 28.6% reported temporarytemporal/frontal branch paresis but no one had permanentparalysis.Alternative therapy: Of the responders, 55% do not performnon-invasive neck rejuvenation such as radiofrequencyablation and/or focused ultrasound therapy. Most (80-85%)do not believe that Ulthera and/or RFA improve the neck fortheir patients. The majority of responders (85-90%) do notbelieve that RFA or Ulthera has changed the number offacelifts they perform.Conclusions: The AAFPRS membership has a richexperience in facelift surgery. Suspending the SMASremains of the highest priority for most facelift surgeons.The complications of facelift surgery have not alteredsignificantly when comparing to prior surveys (2000, 2010).Facelift surgery has not been replaced or overshadowed bynon-invasive technology.

(5) Endoscopy-Assisted Reconstruction in Blow-outFracture (BOF) Management of Blow-out Fractures(BOF)Ahmed El-Saggan, MDAddressed by Different Specialities which have a SubstantialDifference in Opinions. However, there is a wide consensusthat patients with the potential for late enophthalmusdevelopmentCore Competencies: Patient Care, Evidence-based HealthCare, Systems-based PracticeLevel of Evidence: Level IV - Case seriesLearning Objectives: To raise awareness about what can bedone to reduce the potential for late complicationsparticularly enophthalmus and diplopiaStudy Objective: To minimize the late complications ofBOF particularly enophthalmus and diplopiaDesign: Endoscopy assisted techniquesMethod: Different surgical casesConclusions: Endoscopic repair of BOF is more accurateand secure treatment for orbital floor fractures

(6) Analysis of Patient Factors and OperativeTechniques Influencing Longevity of a RhytidectomyYula A. Indeyeva, MD; Lucia S. Olarte, MD; Guimin Gao,PhD; and Michael S. Godin, MDCore Competencies: Practice-based Learning andImprovement, Medical KnowledgeLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseLearning Objectives: Determine whether medical co-morbidities, tobacco and alcohol use, gender, or type ofprimary procedure influenced the time interval betweenprimary and secondary rhytidectomy


42

Study Objective: Determine whether medical co-morbidities,tobacco and alcohol use, gender, or type of primaryprocedure influenced the time interval between primary andsecondary rhytidectomy.Design: This study is a retrospective chart review of theprimary surgeons experience from 2009-2014.Method: A total of 239 rhytidectomy procedures wereperformed during the 5 year interval investigated, 31patients met inclusion criteria for this analysis. Data wascollected on the 31 patients who underwent a secondaryrhytidectomy procedure including sex, co-morbidities(cardiovascular, pulmonary, gastrointestinal, endocrine,hormonal), smoking status, alcohol use, and whetherliposuction or platysma plication was performed inconjunction with rhytidectomy. Univariate and multivariateanalysis were used to assess associations between each riskfactor and the interval between initial and secondaryprocedures, with or without adjustment of confoundingeffects of other risk factors. A one-way ANOVA was usedto compare the three procedure types and pairwisecomparisons were made and adjusted by the Tukeysprocedure to control the overall type I error of 5%. Alltesting was two-sided.Conclusions: The overall revision rate for this particularpractice was 11.1%. There was no statistical significance (allp values >0.15) found by univariate or multivariate analysisof sex, medical co-morbidities, smoking status, or alcoholuse. There was a statistically significant difference ininterval from primary to secondary surgery by a one-wayANOVA comparing rhytidectomy alone versus rhytidectomywith submental liposuction (adjusted p<0.01), rhytidectomywith liposuction versus rhytidectomy with platysmalplication (adjusted p<0.01). However there was not enoughevidence to show significance in time interval betweenrhytidectomy alone versus rhytidectomy with plication(adjusted p=0.097). This suggests that necessitatingsubmental liposuction may be predictive of the need for asecondary rhytidectomy sooner than rhytidectomy alone orwith platysmal plication.

(7) Techniques for Minimizing Postoperative InfectionAssociated with ePTFE Implants in RhinoplastyYong Gi Jung, MDCore Competencies: Practice-based Learning andImprovementLevel of Evidence: Level V - Expert Opinion, case report orclinical exmapleLearning Objectives: Tips for minimizing postoperativeinfectionStudy Objective: To introduce the techniques and tips forminimizing postoperative infection associated with expandedpolytetrafluoroethylene(ePTFE) implants in augmentationrhinoplastyDesign: Retrospective review of medical recordsMethod: A total of 215 Augmentation rhinoplastyprocedures with ePTFE performed by single surgeon from2009 to 2015 were retrospectively reviewed. The incidence

of postoperative infection, inflammation, or implant-relatedskin problem and surgical techniques were investigated.Conclusions: There were 6 revision cases(2.7%) and theothers were primary cases. There was no postoperativeinfection, inflammation, and implant-related skin problem.Meticulous aseptic surgical draping, no hand technique,through saline irrigation were applied. We tried to finish allprocedures in 120 minutes, and never touched intranasalcavity during manipulation of implant.Although it is known that the risk of infection in rhinoplastywith alloplastic material is relatively high, the risk can beminimized with proper surgical preparation and techniques.

(8) Comparison of Permanent versus AbsorbableSuture in the Tongue-in-Groove Technique inEndonasal RhinoplastySameep Kadakia, MD and Alexander Ovchinsky, MDCore Competencies: Practice-based Learning andImprovement, Medical Knowledge, Patient CareLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseLearning Objectives: Examining outcomes in endonasalrhiniplasy with permanent and absorbable sutureStudy Objective: The tongue-in-groove technique inendonasal rhinoplasty is a commonly used method formaking changes in tip rotation and/or projection. The choiceof suture, permanent versus absorbable, can possibly affectthe reliability of long-term results. In this paper, weexamine the outcomes of absorbable and permanent suturetongue-in-groove technique in endonasal rhinoplasty inrelation to maintaining postoperative tip rotation and tipprojection.Design: A retrospective review of the pre-operative andpost-operative photographs of 18 patients treated withendonasal tongue-in-groove technique. 12 of these patientswere treated with permanent suture (nylon), and 6 withabsorbable suture (PDS). Out of 18 patients, there were 9females (50%) and 9 males (50%), with the age rangingfrom 17 to 49 years old. The follow up ranged from 3months to 53 months, with mean follow up of 12.1 months.All patients were treated by the senior author in a majorNYC hospital.Method: All patients were treated with the tongue-in-groovetechnique in endonasal rhinoplasty. 5.0 clear Nylon suturewas used on 12 patients, and 5.0 clear PDS on 6 patients.Post-operative changes in tip rotation and projection werecompared for each suture type independently by measuringthe nasolabial angle as well as the Goode ratio utilizing aphoto editing software.Conclusions: Using an unpaired t-test and an alpha value of0.05, the difference between the pre-operative and post-operative tip rotation and tip projection was statisticallysignificant for nylon suture (0.0069 and 0.0264), and notstatistically significant for PDS suture (0.9385 and 0.7391).Using a permanent suture in patients undergoing tongue-in-groove for endonasal rhinoplasty may be a more reliablemethod for maintaining postoperative changes in tip rotationand projection.


43

(9) Comparison of Tutoplast-processed Fascia Lataand Silicone as Graft Material for Nasal DorsalAugmentationJisun Kim, MD; Min Young Kwak, MD; and Sang WonYoon, MDCore Competencies: Practice-based Learning andImprovementLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseLearning Objectives: nasal dorsal augmentation orrhinoplastyStudy Objective: Autologous dorsal nasal grafts havelimitations including limited tissue availability, dornor sitemorbidity and postoperative deformities owing to warping orresorption. This study compares Tutoplast-processed fascialata (TPFL) for nasal dorsal graft with silicone implant fornasal dorsal augmentation.Design: Retrospective study with 142 patients whounderwent dorsal augmentation in Korean rhinopalsty. Thestudy involved 92 patients (70 male, 22 female), whounderwent TPFL grafting and 50 patients (34 male, 16female), who underwent silicone grafting to the nasaldorsum were included.Method: Implant material was mainly determined by theamount of dorsal augmentation and skin texture. Patient'ssatisfaction was assessed by questionnaire. Postoperativehistories and Photographs were reviewed to assesscomplications including graft resorption, graft infection, andgraft deviation.Conclusions: In TPFL grafting group, most of the patientsneeded minor graft for dorsal augmentation and contouringnasal dorsum. No significant complication existed. Insilicone implant group, most of the patients needed majorgraft for dorsal augmentation and had high aesthetic wishes.Complications were encountered in 4 patients (8%),comprising graft deviation in 3 patients and graft infection in1 patient. After revision operation, complications weresolved. TPFL seemed to have a lower complication raterather than silicone implant.TPFL and silicone appears to be useful graft for dorsalaugmentation. If these grafts would be used appropriately,dorsal augmentation can be achieved effectively. But dorsalaugmentation using silicone implant should be performedmore carefully.

(10) A Novel Application of Ultrasonic BoneAspirator(UBA) for Hump NoseJae Hwan Kwon, MD and Joo Yeon Kim, MDCore Competencies: Patient CareLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseStudy Objective: The study aimed to evaluate the efficacyof using ultrasonic bone aspirator(UBA) in rhinoplasty forhump nose.Design: Retrospective chart review; from Oct. 2013 to Nov.2014. 20 patients underwent humpectomy using the UBAwere included.

Method: Follow up period was above 3months. Pre- andpost-operative photo documentation was taken for allpatients in frontal and profile views. Subperiosteal dissectionwas performed of the overlying nasal bone and the UBAwas utilized to sculpture the bony hypertrophy. Postoperative dorsal status and complications were estimated.Conclusions: Application of ultrasonic bone aspirator torhinoplasty can emulsify the bony spur or hypertrophy withminimal procedure. We can minimize thermal andmechanical injury surrounding soft tissue with continuouslyirrigation and suction. It is an easy, safe, and effectivemethod for correction of hump nose without complications.

(11) A Combined Navigation-assisted OsteoplasticFlap Surgery with Foreheadplasty to the InvertedPapilloma in the Frontal SinusJoohyung Lee, MD; Dongchang Lee, MD; JaehyungHwang, MD; and Geunjeon Kim, MDCore Competencies: Practice-based Learning andImprovementLevel of Evidence: Level V - Expert Opinion, case report orclinical exmapleLearning Objectives: To share the experience of therapauticand aesthetic surgery of upper face simulaneouslyStudy Objective: To share the experience of therapautic andaesthetic surgery of upper face simulaneouslyDesign: A case reviewMethod: A 66 year old man presenting nasal mass extendingto the frontal sinus, which was diagnosed as the invertedpapilloma, was operated successfully under combinednavigation system- assisted osteoplastic flap and endoscopicapproaches simultaneously with conventionalforeheadplasty.Conclusions: Otolaryngologist could consider the operationof upper face both therapautically and aesthetically.

(12) Diagnostic Management of Nasal SeptalPerforations: A Literature Review and EarlyDevelopment of a Diagnostic AlgorithmAmanda Jo Marcellino,MD; Harry Bartels, BS; and JordanWallin, MDCore Competencies: Medical Knowledge, Evidence-basedHealth CareLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseLearning Objectives: To review the current diagnostic toolsin nasal septal perforations, to develop a diagnosticalgorithm that is practical for the clinician to useStudy Objective: The objective is to review thecontemporary literature regarding diagnostic considerationsfor nasal septal perforations for the facial plastic surgeon.This was done in order to develop an algorithmic approachfor the facial plastic surgeon who encounters a nasal septalperforation of unknown origin.Design: Systematic review of the literature for articlesassessing etiologic and diagnostic considerations for theworkup of septal perforations and midline destructive lesions.


44

Method: A search of English language articles in Pubmedwas perfomed. Search terms included nasal septalperforation, CIMDL, midfacial lesions, midline destructivelesions, and GPA nasal. Articles with higher levels ofevidence were given precedence.Conclusions: The presentation of a patient with a nasalseptal perforation can present a significant diagnosticchallenge to the facial plastic surgeon. The most commonlyconfused differential lies between CIMDL and GPA.History and physical examination can provide keydifferentiating features but must be substantiated by furtherwork up. While often necessary to rule out malignancy, theutility of biopsy has been called into question. Recentevidence supports the role of serology in determining theetiology of septal perforations, noting unique ANCA patternsassociated with cocaine-induced lesions versus inflammatoryvasculitis lesions. Initiation and efficacy ofimmunomodulatory therapy can also be of diagnosticsignificance. In conclusion, a summary of the literatureconcludes that an algorithmic approach based on aculmination of research may be useful in the workup ofseptal perforations and midline destructive lesions. Thisalgorithm continues to evolve, incorporating multiplediagnostic modalities in effort to both achieve an efficientaccurate diagnosis and in order to initiate the appropriatetherapy in a timely manner.

(13) Ergonomic Considerations in Reducing PhysicalDiscomfort Among Facial Plastic SurgeonsMatthew Miller, MD; Sheri Rosen, MD; Fiyin Sokoya, MD;Vijay Ramakrishnan, MD; and Adam Terella, MDCore Competencies: Practice-based Learning andImprovement, Patient CareLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseLearning Objectives: Increasing awareness of physicianinjury and ergonomic practicesStudy Objective: To assess the knowledge of Facial PlasticSurgeons about physical discomfort and injury, andergonomic practices during surgery. To quantify surgeondiscomfort and find factors which predict discomfort andphysical symptoms.Design: We performed a cross-sectional analysis of 87members of the American Academy of Facial Plastic andReconstructive Surgeons. They were 48 (?11) years old,69.8 (? 7.5) inches tall, and weighed 177 (?26.7) pounds.Respondents were 7% female, 86% right-handed, and 82%fellowship-trained. Mean cases per month was 27.2 (?14.6).Mean years in practice was 15.5 (?11.2).Method: A 28-question RedCap questionnaire was emailedto all members of the American Academy of Facial Plasticand Reconstructive Surgeons. The questionnaire collectedinformation regarding demographics, professional history,physical symptoms, and ergonomics. Analysis was doneusing Excel and R-Suite, with Odds Ratios (OR), 95%Confidence Intervals and p-values reported.Conclusions: Physical discomfort and injury related to

operating is common among facial plastic surgeons (79.3%?8.4). Awareness of ergonomic interventions is low andfew apply recommendations to practice, with 78% ofrespondents reporting no or slight knowledge of ergonomicrecommendations, and only 29% applying recommendationsto their practice. Age <65, <15 years in practice, andfellowship training were significantly associated with morediscomfort (OR 11.1, p= 0.0005; OR 2.7, p=0.068, OR 4.8,p=0.011), suggesting experience may change ergonomichabits. Height <70 inches was associated with lessdiscomfort (OR 0.29, p=.02), which may have implicationsfor the importance of table height during operations.Weight, gender, handedness and number of surgical casesperformed per month were non-predictive. More study isneeded to determine whether ergonomic practice guidelinesinfluence muscle strain and overall injury, and whether thesechanges ultimately affect patient outcomes.

(14) Use of Diced Irradiated Homologous CostalCartilage Wrapped with Alloderm in Soft TissueAugmentation: An Experimental StudySue Jean Mun, MD; Hyunjung Lee, MD; Dae Woo Kim,MD; and Hong Ryul Jin, MDCore Competencies: Medical KnowledgeLevel of Evidence: Level V - Expert Opinion, case report orclinical exmapleLearning Objectives: to evaluate gross and histologicchanges of diced irradiated homologous costal cartilagewrapped with alloderm in an animal modelStudy Objective: The current study aims to evaluate grossand histologic changes of diced irradiated homologous costalcartilage wrapped with alloderm in an animal model.Design: Animal studyMethod: Bare block irradiated homologous costal cartilage(IHCC) (group A) and diced IHCC wrapped with alloderm(DIHCC) (group B), DIHCC added with powderedalloderm (group C), with chondroitin sulfate (group D), andwith gelatin (group E) were implanted on the rat dorsum.The rats were sacrificed at 3 and 6 months and grossappearance, weight, and histologic changes were compared.Conclusions: While block IHCC maintains its shape andweight, DIHCC shows significant resorption after 6 monthsof implantation on the rat dorsum. Filling with powderedalloderm, chondroitin sulfate, and gelatin does not preventsignificant resorption in DIHCC.

(15) Aesthetic Rhinoplasty Patients Compare TheirPhysical Appearance More FrequentlyMohsen Naraghi, MD and Mohammad Atari, MDCore Competencies: Practice-based Learning andImprovement, Medical Knowledge, Patient CareLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseLearning Objectives: To know whether aesthetic rhinoplastypatients tend to compare their physical appearance moreoften in comparison to a control group.Study Objective: To evaluate physical appearance


45

comparison frequency among rhinoplasty patientsTo compare physical appearance comparison levels betweenrhinoplasty patients and control groupDesign: Case-control studyMethod: A sample of seventy rhinoplasty patients wasrecruited in a consecutive manner. A student sample of 70college students was selected using purposeful samplingstrategy. The purpose of the selection of the students wasrecruiting a demographically matched group who did notintend to undergo aesthetic rhinoplasty. PhysicalAppearance Comparison Scale-Revised (PACS-R) wasutilized to compare cases and controls. Independent t-testwas used to compare the scores.Conclusions: The findings of the present study showed thataesthetic rhinoplasty patients tend to compare their physicalappearance more often in comparison to a control group.

(16) Do Rhinoplasty Patients Appreciate their Body?Mohsen Naraghi, MD and Mohammad Atari, MDCore Competencies: Practice-based Learning andImprovement, Medical Knowledge, Patient CareLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseStudy Objective: To evaluate the positive body imageamong rhinoplasty patients and to compare bodyappreciation scores between rhinoplasty patients and controlgroupDesign: Case-control studyMethod: A sample of seventy rhinoplasty patients wascompared to a sample of seventy college students.Demographic characteristics of the groups were matched.Body Appreciation Scale (BAS) was used to compare as anindicator of positive body image. The BAS has 13 items andeach item is answered on a 5-point Likert-type scale.Psychometric properties of the BAS have been reported tobe satisfactory. Independent t-test was used as statisticalsignificance analysis and Cohen?s d was calculated as effectsize.Conclusions: Interestingly enough, the results showed thataesthetic rhinoplasty patients had significantly higher scoresof positive body image. The findings are apparentlyinconsistent with previous research line; however, they maybe explained by three possible explanations. First, it hasbeen suggested that BAS measures body surveillance tosome extent. Second, the control group might not representthe general population. Third, aesthetic rhinoplasty patientsmay actually appreciate their body more than controls andthe very act of surgery may be representing an index ofimportance of body for this population. Either way,replication of the current results may add confidence to thestatistical findings. Qualitative methods may also explore thepossible underlying reasons for the findings.

(17) Philosphy of Septal Surgery in AdultsNedim Pipic, MD, PhD; and Prof. Ivo Padovan, MDCore Competencies: Practice-based Learning andImprovementLevel of Evidence: Level I - High-quality, multi-centered orsingle-centered, randomized controlled trialLearning Objectives: University ClinicStudy Objective: With this technic is very good folow up.Design: I operated more than 1500 Patients.Post Opresults:excellent.Method: Open aproach more than 80%.Conclusions: I will recomande this technic bei dificullt nose.

(18) Septal Perforation and Plate ExtrusionFollowing Septoplasty with PDS PlatesDiana Ponsky, MD and Madeleine Strohl, BACore Competencies: Patient CareLevel of Evidence: Level IV - Case seriesLearning Objectives: To describe the use of polydioxanoneplate in septoplasty and to increase awareness of itspotential complications which have not been extensivelyreported in the literatureStudy Objective: Polydioxanone (PDS) plates are animportant surgical option for the correction of a deviatedseptum; however, their long-term complications are not wellcharacterized in the current literature. We report here ontwo cases of septal perforation and plate extrusion followingthe use of PDS plates for septoplasty with caudal deviation.Design: We present two case reports of septal perforationand plate extrusion following the insertion of the PDS platesMethod: A 68-year-old male with a past medical historysignificant for nasal trauma presented for repair of his nasalseptal deviation. He had been suffering from nasalobstructive symptoms for a year and a half and had usednasal steroid sprays with no relief of his symptoms. He wastaken to the OR for septoplasty and inferior turbinatereduction. During the operation, a 0.15mm perforated PDSplate was fixed to the quadrangular cartilage. Postoperatively, he showed some reaction of his septum as wellas a non-healing area along one side of the nasal septum. Hewas instructed to use saline nasal sprays bilaterally 3-4 timesa day and return for follow up. Twenty weeks post surgery,the left side showed signs of one-sided perforation. He wasbrought back to the operating room for removal of his PDSplate and repair of the septal perforation using allodermgrafting. Autoimmune studies for Wegener?s granulomatosisand sarcoidosis were negative. He recovered well with nofurther complications. In another case, a 48-year-old malewith a past medical history of obstructive sleep apneadeveloped a 2 mm septal perforation following septoplastyand inferior turbinate reduction for septal deviation. He wastaken back to the OR for revision septoplasty and repair ofthe perforation. At this time, a 0.25 mm unperforated PDSplate was fixed to the quadrangular cartilage during therevision septoplasty. Three months following surgery, hewas noted to have chronic inflammation and dehiscence ofhis surgical wound. The patient was placed on antibiotics


46

and scheduled for the OR. During this third surgery, thePDS plate was found to be partially extruded and wasremoved. The nasal mucosa had begun to heal underneaththe PDS plate directly abutting the quadrangular cartilage.He also recovered well with no further complications.Conclusions: Septal perforation and plate extrusion are rarecomplications following septoplasty with PDS plates that arenot well addressed in the current literature. Our two casesshow that more studies are needed to better understand thelong-term complication rates with PDS plates

(19) Partial Absence of the Lower Lateral Cartilage: ACase ReportGustavo Rabelo, MD; Renato Castro Alves de Sousa, MD;and Henrique Queiroz Correa Garchet, MDCore Competencies: Practice-based Learning andImprovement, Medical KnowledgeLevel of Evidence: Level IV - Case seriesLearning Objectives: Congenital absence as an isolateddeformity of the lower lateral cartilage (LLC) is extremelyrare with only two cases described in the literature to date.Study Objective: To report a case of partial absence oflower lateral cartilageDesign: Case ReportMethod: a 23-year-old male patient, presented to the ENTclinic complaining of chronic alternating nasal obstructionwith no significant improvement after medical treatmentwith topical corticosteroids. The patient?s past medicalhistory was unremarkable except for a history of atopy. Hedenied any previous surgical procedure except for what wasdescribed by his mother as being a nasal infection whichrequired some sort of procedure during his childhood, whichwe understood to be an abscess drainage. During inspirationthere was collapse of the right ala, indicating valveinsufficiency. He also presented with an esthetical complaintof asymmetric tip and a dorsal nasal hump. Rhinoscopyrevealed a septum deviation to the right side in Cottle's area3, a crest to the left side and hypertrophy of inferiorturbinates. After the use of topical vasoconstrictor there wasstill some degree of nasal obstruction, which improved withthe use of nasal dilator. An open approach was performedand the right lateral crura of the lower lateral cartilage wasabsent. Surgery consisted of hump reduction, lateral crurareconstruction with septal cartilage, tip refinement withdomal sutures and camouflage graft. Collumelar strut wasplaced to structure the tip.Conclusions: The pathogenesis of the congenital absence ofnasal cartilages as an isolated entity is unknown.Embryogenic development may explain this condition. Theneural crest cells are precursors of the nose as they migratetowards the midface around the fourth week of gestation.Two nasal placodes develop in a symmetrical fashion. Themedial nasal process gives rise to one half of the nasalseptum and medial crus of the LLC, whereas the lateralnasal process develops into the nasal bones, ULC and lateralcrus of LLC. Local factors, such as teratogenic agents,vascular accident, local pressure by the surroundingstructures may interfere with the regular development ofthose nose components. Continued developmental studies

are crucial for eventual understanding of the complexembryology of these rare anomalies

(20) How Clean is the Rhinoplasty Field? CanChlorhexidine Pretreatment Decrease BacterialRecovery Rate?Keng Lu Tan, MD; Shin Hye Kim, MD; Chae-Seo Rhee, ,MD; and Hong Ryul Jin, MDCore Competencies: Practice-based Learning andImprovementLevel of Evidence: Level II - Lesser-quality, randomizedcontrolled trial; prospective cohort study; or systematicreview of these studiesLearning Objectives: Rhinoplasty operative field is a semi-contaminated surgical field. Chlorhexidine is effective as apreoperative cleaning agent. The role of antibiotics remainimportant in this kind of surgery.Study Objective: This study investigated the bacterialcontamination of the rhinoplasty field and examined theeffect of preoperative chlorhexidine treatment in decreasingbacterial contamination in the rhinoplasty field.Design: Thirty patients who underwent rhinoplasty wereenrolled. Patients with an active Staphylococcus aureus (S.aureus) infection, chlorhexidine allergy, antibiotics treatmentwithin 30 days from the surgery, acute sinusitis, or previousrhinoplasty history were excluded. Patients were blockrandomized into a chlorhexidine, regular-soap, or controlgroup comprising of 10 participants each.Method: The chlorhexidine group was subjected tochlorhexidine showering, shampooing, and facial-cleansing12 hours prior to the operation, the regular-soap group wassubjected to showering, shampooing, and facial-cleansingwith regular soap, and the control group did not have anyskin pretreatment. Bacterial cultures were done at 12 hourspreoperatively from the nasal cavity and perinasal skin,immediately preoperatively from the perinasal skin and at 1and 2 hours intraoperatively from the operation field.Culture results were compared between the three groups,according to operation time, or whether invasive procedureswere undertaken.Conclusions: This study identified that rhinoplasty surgicalfield is not sterile and continuously exposed to bacterialfloras of perinasal skin and nasal cavity. Chlorhexidinepretreatment showed some effect in decreasing the numberof S. aureus and Corynebacterium on the perinasal skin butits effect on the prevention of postoperative infection needsfurther study.

(21) The Results of Polypropylene Mesh Usage forNasal Septal Perforation Repair: An ExperimentalStudyUmit Taskin, MD; Kadir Yucebas, MD; and Samet VasfiKuvat, MDCore Competencies: Medical KnowledgeLevel of Evidence: Level I - High-quality, multi-centered orsingle-centered, randomized controlled trialStudy Objective: The aim of this study was to evaluate theeffectiveness and biocompatibility of the polypropylenemesh in an animal model of nasal septal perforations on


47

rabbitsDesign: animal studyMethod: After creating a 1X1 centimeter full thicknessdefect on 12 rabbits, the perforation was reconstructed withtwo different methods. For Group 1, we used mucosalflaps and polypropylene mesh as an interpositional graft. ForGroup 2, we only used mucosal flaps. After four weeks weremoved the nasal septa of the rabbits and we analyzed thesamples for acute rejection, infection, inflammatoryresponse, fibrosis and granuloma formationhistologically.The samples of the Group 2 showed that allseptal perforations remained the same. On the other hand,the septal structure remained intact on all samples of theGroup 1. None of the samples of the Group 1 showed acuterejection or infection. Five samples of the Group 1 (62.5%)showed +1, one sample (12.5%) showed +2, and twosamples (25%) showed +3 inflammatory responserespectively. Three samples of Group 1 (37.5 %) did notshow any fibrosis, four samples (50%) showed mild fibrosisand only one sample (12.5%) showed moderate fibrosis. Infact, total of seven samples (87.5%) showed mild fibrosis atmost in the Group 1. We did not see any severe fibrosis atall. In the Group 1, we observed that six samples (%75)showed no granuloma formation as a foreign body reactionand two samples (25%) showed few giant cells. Also,severe vascular and epithelial proliferation was seen alongthe borders of propylene meshConclusions: Propylene mesh showed good biocompatibilitywith the septal mucosa, and it can be used for the repair ofseptal perforation as an interpositional graft safely

(22) Frequency and Characteristics of FacialAsymmetry in Deviated Nose PatientsJong Sook Yi, MD; Hye Ran Hong, MD; Yeon Hee Joo,MD; and Yong Ju Jang, MDCore Competencies: Practice-based Learning andImprovementLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseLearning Objectives: facial asymmetry, deviated noseStudy Objective: To analyze the frequency andcharacteristics of facial asymmetry in patients with adeviated nose and to identify predictable parameters for thedetection of the types and severity of facial asymmetryDesign: Preoperative photographs were reviewedretrospectively.Setting: A tertiary referral center.Participants: The study was conducted on patients whounderwent rhinoplasty (152) for a deviated nose betweenJanuary 2008 and December 2012. The incidence of facialasymmetry in these patients was compared with theincidence in 60 control subjects without external nosedeviation undergoing septoplasty.Method: Using frontal photographs, the presence of facialasymmetry and the types of deviated nose were noted andmeasured by two observers.Facial asymmetry was categorized into four types dependingon which subunit of the face was affected, and deviatednose shapes were classified into five types. Anthropometric

measurements were also performed.Conclusions: Facial asymmetry was more common inpatients with a deviated nose than in control patients, andmixed type facial asymmetry was the asymmetry most oftenassociated with deviated nose. This study suggests thatdeviated nose may be a developmental defect caused by adiscrepancy in the growth of facial bony skeleton betweenthe two sides of the face. The objective anthropometricmeasurements developed in this study could be useful formaking appropriate preoperative facial assessments.

(23) Reversing Aging and Stem CellsIbrahim Elachkar, MD and Wissam Achkar, MDCore Competencies: Practice-based Learning andImprovementLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of theseLearning Objectives: fat graft/ stem cellsStudy Objective: Liposculpture (Fat Graft) with Autologusfat graft is one of the safest, most durable and regenerativeprocedures of the face and body.Design: Between January 2000 and 2010 , 5,200 patientshave been treated with Liposculpture. Between 2011 and2012 only 10 patients have been treated with ADRCs(Adipose-Derived Stem & Regenerative Cells) and 20patients have been treated with fat enriched Stem Cells.Method: In this study, we discuss the aesthetic result andregenerative action of: Fat Graft; Fat enriched stem cells(Fat Tissue + ADRCs); ADRCs; Pure Stem CellsConclusions: The use of fat graft with or without ADRCsprovides great results in aesthetic, rejuvenation andregenerative procedures .There is an enormous amount ofpromise with stem cells in plastic and reconstructive surgery,which needs at least 5 years to be scientifically proven

(24) Secondary RhinoplastyIbrahim Elachkar, MD and Wissam Achkar, MDCore Competencies: Practice-based Learning andImprovementLevel of Evidence: Level II - Lesser-quality, randomizedcontrolled trial; prospective cohort study; or systematicreview of these studiesLearning Objectives: open Rhinoplasty/ cartilage graftStudy Objective: Natural sculpturing of the nose duringsecondary rhinoplasty is the goal of every rhinoplasticsurgeon. The aim of this study is to assess secondaryrhinoplasty on patients by presenting the functional andaesthetic techniques, and evaluating the resultsDesign: Between January 2000 and January 2014, 1242secondary rhinoplasties were performed on 162 males and1080 females with a mean age of 26 years old. Open andclosed rhinoplasties were performed on 1170 and 72patients respectively. Local and general anaesthMethod: The reconstructive and aesthetic techniques wereperformed on 13 different categories: 234 nasal tipdeformities; 180 short or pig snout noses; 108 beak nosedeformities; 126 nostril deformities; 198 saddle noses; 108residuals cartilages or bone humps; 54 deviated noses; 36pinched noses and fibrous prominent tips; 18 short, broad,


48

oblique, showing columella; 36 flat noses; 36 inverted V;108 over projected nose; 1 bilateral internal cantus tearing.Conclusions: Preoperative evaluation, complete dissection ofdifferent anatomic elements, identification of nasalrespiratory obstruction and meticulous reconstructionprovide a functional and aesthetic satisfaction.

(25) Surgical Management of Cauliflower EarJeong-Hoon Oh, MD; DH Lee, MD; and KH Park, MDCore Competencies: Practice-based Learning andImprovementLevel of Evidence: Level V - Expert Opinion, case report orclinical exmapleLearning Objectives: Management of high-flowarteriovenous malformation in the auricleStudy Objective: Management of high-flow arteriovenousmalformation (AVM) in the oral and maxillofacial region isone of the greatest challenges facing oral and maxillofacialsurgeons and should be patient-specific in almost all cases.Sclerotherapy, radiotherapy, surgical resection andsuperselective intra-arterial embolization have been used,but the lesions originating from the auricle require specialconsideration during the selection of treatment.Design: Case reportMethod: The authors present a case of auriculararteriovenous malformation which was treated successfullywith surgical resection.Conclusions: Management of AVMs in the maxillofacialregion is complex and has a high rate of recurrence.

(26) Surgical Management of Cauliflower EarJeong-Hoon Oh, MD; DH Lee, MD; and KH Park, MDCore Competencies: Practice-based Learning andImprovementLevel of Evidence: Level IV - Case seriesLearning Objectives: Treatment of cauliflower earStudy Objective: Cauliflower ear, characterized bythickening, irregular projection of the anterior ear anddistortion of the auricular outline, is the result of bleeding orabscess between the perichondrium and the cartilage,followed by scarring and regeneration of cartDesign: Retrospective chart reviewMethod: Seven cauliflower patients underwent surgery torestore normal contour of the auricle. Cosmetic results,patient's satisfaction, ease of technique and the occurrenceof the complication were analyzed.Conclusions: The appropriate reconstructive technique forthe treatment of cauliflower ear must be carefully selectedaccording to the cause, type and degree of deformity andthe availability of donor tissue.

(27) Non-Surgical Rhinoplasty; Rhinoplasty withFillersZiya Saylan, MDCore Competencies: Practice-based Learning andImprovementLevel of Evidence: Level V - Expert Opinion, case report or

clinical exmapleStudy Objective: Noses with dorsal hump and plunging tipare the main nasal deformities which bring the patients tothe cosmetic surgeons. After operating noses for more than100 years we surgeons know that every incision to the nasaltissue will end up with damage of the connective tissueresulting in a dropping /sagging) nose after a few years. Alsofollowing a Rhinoplasty during, the cartilage and the nasalbone tissue are initially intact. However, necrosis of thecartilage with depressions and other deformities may occurdue to the decreased blood supply.Design: For the past two years, 32 patients; 30 females(94%) and 2 males (6%) were treated using 'MedicalRhinoplasty' which is a novel non surgical approach foraesthetic disorders of the nasal structure. Seven cases (22%)were posttraumatic, 3 cases (9%) of noses were hereditarylarge with humps, 9 cases (28%) had one prior and 13 cases(41%) had multiple prior Rhinoplasty. Fillers were used inall 32 cases and Botulinum Toxin was applied in only for 11cases (34%) in combination with the fillers. A Botulinumtreatment without using fillers was not performed. As fillersdouble cross-linked hyaluronic acid was used in 2 cases(6%) calcium hydroxyapatite (CAHA) was used in 25 cases(78%) and permanent filler with Metacrill was used in 8cases (25%). The materials and their comparison will bediscussed during the presentation. Metacrill use does nothave approval in the US, but it is available in Europe and inSouth America.Method: Only one case (3%) of visible hardening wasobserved in the group with Metacrill injections which had tobe taken out through a small stab incision. No othercomplications were observed. The hyaluronic acid fillersdiminished after 6 to 9 months. The CAHA showed asatisfactory results for 12 months, but it was mostly wasdissolved after 14 to 15 months. Metacrill consisting fillershad an ideal result even after 18-24 months and longer. Thepatient satisfaction index for all injections was about 70%.Unsatisfied patients were the group who received onlyhyaluronic acid fillers. All Noses were swollen during thefirst day, 10 patients (31%) had no complaints at the end ofthe second day, only 19 patients (59%) suffered fromswelling and bruising on the third day and 3 patients (9%)had symptoms longer than 3 days.Conclusions: Most of the results were satisfactory (88%)and no major complications have been observed during ourapplications. This new approach for Rhinoplasty fits intotally with realistic patient expectations with less downtimeand enhanced safety. The main inconveniences of thisapproach are the procedure repetition and the short tomedium durability of results (except for the cases that utilizepermanent fillers).

(28) Phenol Peel; Master of the Deep Facial PeelingsZiya Saylan, MDCore Competencies: Medical KnowledgeLevel of Evidence: Level IV - Case seriesStudy Objective: The author shares his 15 years of


49

experience with a modified phenol peel called, Exoderm.Phenol peels penetrate the skin deeper than TCA peelsaddressing more serious imperfections such as blotchiness,coarse wrinkles, and acne scars. Compared to mediumdepth peels, deep chemical peels have more dramaticresults, and requires only a single treatment. However, deep(phenol) chemical peel recovery is lengthy anduncomfortable compared to milder chemical peels. Becausea phenol peel uses carbolic acid to treat the skin, theprocedure is not suitable for partial treatments. It must beused on the full face to avoid color differences.Design: A deep chemical peel with Phenol usually needs twosessions to complete. After the patient is sedated, thechemical solution is applied to the skin. After the phenolsolution has been on the skin for the appropriate amount oftime, a white color appears (freezing) and the face iscovered with occlusive tapes to avoid air contact. After 12-18 hours the second smelted skin is removed (scrubbed)with a gauze. The acne scars will be derma bradedseparately following a second application of the phenol. Aspecial powder applied which remains for the following 8days. The patient remains in a clinic ward for two nights.Method: Phenol peels are performed under carefullymonitored conditions, at a hospital. The patient is put undersedation, and local anesthesia is used to ease the discomfortassociated with this advanced chemical peel. As a side effectarrhythmia and tachycardia may occur so the author givesas a premedication beta blockers routinelyA deep chemicalpeel with Phenol usually needs two sessions to complete.After the patient is sedated, the chemical solution is appliedto the skin. After the phenol solution has been on the skinfor the appropriate amount of time, a white color appears(freezing) and the face is covered with occlusive tapes toavoid air contact. After 12-18 hours the second smeltedskin is removed (scrubbed) with a gauze. The acne scarswill be derma braded separately following a secondapplication of the phenol. A special powder applied whichremains for the following 8 days. The patient remains in aclinic ward for two nights.Conclusions: Exoderm (Phenol) peels are the ones thatpresent the most surprising and dramatic results, but with alarger degree of difficulty in the procedure and in the Post-Peeling. However, it is important that as a facial plasticsurgeon before applying this treatment you must be awareof the side effects and their management. In Europe, PhenolPeel (Exoderm) is also called the Chemical Face Transplantation.

(29) Spreader Flaps Without Dorsal HumpReduction are Equivalent to Spreader Flaps inFunctional RhinoplastyP. Daniel Ward, MD; Cristian Gonzalez, MD; and NikhilLimaye, MDCore Competencies: Practice-based Learning andImprovement, Medical Knowledge, Patient Care, Evidence-based Health CareLevel of Evidence: Level III - Retrospective comparativestudy, case-control study or systematic review of these

Learning Objectives: To better understand the spreaderflaps and learn when they can be successfully utilized infunctional rhinoplastyStudy Objective: To determine if spreader flaps withoutdorsal hump reduction are equivalent to spreader grafts inimproving nasal obstruction.Design: Retrospective case-control series.Method: NOSE scores were obtained on 20 sequentialpatients who underwent spreader FLAP reconstruction ofthe nasal valve (experimental group) as part of acomprehensive treatment for nasal obstruction withconcomitant septoplasty and turbinate sub mucousresection. NOSE scores were obtained on 20 sequentialpatients who underwent spreader GRAFT reconstruction ofthe nasal valve (experimental group) as part of acomprehensive treatment for nasal obstruction withconcomitant septoplasty and turbinate sub mucousresection. None of the patients in either group had dorsalhump reductions performed. Statistical analysis wasperformed comparing the means of the pre-op NOSE scores,the post-op NOSE scores, the NOSE score improvement, andthe percentage improvement in NOSE score.Conclusions: Spreader flaps--even in the absence of dorsalhump reduction--are equivalent to spreader grafts in thetreatment of nasal stenosis as part of a comprehensivesurgical approach to nasal obstruction.

(30) Single Staged Transverse Upper Gracilis Flapwith Skin Resurfacing for Facial ReanimationDemetri Arnaoutakis, MDStudy Objective: There is an abundance of literaturesupporting the use of a standard gracilis myocutaenous flapfor facial reanimation. Our objective is to describe the firstreport of using the transverse upper gracilis (TUG flap) forfacial reanimation and resurfacing as a single staged procedure.Design: A 53 year old male was referred to our practice forevaluation of facial nerve paralysis secondary to priorparotid cancer resection.Method: After the ablative portion of the procedure wascomplete, we identified appropriate vessels for micro-vascular free tissue transfer. A 9 cm wide by 15 cm tallcutaneous flap was centered over a mark at approximately10 cm distal to the posterior inferior ischium. The circum-flex femoral artery, 2 venae communicantes, the motornerve as well as the full length of the gracilis muscle withoverlying skin were harvested for transfer. Total harvesttime for the gracilis muscle was 32 minutes. Flap ischemiatime was 1 hour and 57 minutes.Conclusion: Single-stage transfers for facial reanimationhave documented fewer complications and reducedrecovery time with decreased rehabilitation. We present thefirst report of using a novel technique, the TUG flap, forfacial reanimation and resurfacing as a single staged procedure.


50

(San Antonio A)Thursday, October 1, 20158:00am-9:00am Morning Perk9:00am-9:15am Welcome and Introduction

Debbie Carlisle9:15am-9:30am Introduce OFPSA Member of the Year

Stephen S. Park, MD and Care CreditRepresentative

9:30am-10:00am The Power of Public Relations: UsingMedia To Grow Your PracticeMelissa Kelz, Kelz PR


10:30am-11:30am Subliminally Exposed: Shocking Truthsabout Hidden Desires in Mating, Datingand Communicating--Use CautiouslySteven Dayan, MD

11:30am-12:30pm PANEL: Growing Your AestheticsPractice by Educating Your PatientsElaine Gregory, Aesthetician


1:30pm-3:30pm A Day in the Life of Sam Lam, MDand his Staff

6:00pm-7:00pm AAFPRS Welcome Reception(Grand Hall)

Friday, October 2, 20158:00am-8:30am Morning Perk8:30am-8:45am Review Day’s Schedule

Debbie Carlisle8:45am-9:30am Patients and Relationships

Jon Mendelsohn, MD9:30am-10:00am PANEL: What are the Best and Worst

Aspects of Academics and PrivatePracticeSam P. Most, MD


10:30am-11:00am 2015 Internet Marketing Action PlanDavid Phillips, NKP Medical Marketing,Inc.

11:00am-11:30am Pearls and Pitfalls of InjectableTreatmentsNena Clark-Christoff, RN, Nurse,Injector

11:30am-12:30pm Round Tables: OFPSA Officers andMembers


1:30pm-5:30pm Join the AAFPRS BusinessManagement/Marketing WorkshopEdwin F. Williams, MD

Saturday, October 3, 20158:00am-8:30am Morning Perk8:30am-8:45am Review Day’s Schedule

Debbie Carlisle8:45am-9:30am PANEL: FACE TO FACE Program

How Can Your Doctor Get Involved?Charlie Finn, MD

9:30am-10:00am Patient CommunicationRon Hartley, SolutionReach

10:00am-10:30am Post Op/RecoveryDenise Hightower, RN


11:00am-12:30pm Calming the Chaos of InformationOverloadKaren Zupko & Associates, Inc.


1:30pm-4:30pm Strategic Planning for your OfficeBarbara Sifford, Allergan

organization of facial plastic surgery assistants (ofpsa) program“Let's Put Our Best Face Forward: Building Solid Relationships with our Patients”

The OFPSA “Member of the Year Award” will bepresented at this meeting during the AAFPRS BusinessMeeting.

The AAFPRS Foundation wishes to thank CareCreditfor their non-educational grant in support of the OFPSAMember of the Year Award.

The AAFPRS Foundation wishes to thank Allergan andGalderma for their non-educational grant in support ofthe OFPSA Program.

51

speakers and disclosuresManoj T. Abraham, MD, New York Medical College,Valhalla, New York and Icahn School of Medicine at Mt.Sinai, New York, New York*

Peter A. Adamson, MD, FRCSC, Professor and Head,Division of Facial Plastic and Reconstructive Surgery,Department of Otolaryngology-Head and Neck Surgery,University of Toronto, Ontario, Canada (Consultant:Allergan Canada)

Tracy Ahmad, MD+

Mohammed Hamood Al-Saeedi, MD, Head of PlasticSurgical Department at K.U.Hospital-Sanaa, Yemen (Headof Department: KUH)

Chrisfouad R. Alabiad, MD, University of Miami, Miami,FL*

Donald J. Annino, Jr., MD, DMD, Harvard Medical School,Boston, MA*

Sarah Arron, MD, PhD, University of California SanFrancisco, San Francisco, CA (Consultant: Leo Pharma,Portola Pharmaceuticals; Investigator: Roche/Genentech,Allergan, Anacor, Kythera, Lilly)

Jamil Asaria, MD, University of Toronto, Toronto, Ontario(Consultant, Speakers Bureau: Allergan Inc., Galderma Inc.,Merz Pharma, Ltd.)

Heather D. Rogers, MD, Assistant Professor ofDermatology, University of Washington School ofMedicine, Seattle, WA*

Mohammad Atari, University of Tehran, Tehran, Iran*

Babak Azizzadeh, MD, Assistant Clinical Professor, UCLA,Beverly Hills, CA (Other: Royalty: Elsevier; Stock Purchase:Myoscience, Revance; Editorial Advisory Board: Medscape)

Sameer Ali Bafaqeeh, MD, Professor, Senior UniversityConsultant in Facial Plastic & Rhinology, King SaudUniversity, Riyadh, Kingdom of Saudi Arabia*

Shan R. Baker, MD, Professor, University of MichiganHospitals and Health Centers, Ann Arbor, MI*

Henry P. Barham, MD, Assistant Professor, Louisiana StateUniversity Health Sciences Center, New Orleans, LA*

Daniella Candia Barra, MD, Hospital IPO, Paraná FederalUniversity, Curitiba, Paraná, Brazil*

Jose E. Barrera, MD,Uniformed Services University,Bethesda, MD*

Benjamin Bassichis, MD, Dallas, TX (Research Support,Consultant, Speakers Bureau: Allergan, Valeant; Consultant:Viora)

Rami Batniji, MD, Newport Beach, CA (Speakers Bureau:Allergan; Consultant: Bien Air Surgery, Invuity)

Ferdinand F. Becker, MD, Vero Beach, FL*

Frederick Beddingfield, MD, UCLA, Los Angeles, CA(Stock Purchase, Employee: Kythera)

Cézar Berger, MD, Hospital IPO, Paraná FederalUniversity, Curitiba, Paraná, Brazil*

Alexander Berghaus, MD, Professor, Direktor, Klinic fürHals-Nasen-Ohrenheilkunde; Head, Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Ludwig-Maximilian University, Munich, Germany (Consultant:KARL STORZ Germany, Spiggle & Theis Germany)

Amit D. Bhrany, MD, Assistant Professor, University ofWashington, Seattle, WA*

William J. Binder, MD, Assistant Clinical Professor,Department of Head & Neck Surgery, UCLA, Los Angeles,Beverly Hills, CA (Consultant, Stock Purchase: ImplantechAssociates, Inc.)

John B. Bitner, MD, PhD, Layton, UT*

M. B. Bizrah, FRCS, Consultant, Facial Plastic Surgeon,The Bizrah Clinic, Jeddah, KSA*

Jason D. Bloom, MD, Ardmore, PA (Consultant, SpeakersBureau, Other-Trainer: Allergan Medical, KytheraBiopharmaceuticals; Consultant, Speakers Bureau, Other-Trainer & Advisory Boards: Merz Aesthetics, Galderma;Speakers Bureau, Other-Trainer: ThermiAesthetics;Speakers Bureau: Solta Medical Inc., Zeltiq Aesthetics Inc;Consultant: Pharmaceutical Project Solutions Inc)

Kofi D. Boahene, MD, Associate Professor, Division ofFacial Plastic and Reconstructive Surgery, Department ofOtolaryngology-Head and Neck Surgery, Johns HopkinsInstitute of Medicine, Baltimore, MD*

James P. Bonaparte, MD, FRCSC, MSc, University ofOttawa, Ottawa, Canada (Educational Grant: AllerganCanada)

Fredric S. Brandt, MD, Coral Gables, FL*

*Nothing to disclose +Had not disclosed prior to print

52

speakers and disclosuresGregory Branham, MD, Professor and Chief, Facial PlasticSurgery, Washington University School of Medicine, St.Louis, MO*

Joseph Brennan, MD, COL, USAF, Chief of Surgery, SanAntonio Military Medical Center, San Antonio, TX*

Tara E. Brennan, MD, Assistant Professor of Surgery,University of New Mexico, Albuquerque, NM*

Michael J. Brenner, MD, Associate Professor ofOtolaryngology - Head & Neck Surgery, University ofMichigan, Ann Arbor, MI*

Anthony E. Brissett, MD, Associate Professor, Director ofFacial Plastic Surgery, Baylor College of Medicine,Houston, TX (Speakers Bureau: Paradigm Services)

Robert Brobst, MD, Plano, TX*

Ryan Brown, MD, Kaiser Permanente Colorado, Denver,CO*

Edward D. Buckingham, MD, Director, Buckingham Centerfor Facial Plastic Surgery,PA, Austin, TX*

Michael Byrd, ByrdAdatto

Patrick J. Byrne, MD, Johns Hopkins School of Medicine,Baltimore, MD*

Andrew Campbell, MD, Mequon, WI (Speakers Bureau:Allergan, Sciton, BTL Aesthetics)

Diogo Oliveira E Carmo, MD, Nova Medical School,Lisbon, Portugal*

Paul J. Carniol MD, Director Facial Plastic Surgery andClinical Professor, Rutgers New Jersey Medical School,Summit, NJ (Investor: Carniol Investments)

Jeffrey Castrillon, Medical Student, Western University ofHealth Sciences, Pomona, CA*

Tse-Ming Chang, MD, National Defense Medical Center,Kaohsiung, Taiwan*

Donn R. Chatham, MD, Louisville, KY*

Tony Yu-Hsun Chiu, MD, MMS, National TaiwanUniversity, Taipei City, Taiwan*

Ji Yun Choi, MD, PhD, Chosun University College ofMedicine, Gwang Ju, South Korea*

Raj Chopra, MD, Beverly Hills, CA (Consultant, SpeakersBureau, Stock Purchase: Allergan; Consultant, SpeakersBureau: Galderma)

J. Madison Clark, MD, Burlington, NC+

Roxana Cobo, MD, Cali, Colombia*

C. Spencer Cochran, MD, Clinical Assistant Professor,Dept. of Otolaryngology-Head & Neck Surgery - Universityof Texas Southwestern Medical Center at Dallas, Dallas,TX*

Jody Comstock, MD, Skin Spectrum, PC, Tucson, AZ(Consultant, Speakers Bureau: Allergan; Consultant:Colorscience, Galderma, Lumenis, SkinCeuticals,Thermagen, Valeant; Consultant, Conducting KybellaStudy: Kythera)

Minas Constantinides, MD, Attending Physician, New YorkHead & Neck Institute, New York, NY*

Daniel R. Cox, MD, University of Utah School of Medicine,Salt Lake City, UT*

Craig N. Czyz, DO, Ohio University, Columbus, OH*

Richard E. Davis, MD, Clinical Professor of Facial PlasticSurgery, The University of Miami, Miller School ofMedicine, Miramar, FL*

Terry A. Day, MD, Medical University of South Carolina,Charleston, SC*

Steven H. Dayan, MD, Clinical Assistant Professor,University of Illinois, Chicago, IL (Research Support,Consultant, Speakers Bureau: Allergan, Galderma, Valeant,Merz, Kythera)

Louis M. DeJoseph, MD, Clinical Instructor, EmoryUniversity, Atlanta, GA (Consultant, Speakers Bureau:Merz, Galderma)

Shaun C. Desai, MD, Assistant Professor, Facial Plastic andReconstructive Surgery, Johns Hopkins University,Baltimore, MD*

Javier Dibildox, MD, Universidad Autónoma de San LuisPotosí, México, San Luis potosí, S.L.P., México*

Vasu Divi, MD, Stanford University, Stanford, CA*

David A. F. Ellis, MD, FRCSC, University of Toronto,Toronto, Ontario, Canada (Research Support, Consultant:Allergan Canada)

Jeffrey S. Epstein, MD, University of Miami, Miami, FL*

Sabrina Fabi, MD, Volunteer Assistant Clinical Professor,University of California San Diego, San Diego, CA(Consultant: Valeant; Consultant, Speakers Bureau:Galderma, Allergan, Merz; Speakers Bureau: CoolSculpting,Lumenis)

53

Edward H. Farrior, MD, Associate Clinical ProfessorDepartment of Otolaryngology, University of South Florida,Tampa, FL*

Fred G. Fedok, MD, Professor, Section of Facial PlasticSurgery, Division of Otolaryngology-Head and NeckSurgery, Pennsylvania State University, Hershey, PA;Adjunct Professor Department of Surgery, University ofSouth Alabama, Mobile, AL (Speakers Bureau: AO NorthAmerica, Cynosure)

Mario Ferraz, MD, Campinas, São Paulo, Brazil*

J. Charlie Finn, MD, Assistant Consulting Professor ofSurgery, Duke University, Chapel Hill, NC (Consultant,Speakers Bureau: Allergan; Research Support, StockPurchase: Kythera; Speakers Bureau: Valeant)

Jill Foster, MD, The Ohio State University, Columbus, OH*

M. Sean Freeman, MD, Director, Center for Facial Plastic& Laser Surgery, Charlotte, NC*

Oren Friedman MD, University of Pennsylvania,Philadelphia, PA*

John Frodel, MD, Geisinger Medical Center, Danville, PA*

Nabil Fuleihan, MD, American University of Beirut, Beirut,Lebanon*

Curtis Gaball, MD, CDR, MC, USN, Chairman Dept. ofOtolaryngology, Naval Medical Center San Diego &Uniform Services University of Health Sciences, San Diego,CA*

Holger G. Gassner, MD, University of Regensburg,Regensburg, Germany (Grant, Research Support: DFG,FPSE; Book Contract: Thieme, PMPC)

Richard D. Gentile, MD, MBA, Facial Plastic & AestheticLaser Center, Youngstown, OH (Grant, Research Support,Speakers Bureau, Stock Purchase: Thermi Aesthetics;Research Support: Venus Concept; Research Support,Speakers Bureau: Cynosure, Inc., Syneron Candela)

Deniz Gerecci, MD, Oregon Health & Science University,Portland, OR*

David A. Gilpin, MD, Nashville, TN*

Gergory G. Gion, MMS, CCA, Madison, WI (Owner:Medical Art Prosthetics, LLC)

Mark Glasgold, MD, Assistant Professor of Surgery,Rutgers University, New Brunswick, NJ*

Neil A. Gordon, MD, Yale University, Wilton, CT*

Ryan Greene, MD, PhD, Weston, FL (Consultant, SpeakersBureau, Trainer: Allergan; Consultant, Trainer: Galderma;Consultant, Speakers Bureau: Syneron, Candela, Ulthera)

Roy C. Grekin, MD, Professor of Dermatology, Director ofDermatologic Surgery and Laser Unit, University ofCalifornia, San Francisco, CA*

Todd M. Gross, PhD, Vice President, ClinicalDevelopment, Biostatistics and Data Mgt., KytheraBiopharmaceuticals, Inc., Westlake Village, CA (StockPurchase, Employee: Kythera)

James C. Grotting, MD, Clinical Professor of PlasticSurgery at University of Alabama at Birmingham,Birmingham, AL (Founder: Aesthetic Surgeons FinancialGroup-CosmetAssure; Shareholder: Ideal Implant, KellerFunnel; Royalties: Quality Medical Publishing, ElsevierPublishing)

Lisa D. Grunebaum, MD, Associate Professor of FacialPlastic and Reconstructive Surgery and Dermatology,University of Miami, Miami, FL (Material, Consultant:Merz; Material, Consultant, Stock Purchase: Allergan;Material: Galderma)

Tessa Hadlock, MD, Harvard University, Boston, MA*

Grant S. Hamilton, III, MD, Chair, Division of Facial Plasticand Reconstructive Surgery, Mayo Clinic, Rochester, MN(Consultant: Spirox; Grant: AAFPRS)

Mark M. Hamilton, MD, Clinical Assistant Professor,Indiana University School of Medicine, Indianapolis, IN(Speakers Bureau: Allergan)

Richard Harvey, MD, PhD, Professor, University of NewSouth Wales and Macqaurie University, Sydney, NSW,Australia (Consultant: Medtronic, Olympus, Neilmed; Grant:Stallergenes)

Jill L. Hessler, MD, Adjunct Clinical Faculty, StanfordUniversity, Palo Alto, CA (Consultant, Trainer: Allergan,Galderma)

Peter A. Hilger, MD, Professor, University of Minnesota,Edina, MN*

Jon Hoffenberg, SEOversight

J. David Holcomb, MD, Sarasota, FL*

G. Richard Holt, MD, MSE, MPH, MABE, DBE,University of Texas Health Science Center at San Antonio,San Antonio, TX*


speakers and disclosures

54

Clinton Humphrey, Assistant Professor, Facial Plastic andReconstructive Surgery, University of Kansas MedicalCenter, Kansas City, KS*

Lisa Ishii, MD, MHS, Johns Hopkins School of Medicine,Baltimore, MD*

Andrew Jacono, MD, Albert Einstein College of Medicine,New York, NY*

Yong Ju Jang, MD, Professor, University of Ulsan Collegeof Medicine, Seoul, Republic of Korea (South)*

Andrea Jarchow, MD, University of North Carolina, ChapelHill, NC*

Emmanuel Jáuregui, BA, University of California at SanFrancisco, San Francisco, CA*

Hong Ryul Jin, MD, PhD, Seoul National University, Seoul,Republic of Korea (South)*

Kristin A. Jones, MD, Lexington, KY*

John H. Joseph, MD, Assistant Clinical Professor, UCLA,Beverly Hills, CA (Research Support, Consultant, SpeakersBureau, Stock Purchase: Suneva; Research Support,Consultant, Speakers Bureau: Galderma; Research Support,Stock Purchase: Kythera, Evolus/Alpheon, Teoxane/Alpheon; Research Support: Ulthera, Rxi, Fibrocell,Neothetics)

Sheldon S. Kabaker, MD, Clinical Professor, University ofCalifornia San Francisco, Dept. of OHNS, San Francisco,CA*

Dorina Kallogjeri, MD, MPH, Washington University in St.Louis, St. Louis, MO (Consultant, Stock Purchase:PotentiaSystems)

Kian Karimi, MD, Los Angeles, CA (Consultant:CosmoFrance, Inc)

Matthew Keller, MD, LCDR USN, Naval Medical CenterSan Diego, San Diego, CA*

Robert M. Kellman, MD, Professor and Chair, SUNYUpstate Medical University, Syracuse, New York*

David W. Kim, MD, University of California San FranciscoSchool of Medicine, San Francisco, CA*

Haena Kim, MD, Walnut Creek, CA*

Michael M. Kim, MD, Assistant Professor, Oregon Health& Science University, Portland, OR*

P. Daniel Knott, MD, Associate Professor, Director ofFacial Plastic Surgery, University of California SanFrancisco, San Francisco, CA*

Amit Kochhar, MD, Johns Hopkins School of Medicine,Baltimore, MD*

Heloisa Koerner, MD, Hospital IPO, Paraná FederalUniversity, Curitiba, Paraná, Brazil*

Theda C. Kontis, MD, Assistant Professor, Johns HopkinsHospital, Baltimore, MD (Speakers Bureau: Galderma,Allergan; Stock Purchase: Kythera)

Milos Kovacevic, MD, University of Hamburg, Hamburg,Germany*

J. David Kriet, MD, Professor and Director, Division ofFacial Plastic Surgery, Department of Otolaryngology,University of Kansas Medical Center, Kansas City, KS*

Gorana Kuka, MD, Belgrade University Hospital, MedicalSchool of Belgrade, Belgrade, Serbia*

Keith A. LaFerriere, MD, Clinical Professor, University ofMissouri, Dept. of Oto-HNS, Springfield, MO*

Samuel M. Lam, MD, Dallas, TX*

Phillip R. Langsdon, MD, Professor and Chief, Division ofFacial Plastic Surgery, University of Tennessee HealthScience Center, Memphis, TN*

Wayne F. Larrabee, Jr., MD, Seattle, WA*

Wendy W. Lee, MD, Associate Professor of ClinicalOphthalmology, Bascom Palmer Eye Institute, University ofMiami Miller School of Medicine, Miami, FL (Consultant,Educational Grant: Allergan Medical; Consultant: MerzAesthetics, Elizabeth Arden, Ophthalmology Web;Educational Grant: Bausch & Lomb/Storz, Galderma)

Ryan Lehri, Red Spot Interactive

Jessyka G. Lighthall, MD, Assistant Professor, Facial Plastic& Reconstructive Surgery, Division of Otolaryngology-Headand Neck Surgery, Penn State Hershey Medical Center,Hershey, PA*

Paul F. Lizzul, MD, PhD, MPH, MBA, FAAD, WestlakeVillage, CA (Stock Purchase, Employee: Kythera)

Scott Lovald, PhD, Exponent, Inc., Menlo Park, CA(Consultant, Employee, Shareholder: Exponent, Inc.)

Myriam Loyo, MD, Baltimore, MD*

Sofia Lyford-Pike, MD, University of Minnesota School ofMedicine, Minneapolis, MN*


55

Corey S. Maas, MD, San Francisco, CA (Research Support,Speakers Bureau, Stock Purchase: Allergan; Consultant:Valeant; Research Support, Speakers Bureau: Merz;Research Support: Alpheon; Grant, Consultant: Galderma;Consultant, Speakers Bureau: Lumenis; Research Support,Consultant, Speaker

Benjamin C. Marcus, MD, Director of Facial PlasticSurgery, University of Wisconsin, Madison, WI*

Guy G. Massry, MD, Clinical Professor of Ophthalmology,University of Southern California, Los Angeles, CA(Consultant: Elsevier, Springer)

Umang Mehta, MD, Atherton, CA*

Noah Meltzer, MD, McClean, VA*

Dirk Jan Menger, MD, PhD, University Medical CenterUtrecht (UMCU), Utrecht, The Netherlands*

Alireza Mesbahi, MD, FPS, Ordibehesht Hospital; ShirazUniversity of Medical Sciences, Shiraz, Fars, Iran*

Philip J. Miller, MD, Assistant Professor, New YorkUniversity School of Medicine, New York, NY (SpeakersBureau: Allergan)

Kris S. Moe, MD, Professor and Chief, Division of FacialPlastic Surgery, University of Washington, Seattle, WA(Founder, Board of Directors: SPI Surgical, LLC)

Ali Mokhtarzadeh, MD, University of Minnesota,Minneapolis, MN*

Cassiano Moreti, MD, Hospital IPO, Paraná FederalUniversity, Curitiba, Paraná, Brazil*

Sam P. Most, MD, Division Chief, Facial Plastic &Reconstructive Surgery, Stanford University School ofMedicine, Stanford, CA (Consultant, Stock Purchase: Aerin,Inc.)

Craig S. Murakami, MD, Associate Clinical Professor,University of Washington, Department of Otolaryngology,Seattle, WA*

Suzan Murray, DVM, DACZM, Smithsonian Institution,Washington, DC*

Mohsen Naraghi, MD, Division of Facial PlasticReconstructive Surgery, Tehran University of MedicalSciences, Tehran, Iran*

Paul S. Nassif, MD, Assoc. Clinical Professor, University ofSouthern California, School of Medicine, Beverly Hills,CA*

Antonio Nassif Filho, MD, PUC, Titular Professor of ENT,Pontificia Universidade Catlics do, Curitiba-Parana, Brazil*

L. Mike Nayak, MD, St. Louis, MO*

Steven L. Neal, MD, Oregon Health Science Center (CAP),Peydileton, Boston*

Isaac M. Neuhaus, MD, Associate Professor ofDermatology, UCSF, San Francisco, CA*

Travis Newberry, MD, Assistant Professor, USUHS, SanAntonio Military Medical Center, San Antonio, TX*

Teresa O, MD, Northshore LIJ Health System, New York*

Angela O'Mara, The Professional Image

Pietro Palma, MD, Department ORL/HNS, University ofInsubria, Varese, Milano, Italy*

Ira D. Papel, MD, The Johns Hopkins University,Baltimore, MD*

Sang Hoon Park, MD*

Stephen S. Park, MD, University of VirginiaOtolaryngology-Head and Neck Surgery, Charlottesville,VA*

Sunny Park, MD, MPH, Sunny Park Facial Plastic Surgery,Newport Beach, CA*

Norman J. Pastorek, MD, Clinical Professor, Facial PlasticSurgery, New York Presbyterian Hospital, Cornell WeillMedical Center, New York, NY*

Krishna Patel, MD, PhD, Medical University of SouthCarolina, Charleston, SC*

Jose A. Patrocinio, MD, PhD, Chairman ENT, FederalUniversity of Uberlandia, Uberlandia, MG, Brasil*

Benjamin Paul, MD, New York, New York*

Santdeep Paun, MD, London, England+

Jon-Paul Pepper, MD, Keck School of Medicine, Universityof Southern California, Los Angeles, CA*

Stephen W. Perkins, MD, President, Meridian PlasticSurgery Center, Indianapolis, IN; Clinical AssociateProfessor, Department of Otolaryngology-Head and NeckSurgery, Indiana University School of Medicine,Indianapolis, IN*

David Phillips, NKP Medical



56

Jay F. Piccirillo, MD, Washington University in St. Louis,School of Medicine, St. Louis, MO*

Jess Prischmann, MD, Prischmann Facial Plastic Surgery,Edina, MN (Consultant: Galderma)

Alex Rabinovich, DDS, MD, San Francisco, CA*

Giles Raine, The Professional Image

Srinivasa Rao-Merugumala, BSc, MD, FRCS, DLO, QueenMary University of London, London, UK*

Michael J. Reilly, MD, Georgetown University MedicalCenter, Washington, DC*

Gregory Renner, MD, Professor Emeritus ofOtolaryngology, Head and Neck Surgery, University ofMissouri-Columbia, Columbia, MO+

Peter C. Revenaugh, MD, Rush University Medical Center,Chicago, IL*

John S. Rhee, MD, MPH, Professor & Chairman, MedicalCollege of Wisconsin, Milwaukee, WI*

Joshua D. Rosenberg, MD, Icahn School of Medicine atMount Sinai, New York, NY (Research Support: DermaSciences)

Daniel E. Rousso, MD, Director-Rousso Facial PlasticSurgery Clinic; Assistant Professor of Surgery, University ofAlabama at Birmingham, Birmingham, AL (Consultant:Kythera)

Joseph J. Rousso, MD, Director, Cleft Lip, Palate andCraniofacial Service, The New York Eye and Ear Infirmaryof Mount Sinai, New York, NY*

Rahul Seth, MD, University of California San Francisco,San Francisco, CA*

Scott Shadfar, MD, Indiana University School of Medicine,Indianapolis, IN*

Nimi L. Shemirani, MD, Beverly Hills, CA*

Taha Z. Shipchandler, MD, Associate Professor, ResidencyProgram Director, Indiana University School of Medicine,Indianapolis, IN*

William W. Shockley, MD, University of North Carolina,Chapel Hill, NC*

William E. Silver, MD, Clinical Professor, Department ofOtolaryngology, Emory University, Atlanta, GA*

Robert L. Simons, MD, Clinical Professor, Voluntary,University of Miami, Miami, FL*

Karen L. Sloat, AAFPRS Senior Project Consultant,Northwood University, Midland, MI*

Karson Smith, TouchMD

Ryan M. Smith, MD, Rush University Medical Center,Chicago, IL*

Caio Soares, MD, Hospital IPO, Paraná Federal University,Curitiba, Paraná, Brazil*

Ifeolumipo Sofola, MD, The Woodlands, TX*

Wayne M. Sotile, PhD, Founder-Center for PhysicianResiliance, Davidson, NC (Speakers Bureau: AbbviePharmaceuticals; Author: AMA Press)

Emily Spataro, MD, Washington University, St. Louis,MO*

John A. Standefer, Jr., MD, Dallas, TX*

Jacob D. Steiger, MD, Boca Raton, FL (Consultant:Galderma, Merz)

E. Bradley Strong, MD, University of California, Davis,Medical Center, Sacramento, CA*

Angela Sturm, MD, Volunteer Faculty, University of Texasat Houston, Health Science Center, Houston, TX*

Joyce Sunila, Practice Helpers

Josh Surowitz, MD, Cary, NC*

Gary L. Sussman, Professor, Fellow, NSS, New York, NY*

Jason Swerdloff, MD, Tampa, FL*

Jonathan M. Sykes, MD, Professor and Director FacialPlastic and Reconstructive Surgery, University of California,UC Davis Medical Center, Sacramento, CA (Consultant:Allergan, Galderma; Consultant, Research Support:Kythera)

Monica Tadros, MD, Assistant Professor Otolaryngology,Columbia University Medical Center, New York, NY+

Neelima Tummala, MD, University of California SanFrancisco, San Francisco, CA*

Kristina Tansavatdi, MD, Westlake Village, CA*

Sherard A. Tatum, MD, Professor of Otolaryngology andPediatrics, State University of New York, Syracuse, NY*

J. Regan Thomas, MD, Mansueto Professor, University ofIllinios, Chicago, IL*


57

Travis T. Tollefson, MD, MPH, Associate Professor,University of California, Davis, Department ofOtolaryngology-Head & Neck Surgery, Sacramento, CA*

Dean M. Toriumi, MD, Professor, University of Illinois atChicago, Chicago, IL*

Justin Tuschman, Red Spot Interactive

Thomas L. Tzikas, MD, Delray Beach, FL (Investor:Alphaeon Corp.)

Jill S. Waibel, MD, Asst. Professor, Miller School ofMedicine, University of Miami (Voluntary), Miami, FL(Consultant: Valeant Pharmaceuticals; Research Support,Clinical Trials: Alma, Cutera, Loreal/SkinCeuticals,Syneron/Candela, Lumenis, Lutronic, Sebacia; SpeakersBureau: Loreal/SkinCeuticals, Sciton/Harvest; Equipment:Vivosight; Co-Inventor of Intellectual Property: Universityof Miami)

Milton Waner, MD, Northshore LIJ Health System, NewYork*

Tom D. Wang, MD, Professor, Facial Plastic andReconstructive Surgery, Oregon Health & ScienceUniversity, Portland, OR*

P. Daniel Ward, MD, MS, University of Utah Healthcare,Salt Lake City, UT*

Heather H. Waters, MD, Ear, Nose and Throat Associatesof New York, Brooklyn, NY (Consultant: Galderma)

Mark Wax, MD, Professor, OHSU, Portland, OR*

Ivan Wayne, MD, Assistant Professor, University ofOklahoma Health Sciences Center, Oklahoma City, OK*

Steven Weiner, MD, Santa Rosa Beach, FL (Material,Consultant, Speakers Bureau: Lutronic, Galderma, Suneva,Allergan)

Sara Tullis Wester, MD, Assistant Professor of ClinicalOphthalmology, University of Miami, Miami, FL*

W. Matthew White, MD, NYU Langone University, NewYork, NY (Consultant: Ulthera)

Edwin F. Williams, III, MD, Albany Medical College,Albany, NY (Research Support: Galderma; Stock Purchase:Actavis, Allergan; Consultant: Kythera)

Andrew A. Winkler, MD, Associate Professor, University ofColorado, Denver, CO*

speakers and disclosuresTae-Bin Won, MD, PhD, Seoul National UniversityHospital, Seoul, Korea*

Brian J.F. Wong, MD, PhD, Professor and Vice Chairman,Director, Division of Facial Plastic Surgery, University ofCalifornia Irvine, Irvine, CA (Equity: Praxis BioSciencesInc.; Grant: Lockheed-Martin Corp., OCT Medical Imaging,Inc., Flight Attendant Medical Research Institute, NationalInstitutes of Health; Consultant: Reshape LifeSciences LLC)

Eduardo C. Yap, MD, Belo Medical Group, Manila,Philippines*

Philip Young, MD, Aesthetic Facial Plastic Surgery,Bellevue, WA*

Siegrid Yu, MD, Associate Professor, Department ofDermatology, University of California, San Francisco, CA*

AAFPRS Fall 2015 Leadership

AAFPRS Foundation Board

Minas Constantinides, MD, Attending Physician, New YorkHead & Neck Institute, New York, NY*

Richard E. Davis, MD, Clinical Professor of Facial PlasticSurgery, The University of Miami, Miller School ofMedicine, Miramar, FL*

Edward H. Farrior, MD, Associate Clinical ProfessorDepartment of Otolaryngology, University of South Florida,Tampa, FL*

Fred G. Fedok, MD, Professor, Section of Facial PlasticSurgery, Division of Otolaryngology-Head and NeckSurgery, Pennsylvania State University, Hershey, PA;Adjunct Professor Department of Surgery, University ofSouth Alabama, Mobile, AL (Speakers Bureau: AO NorthAmerica, Cynosure)



Craig S. Murakami, MD, Associate Clinical Professor,University of Washington, Department of Otolaryngology,Seattle, WA*


58

Stephen S. Park, MD, University of VirginiaOtolaryngology-Head and Neck Surgery, Charlottesville,VA*

Wm. Russell Ries, MD, Vanderbilt University, Nashville,TN*

William H. Truswell, MD, Private Practice, Northampton,MA and Charleston, SC; Clinical Instructor, The Universityof Connecticut School of Medicine, Division ofOtolaryngology, Department of Surgery, Farmington, CT*

Edwin F. Williams, III, MD, Albany Medical College,Albany, NY (Research Support: Galderma; Stock Purchase:Actavis, Allergan; Consultant: Kythera)

CME Committee

Marcelo B. Antunes, MD, Austin, TX*

Babak Azizzadeh, MD, Assistant Clinical Professor, UCLA,Beverly Hills, CA (Other: Royalty: Elsevier; Stock Purchase:Myoscience, Revance; Editorial Advisory Board: Medscape)

Sumit Bapna, MD, Columbus, OH (Other: Medicis)

Rami Batniji, MD, Newport Beach, CA (Speakers Bureau:Allergan; Consultant: Bien Air Surgery, Invuity)

Daniel G. Becker, MD, Clinical Professor, Department ofOtolaryngology, University of Pennsylvania, Philadelphia,PA*

Michael J. Brenner, MD, Associate Professor ofOtolaryngology - Head & Neck Surgery, University ofMichigan, Ann Arbor, MI*

J. Jared Christophel, MD, MPH, University of VirginiaOtolaryngology-Head and Neck Surgery, Charlottesville,VA*

Artemus J. Cox III, MD, Associate Professor of Surgery,University of Alabama at Birmingham, Birmingham, AL*

Harley S. Dresner, MD, University of Minnesota,Minneapolis, MN*

Lindsay S. Eisler, MD, Associate Professor, GeisingerMedical Center, Danville, PA*

Oren Friedman MD, University of Pennsylvania,Philadelphia, PA*

Mark M. Hamilton, MD, Clinical Assistant Professor,Indiana University School of Medicine, Indianapolis, IN(Speakers Bureau: Allergan)

Douglas K. Henstrom, MD, Assistant Professor, Universityof Iowa, Iowa City, IA*

G. Richard Holt, MD, MSE, MPH, MABE, DBE,University of Texas Health Science Center at San Antonio,San Antonio, TX*

Clinton Humphrey, Assistant Professor, Facial Plastic andReconstructive Surgery, University of Kansas MedicalCenter, Kansas City, KS*

Lamont R. Jones, MD, Henry Ford Health System, Detroit,MI (Speakers Bureau: AO CMF)

J. Randall Jordan, MD, Professor, University of MississippiMedical Center, Jackson, MS*

Michael M. Kim, MD, Assistant Professor, Oregon Health& Science University, Portland, OR*


Samuel M. Lam, MD, Dallas, TX*

Phillip R. Langsdon, MD, Professor and Chief, Division ofFacial Plastic Surgery, University of Tennessee HealthScience Center, Memphis, TN*

Thomas T. Le, MD, Ellicott City, MD*

David M. Lieberman, MD, Lieberman & Parikh FacialPlastic Surgery, Palo Alto, CA (Speakers Bureau:Ultherapy)

James C. Marotta, MD, Clinical Assistant Professor ofSurgery, Stony Brook University, Stony Brook, NY*

Vishad Nabili, MD, Associate Professor, Department ofHead and Neck Surgery, David Geffen School of Medicineat UCLA, Los Angeles, CA*

Jeffrey D. Rawnsley, MD, MS, Clinical AssociateProfessor, UCLA, Westwood, CA (Consultant: Stryker)

Anthony P. Sclafani, MD, Director of Facial Plastic Surgery,NY Eye and Ear Infirmary of Mt. Sinai, New York, NY;Professor of Otolaryngology, ICAHN School of Medicine atMt. Sinai, New York, NY (Consultant: Aesthetic Factors,Inc.)

Christian L. Stallworth, MD, Assistant Professor, Universityof Texas Health Science Center at San Antonio, SanAntonio, TX*Scott Stephan, MD, Assistant Professor OtolaryngologyHead Neck Surgery, Vanderbilt University Medical Center,Nashville, TN*


59

speakers and disclosuresSherard A. Tatum, MD, Professor of Otolaryngology andPediatrics, State University of New York, Syracuse, NY*

Adam M. Terella, MD, Assistant Professor, University ofColorado School of Medicine, Aurora, CO*

Seth A. Yellin, MD, Founder and Director, Marietta FacialPlastic Surgery, Laser & Aesthetics Center, Marietta, GA(Consultant, Research Grant, Speakers Bureau: Allergan;Consultant: Galderma)

Kenneth C.Y. Yu, MD, Chief, Division Facial Plastic &Reconstructive Surgery, San Antonio Uniformed ServicesHealth Education Consortium, San Antonio, TX*

Evidence-Based Medicine Committee

Patrick J. Byrne, MD, Johns Hopkins School of Medicine,Baltimore, MD*

Harley S. Dresner, MD, University of Minnesota,Minneapolis, MN*

Peter A. Hilger, MD, Professor, University of Minnesota,Edina, MN*

Lisa Ishii, MD, MHS, Johns Hopkins School of Medicine,Baltimore, MD*

Hedyeh Javidnia, MD, FRCS(C), University of Ottawa,Ottawa, Ontario, Canada*


Paul Leong, MD, Pittsburgh, PA*

Robin Lindsay, MD, Harvard University, Boston, MA*


David Reiter, MD, MBA, FACS, Professor ofOtolaryngology (Division of Facial Plastic Surgery),Jefferson Medical College of Thomas Jefferson University,Philadelphia, PA*

Peter C. Revenaugh, MD, Rush University Medical Center,Chicago, IL*

John S. Rhee, MD, MPH, Professor & Chairman, MedicalCollege of Wisconsin, Milwaukee, WI*

Jonathan M. Sykes, MD, Professor and Director FacialPlastic and Reconstructive Surgery, University of California,UC Davis Medical Center, Sacramento, CA (Consultant:Allergan, Galderma; Consultant, Research Support:Kythera)

Harry V. Wright, MD, Sarasota, FL*


Pioneer Plaza commemorates Dallas’ beginnings bycelebrating the trails that brought settlers to Dallas.Pioneer Plaza is a large public park located in theConvention Center District of downtown Dallas, Texas(USA). It contains a large sculpture and is a heavilyvisited tourist site. The large sculpture commemoratesnineteenth century cattle drives that took place along theShawnee Trail, the earliest and easternmost route bywhich Texas longhorn cattle were taken to northernrailheads. The trail passed through Austin, Waco, andDallas until the Chisolm Trail siphoned off most of thetraffic in 1867.[4] The 49 bronze steers and 3 trail riderssculptures were created by artist Robert Summers ofGlen Rose, Texas. Each steer is larger-than-life at six feethigh; all together the sculpture is the largest bronzemonument of its kind in the world.[5] Set along anartificial ridge and past a man-made limestone cliff, nativelandscaping with a flowing stream and waterfall helpcreate the dramatic effect.

60

exhibitorsAAFPRS Membership and Video Learning CenterBooth 415310 South Henry StreetAlexandria, VA 22314703-299-9291703-299-9291, faxwww.aafprs.orgMake sure you come by the AAFPRS Booth to peruse ourpublications and learn more about our programs. Here, youwill also find the Video Learning Center featuring the JohnDickinson Library with over 300 videos. You have theopportunity to watch videos before your purchase. On-sitediscount on all publications and videos is 10 percent. Non-members are encouraged to come by and learn more aboutthe AAFPRS (a gift will be waiting for you).

AAAHCBooth 6185250 Old Orchard Rd., Ste. 200Skokie, IL 60077847-853-6060847-853-8707, faxwww.aaahc.orgAAAHC advocates for high quality health care throughnationally-recognized Standards and a uniquely educationaland collaborative system of on-site review. The AAFPRSsits on our Board as a member organization and, as such,contributes to the development of our programs.Accreditation criteria reflect best practices and relevant toyour practice setting.

AllerganBooth 716-7182525 Dupont DriveIrvine, CA 92623714-246-4500www.allergan.comAllergan's Total Rejuvenation™ portfolio is where scienceand aesthetics meet. The portfolio provides medicalspecialists and their patients with the most comprehensive,science-based aesthetic product offerings available

Alphaeon CorporationBooth 30318191 Von Kaman Ave., Ste. 500Irvine, CA 92612949-284-4555www.alphaeon.comALPHAEON Corporation is a social commerce companywith the goal of transforming self-pay healthcare by bringingto market highly innovative products and services topromote consumer wellness, beauty and performance. Thecompany works in partnership with board certifiedphysicians ensuring access to leading advancements inlifestyle healthcare. For more information, please visitwww.alphaeon.com.

American Society for Aesthetic Plastic SurgeryBooth 32011262 Monarch StreetGarden Grove, CA 92841800-364-2147562-799-2356512-799-1098, faxwww.surgery.orgThe American Society for Aesthetic Plastic Surgery offers awide array of products and services designed specifically tohelp its members build and grow their practice. Discovernew membership options, learn about The AestheticMeeting 2015 in Montreal, Canada, May 14-19, and explorethe Aesthetic Surgery Journal through the RADARResource app. For more information, please visitwww.surgery.org or our patient education websitewww.smartbeautyguide.com

Anthony Products/Gio PelleBooth 515 - 5217740 Records StreetIndianapolis, IN 46226800-428-1610317-543-3289, faxwww.anthonyproducts.comFor 47 years, Anthony Products has specialized in thedistribution of ENT, Plastic Surgery and Dermatologyinstruments and equipment. Gio Pelle, specializes incustomized skincare and microdermabrasion. Gio Pelleoffers personalized gel packs for post procedure recovery.Private label opportunities are available.

ASSI - Accurate SurgicalBooth 619300 Shames DriveWestbury, NY 11590800-645-3569516-997-4948, faxwww.acuratesurgical.comASSI® will be displaying a range of plastic surgeryinstrumentation including the New ISSA Dorsal NasalRasps, Trepsat Facial Dissecting Scissors, FaceLiftRetractors, Ear Lobe Clamp, FaceLift SuperCut Scissors,Endo Forehead instrumentation, Lalonde Skin HookForceps, Zins FaceLift Marker, D'Assumpcao FaceLiftMarking Forceps, Bipolar Scissors and Noble™ True Non-Stick Bipolar Forceps.

61

exhibitorsBellus MedicalBooth 81912001 N. Central Expressway, Ste 250Dallas, TX 75243888-372-3982Bellus Medical aesthetic device company providingcompelling, differentiated products to enhance the patientexperience and represent a significant business opportunityfor partners. Our flagship product SkinPen, a microneedlingdevice, provides dynamic results and significant revenueopportunities for practices, particularly when combined withSkinfuse, our post-microneedling protocol to enhance safetyand results.

Biologica TechnologiesBooth 7072800 Roosevelt StreetCarlsbad, CA 92008800-677-6610858-810-0318, faxwww.biologicatechnologies.comBiologica Technologies is fully dedicated to improvingpatients' lives and the health care providers' experience throughinnovative biologic solutions. Our first aesthetic productAllofill is an adipose-basedfiller containing naturally occurr-ing growth factors. Allofill can be used to fill soft-tissuedefects as a noninvasive alternative to autologous fat grafting.

Black and Black Surgical, Inc.Booth 604-606462 Cascade DriveLilburn, GA 30047770-414-4880770-414-4879, faxwww.blackandblacksurgical.comBlack and Black offers the highest quality instruments forplastic surgery including Black Diamond™ nasal rasps,Liposuction and fat harvesting instruments and equipment,Tebbetts™ rhinoplasty instruments, Guyuron cartilagepunch and Aston facelift scissors. Introducing our NEWDuraEdge™osteotomes, LumiView™ molded plasticfiberoptic lighted retractors and our high output portableLED headlight.

Candace Crowe DesignBooth 2163452 Lake Lynda DriveOrland, FL 32817877-384-7676407-384-7672, faxwww.candacecrowe.comCandace Crowe Design takes the guesswork out ofmarketing for aesthetic practices. Our innovative solutionsenable providers to grow their practice by attracting,engaging and educating patients. With cutting-edge,evidence-based marketing practices, we provide measurableresults to our clients and position them for success withincreased conversion rates and ROI.

Canfield Imaging SystemsBooth 506253 Passaic AvenueFairfield, NJ 07004-2524973-276-0336800-815-4330973-276-0339, [email protected] Imaging Systems is the leading worldwidedeveloper of imaging software and photographic systems forthe medical and skin care industries. Product lines includeMirror® imaging software, VISIA® Complexion Analysis,VECTRA® 3D Systems, Reveal® facial imagers, VEOS™dermatoscopes, customized photographic studio solutionsand specialized imaging devices for clinical photography.

CareCreditBooth 6072995 Red Hill Ave., Ste. 100Costa Mesa, CA 92626714-434-4532www.carecredit.comCareCredit (Booth 607), a part of Synchrony Bank, is ahealth and beauty credit card offering special financingoptions. From injectables, peels & laser treatments tosurgery, we help you help patients achieve their dreams. It'salso ideal for co-pays and deductibles. For moreinformation, call 866-247-3049 or visit carecredit.com.

Cosmofrance, Inc.Booth 3071444 Biscayne ., Ste. 218Miami, FL 33132305-538-0110305-675-2642, faxwww.dermaconcepts.comCosmoFrance Inc., established in 1997, specializes in thedistribution of noninvasive medical aesthetic devices. OurDermaSculpt blunt-tipped microcannulas are revolutionizingdermal fillers injections. Other devices include CosmopenMicroneedling and disposable PRP kits.

CRC Press - Taylor & Francis GroupBooth 6146000 Broken Sound Pkwy., NW, Ste. 300Boca Raton, FL 33487561-998-2507561-998-2559, faxwww.crcpress.comCRC Press - Taylor & Francis Group is a global publisherof print and electronic books for medical, scientific andtechnical communities. Visit our booth to browse our newand bestselling publications in plastic and reconstructivesurgery and take advantage of convention discounts.Register for email alerts at www.crcpress.com.

62

exhibitorsCynosureBooth 7045 Carlisie RoadWestford, MA 01886800-886-2966www.cynosure.comCynosure leads the world in aesthetic laser technologies andresearch, creating innovative, safe, and efficaciousprocedures for the treatments patients want most, includinghair removal, treatment of vascular and pigmented lesions,skin revitalization, tattoo removal, laser lipolysis to removeunwanted fat, and the reduction in the appearance ofcellulite.

DePuy SynthesBooth 7031302 Wrights LaneWest Chester, PA 19380610-715-6873610-719-6533, faxwww.depuysynthes.comDePuy Synthes is a global leader in medical devices,offering a comprehensive portfolio of implant systems forsurgeons to treat patients who have sustained conditionsaffecting the face, head, neck and thorax. DePuy Synthesis part of the Companies of Johnson & Johnson.

Dermaconcepts/Eviron Skin CareBooth 405-407168 Industrial Drive, Bldg. 1Mashpee, MA 02649508-539-8900www.dermaconcepts.comEnviron® Skin Care products, backed by science,incorporate the latest technology in enhancement of highgrade vitamins A, C, E, antioxidants and peptides to helprestore, protect and maintain the appearance of a healthy,youthful and beautiful skin. Assist in undoing the look ofdamage and achieving your skin care goals with the world'smost effective products and treatments.

Eclipse AestheticsBooth 32213988 Diplomat Drive, Ste. 160Dallas, TX 75234972-380-2911972-380-2953, faxwww.eclipesaesthetics.comEclipse Aesthetics, LLC is known for providing superiorsolutions to the aesthetic U.S.-based medical communityand is rapidly becoming a leader in the internationalaesthetic markets. The company offers a portfolio of qualityproducts including the: Eclipse MicroPen TR™, EclipseMicroPen Elite™, MicroGlide GF™, SkinfinityRF™,Eclipse PRP™ and ScarMD™, among others.

Galderma Laboratories, L.PBooth 321-32314501 N. FreewayFort Worth,TX 76177817-961-5041www.galdermausa.comGalderma is committed to delivering innovative medicalsolutions to meet the dermatological needs of peoplethroughout their lifetime while serving healthcareprofessionals around the world. www.galdermausa.com

Hanson Medical, Inc.Booth 40215960 Ohio Ave., Ste. 200Kingston, WA 98346360-297-1997360-297-1998, faxwww.hansonmedical.comHanson Medical offers Sterile Silicone Facial Implants,Silicone Body Contouring Implants, Scarfade Silicone ScarGel, Compression Garments and a complete line ofprofessional skincare.

Harvest TechnologiesBooth 21710811 W. Collins Ave.Lakewood, CO 80215303-231-4691www.harvesttech.com

Implantech Associates, Inc.Booth 4206025 Nicole StreetVentura, CA 93003800-733-0833805-339-9414, faxwww.implantech.comImplantech is the recognized leader in manufacturinginnovative facial implants for aesthetic and reconstructivesurgery. We offer more than 150 sizes and shapes insilicone, Conform™ style, ePTFE Composite® facialimplants and ePTFE sheeting. Choose custom implants forthe perfect fit! Also available: body contouring implants(gluteal, pectoral and calf), Cimeosil® scar managementproducts and GelZone® compression with scar healing.High quality products offered by Implantech for SuperiorPatient Aesthetics!

63

exhibitorsIncredible MarketingBooth 620310 Goodard, Ste. 200Irvine, CA 92618800-949-0133www.incrediblemarketing.comWe're web scientists with attitude! Online marketingexperts, to be exact...We took the medical world by storm 6years ago, serving up the world's best medical SEO (SearchEngine Optimization), Social Media Marketing (SMM),Content Marketing, Mobile Websites, & Custom Web Design.

Infinite TherapeuticsBooth 90668 Rt. 125Kingston, NH 03848603-347-6006603-642-9291, faxwww.infinitymassagechairs.com

Interni Healthcare USA, Inc.155 Northfield AvenueEdison, NJ 08837848-219-2666732-346-9448, faxwww.interniusa.comOur company Interni Healthcare USA, Inc., was establishedin 1993, and specializing in healthcare products. Wedistribute fully motorized tables for use in procedures andother related products as armboards and stir-ups and alsomicrodermabrasion machines.

Jan Marini Skin Research, Inc.Booth 6155883 Rue FerrariSan Jose, CA 95138408-620-3600408-362-0140, faxwww.janmarini.comJan Marini Skin Research is a recognized leader in providingmedically based topical skin care solutions to physicians andskin care professionals.

KLS MartinBooth 502P.O. Box 16369Jacksonville, FL 37245904-641-7746904-641-7378, faxwww.klsmartinnorthamerica.comKLS Martin is a company dedicated to providing innovativemedical devices and power systems for craniomaxillofacialsurgery. The company's rich history began with surgicalinstrument production in Tuttlingen, Germany in 1896 andcontinued with miniplate production in 1975. KLS Martinhas advanced the capabilities of distraction osteogenesis,and revolutionized resorbable fixation with the SonicWeldRx system.

Kythera BiophamaceutcalsBooth 31730930 Russell Ranch Road3rd FloorWestlake Village, CA 91362858-922-4712www.kythera.comKYTHERA Biopharmaceuticals, Inc. is focused on thediscovery, development and commercialization of innovativedrugs and medical devices for the aesthetic medicinemarket. The company's lead product KYBELLA™(deoxycholic acid) injection is the first and only FDA-approved submental contouring injectable drug.KYBELLA™ is a non-surgical option for treating adultswith moderate to severe sub mental fullness.

LumenisBooth 719-7212033 Gateway PlaceSan Jose, CA 90110408-764-3824408-765-3695. faxwww.lumenis.comLumenis®, the world's largest medical laser company, is aglobal developer, manufacturer and distributor of laser andenergy based medical devices. With 225 registered patents,numerous FDA clearances, an installed base of over 80,000systems and a presence in over 100 countries, Lumenis

LutronicBooth 605850 Auburn CourtFreemont, CA 94538408-373-9064408-912-1991, faxwww.lutronic.comLutronic, a leading innovator in advanced aesthetic andmedical laser and related technology, was established in1997 to bring intuitive, robust, versatile devices that areaffordable and efficacious to the worldwide medicalcommunity. Committed to improving medicine, Lutronicpartners with key opinion leads to advance science andensure the efficacy of its systems. All systems are versatileand offer multiple settings and treatment options forcustomized treatments, which optimize outcomes for a widevariety of conditions and treatments including melasma,tattoo removal, soft tissue incision, vascular lesions, hairremoval, wrinkle reduction, rejuvenation, body/facecontouring, chronic pain, healing and more.

64

exhibitorsMarina Medical InstrumentsBooth 603955 Shotgun RoadSunrise, FL 33326800-697-1119800-748-2089, faxwww.marinamedical.comMarina Medical Instruments designs, manufactures, anddistributes medical devices for the plastic, aesthetic,reconstructive, and regenerative medicine fields of surgery.Our innovative product line consists of aesthetic surgeryinstrumentation and our premium lipoplasty products, whichinclude Koume cannulas and lipoplasty accessories. Sehabla espanol.

Medical Art Prosthetics, LLCBooth 7207818 Big Sky Drive, Suite 111Madison, WI 53719(608)833-7002(608)833-7090, faxSince 1985 Medical Art Prosthetics, LLC has developed aninternational reputation for providing superior aestheticfacial prostheses by certified clinical anaplastologists AllisonVest and Gregory Gion. With main clinics in Dallas, Texasand Madison, Wisconsin, the growing practice includessatellite locations in Los Angeles, San Francisco, Chicago,Newark, Rochester and New York City.

Medtronic Surgical TechnologiesBooth 2066743 Southpoint Drive northJacksonville, FL 32216904-279-2629904-281-2771, faxwww.medtronicentcomMedtronic ENT is a leading developer, manufacturer andmarketer of surgical products for use by ENT specialists.Medtronic ENT markets over 5,000 surgical productsworldwide addressing the major ENT subspecialties - Sinus,Rhinology, Laryngology, Otology, Pediatric ENT. and ImageGuided Surgery.

Merz North AmericaBooth 5046501 Six Forks RoadRaleigh, NC 27615919-582-8070919-615-4851, faxwww.merzusa.comMerz North America is a specialty healthcare company thatdevelops and commercializes innovative, high-qualitytreatment solutions in aesthetics, dermatology andneurosciences in the U.S. and Canada. As part of the MerzPharma Group of companies, our ambition is to become themost admired, trusted and innovative aesthetics and

neurotoxin company. By developing products that improvepatients' health and help them to live better, feel better andlook better, we will continue to make significantcontributions to the well-being of individuals around theworld. Founded in 1908, Merz Pharma Group is a privately-owned company headquartered in Frankfurt, Germany. Formore information about Merz and the Company's U.S.product portfolio, please visit www.merzusa.com.

MicroAire Surgical InstrumentsBooth 6023590 Grand Forks Blvd.Charlottesville, VA 22911434-975-8000434-975-4144, faxwww.microaire.comMicroAire Aesthetics, a world leader in aesthetic plasticsurgery, produces the PAL® LipoSculptor™ (power-assisted lipoplasty); Endotine® bioabsorbable multi-pointfixation devices for cosmetic facial procedures; andLipoFilter™ high-volume fat filtration and harvestingsystems. MicroAire Aesthetics also makes EpiCut(epithelium tissue removal), and SurgiWire™ (subcutaneousdissection). For more information, please visitmicroaire.com.

Microsurgery Instruments, Inc.Booth 414P.O. Box 1378Bellaire, TX 77402713-664-4707713-664-8873, [email protected] Instruments is one of the leading suppliers ofsurgical instruments and loupes. Our instruments include:titanium scissors, needle holders, and debakey forceps. OurSuper-Cut scissors are the sharpest in the market, and ournewly designed surgical loupes offer up to 130mm field ofview, and up to 11x magnification.

MTFBooth 81610811 West Collins Ave.Lakewood, 80215303-231-4691www.mtf.comThe Musculoskeletal Transplant Foundation was foundedby surgeons in 1987 with the goal of providing safe, high-quality tissue while advancing the science of tissuetransplantation. Since then, MTF has recovered tissue frommore than 100,000 donors and distributed more than 6million grafts for transplantation.

65

NeoGraftBooth 403419 Southfork Dr., Ste. 103Lewisville, TX 75057972-219-5600760-943-1653, faxwww.neograft.comNeoGraft is the first and only FDA cleared follicular unitharvesting and implantation system. The NewGraft systemdelivers automation of the FUE technique, the mostadvanced technique in the hair transplant industry. Thisrevolutionary automated hair transplantation system is theonly complete harvesting system on the market. Thesystem has the only "NO TOUCH" implantation technology.NeoGraft is a minimally invasive procedure that providesnatural looking results with no scalpel incision, no sutures,no staples, and no unsightly linear scar allowing for a quickrecovery time.

NewBeauty MagazineBooth 8153651 NW 8th AvenueBoca Raton, FL 33431646-805-0223646-805-0242, faxwww.sandowmedia.comNewBeauty has established itself as a leading powerhousebeauty brand, educating and empowering women in theirbeauty decisions through diverse, multi-channel platforms.Committed to providing scientifically accurate and ethicallybalanced information about the latest advances in facialplastic surgery, NewBeauty features prominent board-certified facial plastic surgeons from across the UnitedStates and beyond.

NextechBooth 2075550 W. Executive Dr., Ste.Tampa, FL 33609813-425-9260www.nextech.comNextech deploys specialty-focused healthcare technology forPlastic Surgeons. A trusted advisor to thousands of specialtyproviders since 1997, Nextech delivers consultativeguidance, professional services and innovative tools thatenable clients to increase efficiencies while meeting long-term business goals. Learn how Nextech's advancedofferings help specialty providers succeed atwww.nextech.com.

NKP Medical MarketingBooth 5078939 S. Sepulveda Blvd., #320Los Angeles, CA 90045866-539-2201800-207-8023, faxwww.nkpmedical.comNKP Medical Marketing will handle all aspects of yourinternet marketing. We work with hundreds of clientsworldwide. We are experts in SEO, Custom WebsiteDesign, Responsive and Adaptive Websites, Pay Per Click,Patient Conversion and much more. Stop by our booth anddominate your market!

PCA SkinBooth 503-5056710 Camelback RoadSte. 230Scottsdale, AZ 85251480-281-5349480-946-5699, faxwww.pcaskin.comCommitted to advancing professional skincare expertisethrough robust clinical education and the scientificdevelopment of quality products, PCA SKIN has been atrusted innovator for over 25 years. From professionaltreatments to daily care, we are dedicated to formulatingwith the optimal combination of ingredients that targetindividual skin types, concerns and overall skin health forsuperior results. Through partnering with physicians andclinicians, we improve people's live by providing healthy,beautiful skin.

Plastic Surgery StudiosBooth 8178667 Haven AvenueRancho Cucamonga, CA 91730909-758-8300909-758-8384, faxwww.plasticsurgerystudios.comSince 1998, Plastic Surgery Studios has been makingInternet marketing easier for plastic and reconstructivesurgeons. We develop your distinct, customized onlinepresence to attract new clients to your practice. Wespecialize in dynamic website design/redesign, contentgeneration, social media (Facebook, Twitter, Google+, andPintrest), marketing campaigns, and video production.

exhibitors

66

Poriferous, LLCBooth 109535 Pine Road, Ste. 206Newnan, GA 30263770-683-3855770-683-7459, faxwww.poriferous.comPoriferous LLC distinguishes itself from other medicaldevice companies in their extensive ownership of technologyand in-house services in the design and manufacture ofporous polyethylene implants for reconstructive andaesthetic procedures. The Poriferous team has a combined80+ years of experience and expertise specific to porouspolyethylene medical devices.

Prosper Healthcare LendingBooth 717380 Data Drive, Ste. 100Salt Lak City, UT 84020801-335-9972www.prosperhealthcare.com

PMT Corporation/PermarkBooth 7051500 Park RoadChanhassen, MN 55317952-470-0866952-470-0865, faxwww.pmtcorp.comPMT® Corporation is proud to offer Integra™ andAccuSpan® low profile breast and extremitytissue expanders. PMT also manufactures Permarkmicropigmentation equipment, pigments andsupplies, New Beginnings™ GelShapes™, a surgeryspecific treatment for scars, A.F.TCannulas, MicroMat™ microsurgical background, and theJaw Bra™, facial compressiongarment.

Quantificare, Inc.Booth 9141670 S. Amphlett Blvd., Ste. 250San Mateo, CA 94402510-868-0737510-225-3700, faxwww.quantificare.com

ReachLocalBooth 62121700 Oxnard StreetSuite 1000214-294-0169Woodland Hills, CA 91367www.reachlocal.comAs a global Google Premier SMB Partner, ReachLocal helpsphysicians get more patients online with a total digitalmarketing system. ReachLocal's technology, insights andservice combine to help you get the most return from your

digital marketing. Our solutions include: responsive websitesand lead conversion software, search engine advertising andSEO, display and retargeting, mobile in app advertising, webpresence and content marketing, and live website chat.

Red Spot InteractiveBooth 8201001 Jupiter Park DriveJupiter, FL 33458561-320-0211www.redspotinteractive.comSince 2011, Red Spot Interactive has developed andimplemented an integrated marketing and customeracquisition platform for small business advertisers tooptimize and maximize ROI from their online and offlinemarketing channels. RSI's platform is designed for smallbusiness advertisers to generate, track, and optimize salesand ROI, not just leads.

Rohrer Aesthetics, LLCBooth 404-406105 Citation CourtHomewood, AL 35209205-940-2200205-942-9905, faxFounded by the former owner of Sandstone Medical,Rohrer Aesthetics provides cosmetic devices atAFFORDABLE prices. Our flagship product is theSpectrum. The Spectrum is the only multi-platform systemthat includes 4-lasers, an IPL and is priced under $50,000.Procedures include: the removal of vascular & pigmentedlesions, tattoos, unwanted body hair & skin resurfacing.

Rose Micro SolutionsBooth 7144105 Seneca StreetWest Seneca, NY 14224716-608-0009716-608-0006www.rosemicrosolutions.comRose Micro Solutions sells High Quality Optical Loupes &LED Lights for Less! Our loupes start @ $279.00. We are a"Family" Business consisting of 4 Brothers.We named thecompany after our mother "ROSE".Visit us online @www.rosemicrosolutions.com 716-608-0009.

ScitonBooth 717925 Commercial StreetPalo Alto, CA 94303650-493-9155www.sciton.comSciton is a leading manufacturer and provider of superiorlaser and light based aesthetic solutions. When the needs ofyour practice expand, you can upgrade your existing systemwith new and innovative modules allowing you to offermore treatment options. Come learn about Halo, theworld's first and only hybrid fractional laser.

exhibitors

67

SmartGraft by Vision Medical, Inc.Booth 30546 Regency PlazaGlen Mills, PA 19342610-680-7676www.SmartGraft.comAt SmartGraft, we not only provide you with a superiortechnology for minimally invasive hair restoration, but wealso help you grow your practice and increase yourrevenues. Flexible payment plans available plus marketingtools and programs to effectively promote, market andadvertise your hair restoration service offerings.

SolutionreachBooth 7152912 Executive Pkwy., Ste. 300Lehi, UT 84043801-331-7114,faxwww.solutionreach.comSolutionreach is a cloud-based, patient engagement platformthat offers solutions to healthcare providers for increasingoffice efficiency, managing online reputation and marketingthrough social media.

Sono BelloBooth 6168900 E. Pinnacle Peak Road, Ste. E200Scottsdale, AZ 85255480-385-9523480-223-1279, faxSono Bello is a national aesthetic practice with 22 AAAHCaccredited locations across the United States. We recentlyadded awake facial rejuvenation procedures and are seekingexperienced surgeons for both FT and PT affiliations.Make a great living working just 3-1/2 days per week withno practice management concerns.www.sonobello.com

Sontec Instruments, Inc.Booth 8147248 S. Tucson WayCentennial, CO 80211303-790-9411303-792-2626, faxwww.sontecinstruments.comSontec offers a comprehensive selection of exceptional handheld surgical instruments, headlights and loupes available tothe discriminating surgeon. There is no substitute forquality, expertise and individualized service. Sontec's vastarray awaits your consideration at our booth.

Suneva MedicalBooth 8065383 Hollister Ave., Ste. 100Santa Barbara, CA 93111805-845-0026www.sunevamedical.comSuneva Medical, Inc. is a privately-held aesthetics companyfocused on developing, manufacturing and commercializingnovel, differentiated products for the general dermatologyand aesthetic markets. The company currently marketsBellafill® in the U.S. and Canada; ArteFill® in Korea andSingapore; Regenica® in the U.S. and Canada; andReFissa® in the U.S. For more information, visitwww.sunevamedical.com.

SurgisilBooth 4186020 W. Plano Pkwy.Plano, TX 75093888-551-5477888-543-5477, faxwww.surgisil.comSurgiSil is a medical device company specializing in thedesign, development, and commercialization of silicone-based products for plastic, cosmetic and reconstructivesurgery.We are proud to introduce our flagship products - thePerma Facial Implant™ and PermaLip™.

Syneron CandelaBooth 706530 Boston Post RoadWayland, MA 01778866-259-6661www.syneron-candela.comSyneron Candela is the global leader in the aesthetic medicaldevice marketplace. We combine a level of expertise andcustomer understanding superior to that of any company inour industry, offering customers the broadest availableproduct portfolio, the best global service organization, andan expansive worldwide distribution network.

ThermiBooth 416401 N. Carrol AvenueSouthlake, TX 76092866-981-5017817-796-1430, faxwww.thermi.comThermi is a leading manufacturer of TemperatureControlled Radio Frequency technology. The company'sflagship product is ThermiRF, a platform technology whichuses temperature as an endpoint for various minimally andnon-invasive aesthetic applications.

exhibitors

68

Tulip Medical ProductsBooth 6174360 Morena Blvd., Ste. 100San Diego, CA 92117858-270-5900858-270-5901, faxwww.tulipmedical.comTulip® is the leader in liposuction and fat transferinstrumentation. As innovators in liposuction cannulas,injector design and manufacturing, Tulip creates instrumentsand accessories for successful liposuction and fat transferprocedures. With our patent-pending CellFriendlyTMTechnology and our new premium GemsTM Single-Use fattransfer instruments, Tulip is your source for liposuction,fat-transfer and regenerative medicine cannulas, micro-injectors and accessories.

Valeant PharmaceuticalsBooth 807400 Somerset Corporate Blvd.Bridgewater, NJ 08807908-927-0756908-927-0944, faxwww.valeant.comValeant Pharmaceuticals North America LLC is a specialtypharmaceutical company that is committed to understandingand meeting the needs of our customers and in deliveringconsistently high performance. Valeant develops andmarkets a broad range of pharmaceutical products primarilywithin the areas of dermatology, eye health, oral health,consumer healthcare and other therapeutic areas. Moreinformation about Valeant can be found atwww.valeant.com

Wolters KluwerBooth 702318 N. Heartz RoadCoppell, TX 75019214-244-7170972-393-0611, faxwww.lww.comOn display at our Wolters Kluwer booth will be our mostrecent books and journals in Plastic Surgery, Facial PlasticSurgery, Otolaryngology, and miscellaneous topics of relatedinterest to the Facial Plastic Surgery market such asdermatology, primary care, and head & neck anatomy.

ZO Skin Health, Inc., by Zein Obagi, MDBooth 316-33185 Technology DriveIrving, CA 92618949-988-7524925-317-7279, faxwww.zoskinhealth.comFounded by Dr. Zein Obagi, ZO Skin Health, Inc. is acompany guided by a single-minded goal - to providephysicians & patients with the world's most innovative &effective skin health solutions.

exhibitorsThe AAFPRS Foundation would like to thank the

following companies for their support of this year's FallMeeting. All financial and in-kind contributions receivedin support of the AAFPRS educational programs complywith the Standards for Commercial Support as specified

by the Accreditation Council for Continuing MedicalEducation. (List as of August 27, 2015)

Educational

Non-educational

69

new and upgraded members research grants and awards recipientsCongratulations to the following AAFPRS members forreceiving the following grants and awards from theAAFPRS.

Bernstein GrantsO Bernstein Grant, $25,000, Jacqueline Greene, MD,Chicago, IL for “Facial Nerve Nano-engineering and Regen-eration”O Resident Research Grant, $5,000, Robert M. Brody, MD,Philadelphia, PA for “Optimizing Cartilage Autografts inSeptorhinoplasty”O Resident Research Grant, $5,000, Joseph Bayer Vella II,MD, Rochester, NY for “Craniofacial Reconstruction via3D Printing and Mesenchymal Stem Cells”

Research Center GrantsO Research Scholar Award, $30,000, Lamont Jones, MD,Detroit, MI for “Assessing the Role of AHNAK Methylationin Keloid Pathogenesis”O Research Scholar Award, $30,000, Jon Paul Pepper, LosAngeles, CA for “Peripheral Nerve Grafts Engineered fromMature Human Fibroblasts”O Clinical Research Scholarship, $15,000, David A. Shaye,MD, Boston, MA,attending Harvard School of Public HealthO Clinical Investigation Award, $2,500. Grant Hamilton, III,MD, Iowa City, IA for “Comparison of Electospun Scaffoldsfor In-Vitro Cartilage Growth”

John Orlando Roe Award, $1000, Sang W. Kim, MDEast Syracuse, NYfor “Determining the Volumetric Thresh-old for Perception of Artificial Appearing Lips”

Sir Harold Delf Gillies Award, $1000, Melissa Hu, MDHouston, TX for “Mesenchymal Stem Cells and the Produc-tion of Anti-inflammatory Cytokines in Post-IschemicCutaneous Flaps”

Community Service AwardCraig S. Murakami, MD, Seattle, WA

F. Mark Rafaty AwardDonn R. Chatham, MD, New Albany, IN

John Dickinson Teacher AwardDavid W. Kim, MD, San Francisco , CA

William K. Wright AwardWilliam W. Shockley, MD, Chapel Hill, NC

The Awards Committee would like to ask recent fellowshipgraduates to consider submitting your research papers forthe Ben Schuster and Ira Tresley awards, as well as encour-age medical students and resident application for the Resi-dency Travel Awards for next year's Fall Meeting.

Congratulations to the new and upgraded members (June2014-May 2015).

FellowKenneth Anderson, MDJamil Asaria, MDAmit Bhrany, MDMichael Adelard Carron, MDDaniel G. Danahey, MD, PHDKaran Dhir, MDAlexander S. Donath, MDDouglas K. Henstrom, MDTang Ho, MDBrian S. Jewett, MDEric M. Joseph, MDJi-Eon Kim, MDJacques LeBeau, MDTimothy J. Minton, MDAlicia Ruth Sanderson, MDDavid Shirfin, MD W. Grant Stevens, MDEdward Szachowicz MDKristina Zakhary, MD

InternationalKhalid Alsebeih, MDFaris Bahammam, MD Luciano Catalfamo, MDDaniel Kokong, MDAmani Obeid, MD

MemberFarhad Ardeshirpour, MDScott Alan Asher, MDBehrad Aynehchi, MDMelynda Barnes, MDMichael M. Bibliowicz, DORyan C. Case, MDScott Chapin, MDAndrew Michael Compton, MDNatalie Earl Jackson, MDRandall Falconer, MDJames Fernau, MDInessa Fishman, MDAlexis Furze, MDK. Kelly Gallagher, MDChad A. Glazer, MDJennifer Goodrich, MDKathryn Hall, MD Sanaz Harirchian, MDDavid Hartman, MDDavid Hohuan, MD

Roger Horioglu, MDTheresa Jarmuz, MDHedyeh Javidnia, MDSang W. Kim, MDAndrew Jason Kleinberger, MDJeannie Larson, MDJudy W. Lee, MDLinda N. Lee, MDJoy O. Obokhare, MDPeter C. Revenaugh, MDDavid Watson Rodwell, MDRahul Seth, MDTravis Laron Shaw, MDDavid A. Shaye, MDPatrick Edward Simon, MDParker Anthony Velargo, MDMichael Yerukhim, MDMaher N. Younes, MD

Non-members areencouraged to comeby the AAFPRSMembership Booth(Booth #415) tolearn more about theAAFPRS (a gift willbe waiting for you).

70

about the aafprsITS HISTORYThe American Academy of Facial Plastic and Reconstruc-tive Surgery (AAFPRS) was founded in 1964 and repre-sents more than 2,500 facial plastic and reconstructivesurgeons throughout the world. The AAFPRS is a NationalMedical Specialty Society of the American MedicalAssociation (AMA). The AAFPRS holds an official seat inthe AMA House of Delegates and on the American Collegeof Surgeons board of governors.

ITS MEMBERSThe majority of AAFPRS members and fellows arecertified by the American Board of Otolaryngology-Headand Neck Surgery, which includes examination in facialplastic and reconstructive surgery procedures, and theAmerican Board of Facial Plastic and ReconstructiveSurgery. Other AAFPRS members are surgeons certified inophthalmology, plastic surgery, and dermatology.

ABOUT THE AAFPRS FOUNDATIONIn 1974, the Educational and Research Foundation for theAmerican Academy of Facial Plastic and ReconstructiveSurgery (AAFPRS Foundation) was created to address themedical and scientific issues and challenges which confrontfacial plastic surgeons.

The AAFPRS Foundation established a proactive researchprogram and educational resources for leaders in facialplastic surgery. Through courses, workshops, and otherscientific presentations, as well as a highly respectedfellowship training program, the AAFPRS Foundation hasconsistently provided quality educational programs for thedissemination of knowledge and information among facialplastic surgeons.

In the early 1990s, FACE TO FACE humanitarian pro-grams were established so that AAFPRS members coulduse their skills and share their talent in helping the lessfortunate individuals here and abroad.• FACE TO FACE: International brings AAFPRS membersto third world countries where they treat children withfacial birth defects and anomalies.• FACE TO FACE: The National Domestic ViolenceProject allows AAFPRS members to perform surgeries onsurvivors of domestic abuse here in the United States, whohave received injuries to their faces.• The newest member to FACE TO FACE is FACES OFHONOR. This program offers free surgical care forsoldiers who have been injured in the line of duty.

AAFPRS LeadershipEXECUTIVE COMMITEEThe year indicates the expiration of term as a board member.Stephen S. Park, MD, President (2016)Edward H. Farrior, MD, Immediate Past President (2015)Edwin F. Williams, III, MD, President-elect (2017)Minas Constantinides, MD, Secretary (2017)William H. Truswell, MD, Treasurer (2016)Wm. Russell Ries, MD, Group VP for Public and Regulatory Affairs (2018)Theda C. Kontis, MD, Group VP for Membership and Society Relations (2016)Fred G. Fedok, MD, Group VP for Education (2015)*Craig S. Murakami, MD, Group VP for Research, Development, and Humanitarian Programs (2015)*Richard E. Davis, MD, Group VP for Education-elect (2019)*+Sam P. Most, MD, Group VP for Research, Awards, and Development-elect (2019)*+Stephen C. Duffy, Executive Vice President+* Ex-officio member of the Executive Committee+ Non-voting member of the Executive Committee

BOARD OF DIRECTORSThe Board also includes all those listed under the ExecutiveCommittee.Patrick J. Byrne, MD, Eastern Regional Director (2016)David W. Kim, MD, Western Regional Director (2016)Andres Gantous, MD, Canadian Regional Director (2017)John S. Rhee, MD, Midwestern Regional Director (2017)Phillip R. Langsdon, MD, Southern Regional Director (2017)Lisa E. Ishii, MD, Young Physician Representative (2018)Anthony P. Sclafani, MD, Director-at-Large (2017)

PAST PRESIDENTSEdward H. Farrior, MD 2013Robert M. Kellman, MD 2012Tom D. Wang, MD 2011Jonathan M. Sykes, MD 2010Daniel E. Rousso, MD 2009Donn R. Chatham, MD 2008Vito C. Quatela, MD 2007Peter A. Hilger, MD 2006Ira D. Papel, MD 2005Steven J. Pearlman, MD 2004Keith A. LaFerriere, MD 2003Dean M. Toriumi, MD 2002Shan R. Baker, MD 2001Russell W.H. Kridel, MD 2000Devinder S. Mangat, MD 1999Stephen W. Perkins, MD 1998G. Richard Holt, MD 1997Peter A. Adamson, MD 1996Wayne F. Larrabee, MD 1995Roger L. Crumley, MD 1994H. George Brennan, MD 1993J. Regan Thomas, MD 1992Fred J. Stucker, MD 1991Norman J. Pastorek, MD 1990Ted A. Cook, MD 1989Frank M. Kamer, MD 1988John R. Hilger, MD 1987

E. Gaylon McCollough, MD 1986Robert L. Simons, MD 1985Richard L. Goode, MD 1984Howard W. Smith, MD, DMD 1983M. Eugene Tardy, Jr., MD 1982*Charles J. Krause, MD 1981Sidney S. Feuerstein, MD 1980*Jerome A. Hilger, MD 1979*George A. Sisson, MD 1978Leslie Bernstein, MD 1977*Richard C. Webster, MD 1976*Carl N. Patterson, MD 1975*Trent W. Smith, MD 1974*G. Jan Beekhuis, MD 1973Walter E. Berman, MD 1972*Jack R. Anderson, MD 1971*William K. Wright, MD 1970*Ira Tresley, MD 1969*Morey L. Parkes, MD 1968Richard T. Farrior, MD 1967*John J. Conley, MD 1966*John T. Dickinson, MD 1965*Irving B. Goldman, MD 1964*Deceased

71

Manoj T. Abraham, MDPeter A. Adamson, MDDaniel S. Alam, MD*Roger A. Allcroft, MDAllerganBryan T. Ambro, MDMark A. Armeni, MDBabak Azizzadeh, MDShan R. Baker, MDJose E. Barrera, MD*Benjamin A. Bassichis, MD*Rami K. Batniji, MD*Mark M. Beaty, MDDaniel G. Becker, MD*William J. Binder, MD*D. Kofi O. Boahene, MDGregory H. Branham, MDEdward D. Buckingham, MDRoman P. Bukachevsky, MD*Sydney Butts, MD*Patrick J. Byrne, MD*Andrew C. Campbell, MD*Randolph B. Capone, MDCandela CorporationCandace Crowe Design*CareCreditPaul J. Carniol, MDW. Gregory Chernoff, MD*Jen Y. Chow, MD*Michael M. Churukian, MDBenjamin W. Cilento, MDPerrin C. Clark, MD*Ross A. Clevens, MDMark A. Clymer, MD*Mark. V. Connelly, MDKris Conrad, MDTed A. Cook, MD*Kent G. Davis, MD*Richard E. Davis, MDSteven H. Dayan, MDDePuy Synthes*

Are you on the 1887 Luncheon Invitation List?2014 and 2015 Members (* Current 1887 Members in 2015)

Jaimie DeRosa, MD*Timothy Doerr, MD*Alexander S. Donath, MD*Yadro Ducic, MD*J. Kevin Duplechain, MDJeffrey S. Epstein, MD*Edward H. Farrior, MD*Fred G. Fedok, MD*J. Charles Finn, MDAlbert J. Fox, MDAndrew S. Frankel, MDOren Friedman, MDJohn L. Frodel, Jr., MD*Galderma Laboratories*Julio F. Gallo, MDGlasgold Group*Paul E. Goco, MD*Theodore A. Golden, MD*Neal D. Goldman, MD*Stephen A. Goldstein, MDNeil A. Gordon, MD*Carla C. Graham, MD*H. Devon Graham, III, MDRobert F. Gray, MD*Cynthia M. Gregg, MD*Theresa A. Hadlock, MD*Grant S. Hamilton, III, MD*Mark Hamilton, MDJill Lynn Hessler, MDPeter A. Hilger, MD*John M. Hodges, MDJohn F. Hoffmann, MD*J. David Holcomb, MDCarlo P. Honrado, MD*David B. Hom, MDClinton D. Humphrey, MDLisa E. Ishii, MD*Andrew A. Jacono, MD*Calvin M. Johnson, Jr., MDJ. Randall Jordan, MDMichael C. Jungkeit, MDSheldon S. Kabaker, MDRobert M. Kellman, MD

Ms. Sarah KendallMatthew A. Kienstra, MDDavid W. Kim, MD*Theda C. Kontis, MDRussell W.H. Kridel, MDJ. David Kriet, MDSamuel M. Lam, MD*Keith A. LaFerriere, MDWayne F. Larrabee, MDDeirdre Smith Leake, MD*Samson J. Lee, MDPaul L. Leong, MDJennifer Levine, MDLumenisDevinder S. Mangat, MDBenjamin C. Marcus, MDKeith A. Marcus, MD*James C. Marotta, MDJon Mendelsohn, MD*MERZPhilip J. Miller, MD*Harry Mittelman, MD*Steven R. Mobley, MDAmir Moradi, MDMary Lynn Moran, MD*Sam P. Most, MDThomas H. Moulthrop, MDJeffrey S. Moyer, MD*Craig S. Murakami, MD*Nathan E. Nachlas, MDNCADVNKP Medical Marketing*James Newman, MDWilliam E. O'Mara, MDPCA SKIN*Ira D. Papel, MD*Stephen S. Park, MD*Krishna G. Patel, MD, PhDSteven J. Pearlman, MD*Stephen W. Perkins, MD*Harrison C. Putman, III, MD*Vito C. Quatela, MD

Amir A. Rafii, MD*Angelo D. Reppucci, MDRestorseaReVanceJohn S. Rhee, MD*Brock D. Ridenour, MD*Wm. Russell Ries, MD*Thomas Romo, III, MDDavid B. Rosenberg, MD* and Jessica M. Lattman, MD*Daniel E. Rousso, MDPaul A. Sabini, MD*Walter W. Schroeder, MD*David A. Sherris, MD*Charles W. Shih, MD*Frank Simo, MD*Robert L. Simons, MDDouglas M. Sidle, MDJ. George Smith, MDStephen P. Smith, MD*Gary M. Snyder, MD*John A. Standefer, Jr., MDHarvey D. Strecker, MD*Sarmela Sunder, MDFred J. Stucker, MDJonathan M. Sykes, MD*Sherard A. Tatum, III, MDThermiGen, Inc.Christopher J. Tolan, MD*Travis T.T. Tollefson, MDDean M. Toriumi, MD*William H. Truswell, IV, MDThomas L. Tzikas, MD*Valeant PharmaceuticalsS. Randolph Waldman, MDTom D. Wang, MD*Preston Daniel Ward, MD*Ivan Wayne, MDMark K. Wax, MD*Richard W. Westreich, MD*Edwin F. Williams, III, MD*Carlos L. Wolf, MDHaresh Yalamanchili, MD*

Cumulative cash gifts (between January 1 - December 31) which total $1,000+ automatically enrolls you as an 1887member. 1887 is the year that the first credited intranasal rhinoplasty was performed in the United States.

All current "1887" members (from 2014 and 2015) are recognized for their commitment to the AAFPRS during the1887 Luncheon. Please contact Ann H. Jenne to enroll today!

72

Howard W. Smith Legacy SocietyThe Howard W. Smith Legacy Society recognizes individuals, foundations, and corporations whose cumulative life-timegifts to the AAFPRS Foundation and the FPS Fellowship Examination Corporation total $50,000 or more. Those whoachieved this goal by the fall of 2004 were accorded the status of charter members in the society, which was founded in2002. The Howard W. Smith Legacy Society 2014 member list:

Distinguished Philanthropists ($500,000+)Dr. and Mrs. Jack R. AndersonAllerganMedicis Aesthetics (renamed to Medicis, A division of Valeant Pharmaceuticals)Howard W. Smith, MD, DMD, and Smith Family FoundationSYNTHES Maxillofacial (renamed to DePuy SYNTHES)

Patrons ($250,000 to $499,999)Leslie Bernstein, MD, DDSAndrew A. Jacono, MDBioForm Medical, Inc. (merged with Merz Aesthetics)CareCreditLifeCELLPhysician's Choice (renamed PCA Skin)Sanofi-aventis (merged with Medicis, A division of Valeant Pharmaceuticals)

Benefactors ($100,000 to $249,999)Canadian Foundation Facial Plastic SurgeryAndrew C. Campbell, MDJohn J. Conley, MDETHICON, Inc.John M. Hodges, MDValeant PharmaceuticalsKeith A. LaFerriere, MDMerz Aesthetics (BioForm Medical is now merged with Merz)Ira D. Papel, MDPCA SkinDavid B. Rosenberg, MDRobert L. Simons, MDFred J. Stucker, MDStryker LeibingerM. Eugene Tardy Jr., MD

Members ($50,000 to $99,999)Peter A. Adamson, MDT. Susan HillRussell W. H. Kridel, MDLeibingerLumenisDevinder S. Mangat, MDE. Gaylon McCollough, MDPhilip J. Miller, MDPaul S. Nassif, MDJohn W. Pate Jr., MDStephen Perkins, MDHarrison C. Putman III, MDVito C. Quatela, MDThomas Romo, MDWilliam E. Silver, MDDean M. Toriumi, MDEdwin F. Williams III, MDWilliam J. Wolfenden, Jr., MD

For more information, contact:Laurie Wirth, Executive DirectorABFPRS and FPS FEC115C South St. Asaph Street Alexandria, VA 22314phone (703) 549-3223; e-mail [email protected].

DisclaimerRegistrants for this course understand that medical and scientific knowledge is constantly evolving and that theviews and techniques of the instructors are their own and may reflect innovations and opinions not universallyshared. The views and techniques of the instructors are not necessarily those of the Academy or its Foundationbut are presented in this forum to advance scientific and medical education. Registrants waive any claim againstthe Academy or its Foundation arising out of information presented in this course. Registrants also understandthat operating rooms and health-care facilities present inherent dangers. Registrants waive any claim against theAcademy or Foundation for injury or other damage resulting in any way from course participation. This educa-tional program is not designed for certification purposes. Neither the AAFPRS nor its Foundation providescertification of proficiency for those attending.

74

capital campaign

75

capital campaign

76

capital campaign

77

Dallas is a major city in Texas andis the largest urban center of thefourth most populous metropolitanarea in the United States. The cityproper ranks ninth in the U.S. andthird in Texas after Houston andSan Antonio. The city’s prominencearose from its historical importanceas a center for the oil and cottonindustries, and its position alongnumerous railroad lines. Accordingto the 2010 United States Census,the city had a population of1,197,816. Dallas and nearby FortWorth were developed due to theconstruction of major railroad linesthrough the area allowing access tocotton, cattle, and later oil in Northand East Texas.

Enjoy sightseeing at your own pace on theonly fully narrated hop-on hop-off trolleytour in Dallas! With 16 stops and 100 pointsof interest (including highlights of the JFKTour),it’s the easiest way to explore theunique, BIG blend of modern entertainment,history and culture you’ll only find in Dallas.Learn where the city got its start, where it istoday and where it’s going.

78

API (free)

81

PCA free

84

new beauty

fall mtg 2015 onsite - american academy of facial plastic ... mtg 2015 onsite... · 5 accreditation...

Documents